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Introduction 
Bioinformatics is a discipline bridging biology and informatics, as is reflected in the 
title of this thesis Web services for Transcriptomics where the term web services 
represents the informatics and transcriptomics the biology. This introduction covers 
both and explains how the latter can benefit from the former. 
Transcriptomics
Since DNA microarray technology was introduced [1, 2] it has evolved rapidly to 
become the most popular platform for high throughput gene expression analysis. 
Microarrays allow biologists to measure the expression of entire transcriptomes 
at relatively high speed and low cost, which is ideal for applications like sample 
clustering or fingerprinting, genome annotation, detection of differential gene 
expression and detection of polymorphisms [3, 4]; hence the term transcriptomics. 
There are other techniques for high throughput gene expression experiments 
like RAGE and SAGE (Rapid / Serial Analysis of Gene Expression), but these never 
managed to get as popular as microarrays as they are less cost effective.
 A wide variety of technical differences exists between microarray platforms, 
but they all share the same principle: hybridisation of strands of nucleotides to 
form a duplex. For each gene (the target) a microarray contains one or more oligo 
nucleotides (the probes) complementary to its expressed product or to a sequence 
derived thereof. Hence, depending on array platform and type the probes either 
detect the gene’s product directly by hybridizing to mRNA or indirectly by hybridizing 
to cDNA or cRNA derived from the gene’s mRNA. The probes are attached to a 
solid support and many thousands of copies of a probe are grouped together in 
microscopic areas called spots or features. Depending on the microarray platform 
the amount of spots can vary from several thousands to more than 1 million. In a 
microarray experiment expressed sequences are labelled and allowed to hybridise 
to the probes making the amount of label at each spot an indicator for the amount 
of expression of the target.
 Since all spots are processed simultaneously, it is essential that all probes have 
optimal target specificity under the same experimental conditions. This is usually 
accomplished by keeping the predicted free energy for probe-target duplexes within 
a narrow range or by keeping the GC percentage of the probes within a narrow 
range combined with a fixed probe length. Furthermore, a probe must be unique 
for a certain target. Therefore, optimal microarray design requires 1) a completely 
sequenced reference genome for the species of interest, 2) complete annotation 
of this reference genome to know what parts may be expressed and what their 
biological function is in the cell, 3) complete knowledge about the natural variation 
amongst the sampled individuals and 4) knowledge on the experimental conditions 
that define how much oligo versus non-target alignments must differ from oligo 
versus target alignments to prevent cross-hybridisation. Although we have partial 
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information for these topics, our knowledge is not complete for any of these four 
pre-requisites. For example the human reference genome was announced to be 
“complete” (at least) twice [5-7] and although it is nearly complete it still contains 
small gaps [8, 9]. Even if it were complete, the reference genome is based on 
samples from only a limited amount of individuals, which are usually not the same 
as the ones sampled in microarray experiments. In addition, genomes are not static 
and although evolution proceeds relatively slowly, a reference genome will already 
be slightly outdated by the time its complete sequence is published.
 Nevertheless, the lack of complete a priori knowledge required for optimal 
oligo design has not stopped researchers from designing and using microarrays. 
This does make sense, because microarrays contain so many data points that they 
can be highly informative for detecting global trends even when a considerable 
amount of the probes is unreliable. For example if a pathway contains 15 genes 
and 12 of those are upregulated in a microarray experiment, that pathway is likely 
to be activated even if a quarter of the probes is unreliable on average. Drawing 
conclusions for individual genes on the other hand is more problematic without 
further evidence from follow-up experiments based on a different technology. The 
fact that microarray probes are designed based on incomplete a priori knowledge 
makes regular updating of probe annotation and target specificity essential; this is 
the central topic of chapters 2, 3 and 4 of this thesis.
Web services
Microarray analysis, or transcriptomics in general, is part of a family of related 
omics fields like genomics, proteomics, metabolomics et cetera. These all cover 
different parts of molecular biology and share the fact that they are dedicated 
to high-throughput experiments. As a result of their high-throughput nature the 
omics fields like transcriptomics produce enormous data sets at an ever-increasing 
speed. Since it is no longer feasible for biologists to analyse the results from such 
experiments by hand this has sparked a revolution in bioinformatics to develop new 
algorithms and tools for automated analysis. Due to the complexity of the biological 
systems under investigation it is usually required to combine several tools in a 
multi-step analysis. In addition, the omics fields evolve very rapidly stimulating the 
development of modular software pipelines. This allows easy recombination of new 
and existing modules enabling bioinformaticians to adapt quickly to the changing 
needs of biologists.
 To build such modular pipelines bioinformaticians can choose between two 
different strategies. With a centralised or data-warehousing strategy tools are all 
installed in a local, central system. This usually requires re-formatting of data to 
create a common standard to link modules, which means extra work for system 
administrators, as databases need to be updated regularly. In addition it requires 
more expensive hardware. The advantage of a centralised system is that modules 
can be executed faster as everything is locally available. A federated or distributed 
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strategy is the opposite of a centralised strategy and means that software and data 
are accessed remotely. This usually requires less expensive hardware and less work 
for system administrators, because databases and analysis tools are up-to-date as 
soon as the providers of the original content update them. The disadvantage of a 
distributed system is that it is not as fast as compared to a centralised system and 
that users become dependent on the remote services. So, both strategies have 
their strengths as well as their weaknesses and therefore bioinformaticians often 
use a mix of centralised and distributed systems.
 Web services represent the latest breed in technology for remote modules/
subroutines that can be used to build distributed systems. Unfortunately the term 
web services can be very confusing. It would be logical to consider every service 
offered on the World Wide Web a web service, but according to the definition 
of the World Wide Web Consortium (W3C) this is not the case: “The World Wide 
Web is more and more used for application to application communication. The 
programmatic interfaces made available are referred to as web services.” [10] 
Hence web services is reserved for programmatic interfaces and does not cover the 
vast amount of services on the web with a graphical interface that was designed for 
human interaction. There are dozens of other definitions for the term web services, 
but in this thesis I will adhere to the definition of the W3C, which is the most widely 
accepted.
 With the ability to bridge the boundaries of scripting or programming languages, 
of communication protocols on the Internet and of research institute’s firewalls, web 
services have the potential to become a bioinformatician’s superglue of choice. The 
evolution of web services is reviewed in chapter one and web service technology 
plays an important role in the tools and analysis described in the remaining chapters 
of this thesis.
 OligoRAP - the oligo re-annotation pipeline described & used in chapters 2, 3 
and 4 - is basically a large workflow completely build from web services. With the 
heterogeneity and large amount of data that needs to be processed to update the 
annotation for a typical microarray, OligoRAP explores the boundaries of what is 
possible with current web service technology. 
 Chapter 5 is a collection of short application notes describing tools that can 
aid in other aspects of microarray data analysis. MADMAX services (chapter 5b) 
are dedicated to normalisation and quality control for the Affymetrix microarray 
platform, but RShell (5a) and GeneIlluminator (5c) are not necessarily restricted 
to microarray analysis. R is a language for statistical computations and after 
the members of the Bioconductor project chose it as the foundation for their 
collaborative effort to create extensible software for computational biology 
and bioinformatics [11] it quickly became the de facto standard for analysis of 
microarrays. The Taverna workbench [12] is a workflow management system that 
gained wide community support in bioinformatics. One of the reasons Taverna 
became popular for bioinformatics workflows is that it supports all major standards 
for bioinformatics web services: “plain” WSDL-based services, BioMoby services, 
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BioMart services and Soaplab services. RShell is a plug-in that extends Taverna’s 
ability to orchestrate bioinformatics web services to the world of R. It allows 
users to execute R-scripts on (remote) R-servers and mix this with other types of 
technology for (remote) data analysis creating a highly flexible, distributed system. 
Finally, GeneIlluminator is a tool to distinguish one gene from another in case their 
symbols are ambiguously used in literature and databases, which is still a major 
problem despite efforts to standardise gene symbols. This is important for any 
biologist investigating genes and their effect on phenotypes and hence can also 
help to improve functional annotation for microarray probes.
 In contrast to OligoRAP the tools described in chapter 5 are not workflows 
made of web services, but individual services that could be used in workflows. 
Although MADMAX services, RShell and GeneIlluminator were never used together 
in a single workflow they all use web service technology in one way or another. The 
different strategies (or sometimes even “hacks”) used to make these tools and the 
components of OligoRAP available as services on the web have various benefits as 
well as disadvantages. Therefore, I will describe how these strategies relate to each 
other in the discussion and conclusions section and finally present an overview on 
the successes and failures of web service technology as used for the work described 
in this thesis.
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Abstract
Bioinformaticians have developed large collections of tools to make sense out of 
the	rapidly	growing	pool	of	molecular	biological	data.	Biological	systems	tend	to	
be complex and in order to understand it is often required to link many data sets 
and	use	more	than	one	tool.	Therefore,	bioinformaticians	have	experimented	with	
several	strategies	to	try	to	integrate	data	sets	and	tools.	Due	to	the	lack	of	standards	
for	data	sets	and	the	interfaces	of	the	tools	this	is	not	a	trivial	task.	Over	the	past	
few	years	building	services	with	web-based	interfaces	has	become	a	popular	way	
of	sharing	the	data	and	tools	that	have	resulted	from	many	bioinformatics	projects.	
In this paper we discuss the interoperability problem and how web services are 
being	used	to	try	to	solve	it,	resulting	in	the	evolution	of	tools	with	web	interfaces	
from	HTML/web	form-based	tools	not	suited	for	automatic	workflow	generation	to	
a	dynamic	network	of	XML-based	web	services	that	can	easily	be	used	to	create	
pipelines.	
The interoperability problem
Many tools have been generated over the past decade in order to deal with the 
never-ending	data	tsunami	[1]	that	is	flooding	the	hard	drives	of	molecular	biologists.	
Most	of	these	tools	are	specialised	in	one	particular	task	such	as	aligning	sequences.	
But understanding what is going on in a complex biological system usually requires 
integrating different types of data from multiple sources and hence requires multiple 
tools.	Therefore	there	is	a	clear	need	for	a	technology	that	links	both	data	and	tools	
to	create	workflows	that	can	easily	be	used	by	biologists.	Creating	such	technology	
is	not	a	trivial	task	due	to	a	lack	of	standards	for	both	data	and	inter-application	
communication	(the	interoperability	problem).
 Systems that have been designed to integrate biological data and tools can be 
divided in two groups:
		•		Systems	based	on	a	centralisation	or	data	warehousing	strategy
		•		Systems	based	on	a	federated	or	distributed	strategy
Centralisation-based	 systems	 are	 usually	 built	 using	 a	 database	 management	
system	(DBMS)	or	flat-file	 indexing	system	to	handle	the	 integration	of	the	data.	
Frequently	 used	DBMS’	 in	bioinformatics	 applications	 include	MySQL,	PostgreSQL	
and	Oracle	while	the	Sequence	Retrieval	System	(SRS)	[2,	3]	is	a	prominent	example	
of	a	data	warehouse	based	on	flat-file	 indexing.	 In	order	 to	make	these	systems	
work,	administrators	have	to	install	software	on	their	local	systems,	fetch	data	from	
remote	servers,	and	subsequently	parse	the	data	to	convert	and	import	it	into	their	
system.	
 Having all the tools and data available on a local system certainly has its 
advantages.	The	most	 important	one	 is	 speed:	 tools	can	 fetch	data	much	faster	
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from	a	local	hard	drive	than	from	a	source	on	the	internet.	Hence	for	research	that	
for example needs to annotate complete genomes using a centralised strategy is 
currently	the	only	realistic	option.	Another	benefit	of	having	tools	and	data	installed	
locally is that administrators have more control over updating processes and that 
they	can	customise	 the	 system	to	highly	 specific	needs.	The	major	drawback	of	
centralisation-based	 strategies	 is	 that	 they	 require	 a	 lot	 of	 time	 and	money	 to	
maintain,	 as	 databases	 and	 tools	 change	 frequently	 in	 response	 to	 the	 rapidly	
evolving	field.	
	 The	alternative	 is	 to	 use	 a	 system	based	on	 a	 federated	 strategy.	 In	 such	a	
system the data and/or tools are accessed using remote access to services provided 
by	the	creators	of	the	original	content.	In	this	setup,	the	client	has	to	create	its	own	
workflow	by	fetching	data	from	one	spot,	possibly	reformat	it,	send	it	to	a	service	
at	another	site,	parse	the	result,	reformat	the	result,	and	so	on.	Several	protocols	
or	standards	have	been	proposed	to	link	distributed	services	together,	but	the	most	
wide	 spread	used	 services	are	certainly	web	 services.	The	 term	web	 services	 is	
sometimes used exclusively to refer to services which are accessible using a web 
browser,	but	 in	this	 review	we	will	use	the	definition	from	the	World	Wide	Web	
Consortium	(W3C):	“The	World	Wide	Web	is	more	and	more	used	for	application	
to	 application	 communication.	 The	 programmatic	 interfaces	 made	 available	 are	
referred	to	as	web	services	[4].”	Web	servers	providing	access	to	tools	using	a	web	
browser	do	indeed	provide	a	service	too,	but	for	clarity	we	will	refer	to	such	tools	
as	HTML/web	form-based	tools.	
Grids
Several projects have tried to solve the interoperability problem by developing 
specialised	 software	 to	 create	 bioinformatics	 grids.	 In	 a	 grid	 [5]	 services	 are	
distributed	over	many	servers,	and	clients	use	specialised	software	to	discover	and	
execute	 these	 services.	 Usually	 a	 grid	 uses	 a	 software	 layer	 called	middleware	
that	uses	wrappers	around	programs	to	create	a	standard	Application	Programming	
Interface	(API)	for	communication	between	services.	Grids	are	successfully	deployed	
in	relative	small	environments	linking	services	from	several	research	groups,	but	for	
the bioinformatics community the technology still has not taken off to the scale of 
a	world	wide	web.	
	 One	of	the	first	pre-grid	solutions	for	bioinformatics	was	the	Hierarchical	Access	
System	 for	 Sequence	 Libraries	 in	 Europe	 (HASSLE)	 developed	 by	 Reinhard	Doelz	
at	 the	 University	 of	 Basel	 [6].	 It	 included	 support	 for	many	 platforms	 including	
several	UNIX	flavours,	Linux,	Windows,	Mac	OS	and	OS/2.	HASSLE	provided	many	
advanced	 features	 including	 automatic	 service	 discovery,	 redirection	 in	 case	 a	
service provider was overloaded or unreachable and both anonymous and secure 
connections	 [7].	Ahead	of	 its	 time,	 the	project	was	declared	dead	 in	1996,	and	
since	then	all	the	servers	that	once	provided	HASSLE	services	have	ceased	to	exist.	
After	HASSLE,	the	ability	to	create	grids	or	multi	agent	systems	based	on	languages	
like	Common	Object	Request	Broker	Architecture	(CORBA)	and	Java	Remote	Method	
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Invocation	(RMI)	was	explored	to	create	similar	functionality	[8-10].	But	maintaining	
the	specialised	software	required	to	support	many	platforms	for	such	grids,	the	lack	
of	user-friendly	interfaces	and	firewall	restrictions	turned	out	to	be	too	much	of	a	
hassle	for	these	projects	to	gain	wide	community	support	and	become	the	de-facto	
standard	for	integration	of	bioinformatics	services.	Several	groups	cited	problems	
with	firewalls	as	the	mean	reason	to	migrate	to	remote	services	that	tunnel	their	
communication	through	web	servers	[11,	12].
Tools with HTML-based interfaces
There	are	several	good	reasons	why	tools	with	interfaces	using	HTML-forms	have	
become	very	popular	in	the	bioinformatics	field.	Next	to	having	a	pipette	and	a	pen,	
access	to	a	web	browser	is	probably	the	most	wide-spread	tool	available	to	biologists.	
Therefore it is much more interesting for developers to write an interface for their 
program that can be accessed using a web browser than to develop and maintain 
interfaces	for	specific	computing	platforms.	Small	differences	in	the	way	web	pages	
are	rendered	or	differences	 in	supported	plug-ins	make	 interfaces	based	on	web	
browsers	not	necessarily	completely	platform	independent,	but	web	browsers	are	
currently	as	close	to	platform	independence	as	it	gets.	But	even	if	a	user	would	
install	 a	 specific	client	program	 to	access	a	 remote	 service,	biologists	 are	often	
handed	over	to	paranoid	system	administrators.	As	a	result	firewalls	sometimes	not	
only	block	unwanted	traffic,	but	also	kill	useful	 functionality.	Finally,	 the	use	of	
web	browsers	as	a	front-end	for	bioinformatics	services	makes	the	development	of	
simple	graphical	user	interfaces	relatively	easy.	Therefore,	services	with	interface	
based on web browsers do not suffer from the issues that prevented service grids 
running	on	custom,	platform-dependent	software	from	gaining	wide	support.
	 Tools	with	HTML/web	form	interfaces	do	have	a	serious	disadvantage	as	well.	
They have become very popular because they provide convenient access to a 
single	tool,	but	manually	integrating	many	of	these	tools	to	create	workflows	is	a	
cumbersome process: data fetched from one web server needs to be processed and 
often	reformatted	before	 it	can	be	submitted	to	the	next	one.	Bioinformaticians	
have	 tried	 to	 automate	 this	 process	 using	 “screen	 scraping”	 scripts	 to	 create	
pipelines,	but	HTML-based	web	interfaces	were	designed	for	access	by	humans	and	
not	by	scripts.	HTML	is	used	to	encode	how	data	should	be	displayed,	but	not	what	
kind	of	data	is	represented.	Therefore,	the	scripts	easily	break	when	the	HTML	web	
interface	is	updated	to	improve	the	user-friendliness	or	to	implement	new	features,	
this	making	automated	workflows	like	these	difficult	to	maintain.
 The bioinformatics community has generated several tools to make developing 
workflows	 using	 HTML-based	 tools	 as	 simple	 as	 possible.	 Firstly	 there	 are	 Open	
Source	 libraries,	 like	 BioPerl,	 BioPython,	 BioJava,	 and	 BioRuby	 [13],	 providing	
reusable	modules	for	many	languages.	Reusable	subroutines	save	developers	from	
reinventing	the	wheel,	but	they	cannot	prevent	the	brittleness	of	screen	scraping	
scripts.	 Systems	 have	 been	 developed	 for	 the	 (semi)automatic	 generation	 of	
wrappers	around	web	form-based	tools	to	ease	their	integration	[9,	14,	15].	For	the	
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biologist that does not want to do any programming at all there is for instance the 
Sight	project	[16],	which	is	advertised	as	“Automatic	genomic	data-mining	without	
programming	 skills”.	The	Sight	 system	uses	a	web	 form	analyser,	which	extracts	
data	from	a	web	form	and	presents	it	to	the	user.	The	user	can	then	select	the	data	
of	 interest	and	create	an	agent	from	this	selection.	Sight	agents	can	also	handle	
transformations	to	map	data	between	models.	Creating	a	workflow	is	reduced	to	
simply	connecting	 the	response	data	fields	of	one	agent	 to	the	request	fields	of	
another	 agent	 in	 the	 “application	 generator”.	 Although	 the	 Sight	 project	 might	
provide	a	rapid	application	development	for	bioinformatics	workflows	it	still	does	
not	deal	with	the	problem	of	the	brittleness	of	services	based	on	HTML	web	forms.	
Each	time	a	service	provider	updates	its	interface,	the	web	form	analyser	has	to	be	
used	to	reanalyse	the	interface	and	fix	the	corresponding	agent.
From web forms to web services 
In	 order	 to	 overcome	 the	 limitations	 of	 HTML-based	 tools,	 XML-based	 solutions	
are	 gaining	more	 and	more	momentum.	 XML	 (eXtensible	 Markup	 Language)	was	
designed	 to	 overcome	 the	 limitations	 of	 HTML.	 XML	 is	 a	 light-weight	 markup	
language dedicated to the World Wide Web and was derived from the older and 
more	complex	SGML.	The	difference	between	HTML	and	XML	is	that	XML	can	contain	
meta-data	to	create	a	self-describing	data	format,	whereas	HTML	can	only	encode	
how	data	should	be	formatted.	For	example	HTML	can	be	used	to	specify	that	a	text	
string	is	to	be	displayed	in	a	bold	font,	whereas	XML	can	also	be	used	to	specify	
that	this	 text	 is	a	gene	name.	An	excellent	overview	of	both	the	huge	potential	
and limitations of XML versus other data formats for bioinformatics was written by 
Achard	et	al.	[17].	The	self-describing	nature	of	XML	files	makes	them	more	suitable	
for	parsing	by	scripts,	while	maintaining	human	readability	at	the	same	time.	To	
create	web	services	that	can	easily	be	used	by	scripts,	XML-based	standards	have	
been	developed	to	describe	data,	services	and	the	communication	between	these	
services.	The	predominant	standards	are:
Simple Object Access Protocol	 (SOAP)	 [18],	 a	 lightweight	 protocol	 intended	 for	
exchanging	 structured	 information	 in	 a	 decentralised	 environment.	 The	 SOAP	
standard	is	developed	by	the	Web	Services	Activity	group	of	the	W3C	[4]	and	uses	
XML to create an extensible messaging framework that can exchange data over 
underlying	protocols.	Hence,	SOAP	is	not	protocol	bound,	so	it	is	possible	to	develop	
services	that	communicate	using	SOAP	over	FTP,	SMTP,	Jabber,	or	POP3,	but	SOAP	
is	most	frequently	used	over	HTTP.
Web Services Description Language	 (WSDL)	 [19],	 an	XML	 format	 for	describing	
network services as a set of endpoints operating on messages containing either 
document-oriented	 or	 procedure-oriented	 information.	 The	 operations	 and	
messages	are	described	abstractly,	and	then	bound	to	a	concrete	network	protocol	
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and	 message	 format	 to	 define	 an	 endpoint.	 Related	 concrete	 endpoints	 are	
combined	into	abstract	endpoints	(services).	WSDL	is	extensible	to	allow	description	
of endpoints and their messages regardless of what message formats or network 
protocols	are	used	to	communicate.	Like	SOAP,	WSDL	is	a	W3C	standard.
Universal Description, Discovery and Integration protocol	(UDDI)	[20],	a	standard	
to	create	service	directories	that	enable	applications	to	dynamically	find	and	use	
web	services.	In	contrast	to	SOAP	and	WSDL,	UDDI	is	not	a	W3C	standard,	but	an	
effort	driven	by	several	companies	gathered	in	the	OASIS	standards	consortium.	The	
UDDI	project	takes	advantage	of	standards	such	as	SOAP,	HTTP	and	Domain	Name	
System	(DNS)	protocols.
Figure	1	shows	a	schematic	overview	of	the	differences	between	classic	grid	services,	
tools	 with	 HTML	 web	 form	 interfaces	 and	 SOAP	 services.	Whereas	 classic	 grids	
require	custom	software	and	communication	protocols,	web	services	use	de-facto	
standards	like	HTTP	to	circumvent	platform	dependency	issues	and	bypass	firewalls.	
SOAP	 has	 already	 gained	 a	 significant	 position	 in	 the	 bioinformatics	 community.	
Many of the large service providers in the bioinformatics community are currently 
providing	versions	of	their	services	with	SOAP	interfaces	or	are	experimenting	with	
them:
  •   Distributed Annotation System	(DAS)	[21]	is	an	Open	source	project	from	biodas.
org	 [22].	DAS	 is	 software	to	provide	access	to	complete	genome	annotations	
using	a	SOAP	web	interface.	There	are	currently	already	13	public	DAS	servers.	
DAS	is	used	amongst	others	by	Ensembl,	WormBase	and	FlyBase.
  •   Pathway Database System	[23]	and	KEGG API	[24]	provide	access	to	pathways	
using	SOAP	web	interfaces.
  •   PDBML	[25]	is	an	XML-based	schema	for	the	data	in	the	Protein	Data	Bank	(PDB)	
[26].	One	of	 the	members	of	 the	PDB	organisation,	Protein	Data	Bank	Japan	
(PDBj),	has	developed	a	tool	called	xPSSSS	that	provides	a	SOAP-based	service	
to	retrieve	PDBML	data	[25].
  •   XEMBL	at	the	EBI	[27],	the	SoapLab services	at	the	EBI	[28],	XML Central at the 
DDBJ	[11]	and	Entrez Utilities	at	the	NCBI	[29]	provide	SOAP-based	services	to	
access several tools and bioinformatics core databases like the International 
Nucleotide	Sequence	Database	(INSD)
  •   MAGE-ML Server is a tool to map proprietary database schemas for storage of 
microarray	data	into	Microarray	And	Gene	Expression	Markup	Language	(MAGE-
ML)	and	make	them	accessible	using	SOAP	[30].
Evolution of Web Services in Bioinformatics
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Figure 1:  A schematic representation of the differences between classic grid services, 
HTML web form services and SOAP services.
	 	 	 	Whereas	 classic	 grids	 require	 custom	 software	 and	 communication	 protocols,	
web services use de facto standards to circumvent platform dependency issues 
and	bypass	firewalls	making	them	suitable	for	deployment	in	wide	area	networks	
(WANs).	 The	 use	 of	 custom	 communication	 protocols	 for	 grids	 restricts	 their	
effective	use	to	local	area	networks	(LANs).	In	this	example	HTML-based	services	
and	SOAP-based	 services	are	 served	 from	a	web	 server	using	HTTP,	but	other	
protocols	might	be	used	as	well.		
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  •   AGML Central provides access to databases containing proteomics information in 
Annotated	Gel	Markup	Language	(AGML)	using	a	SOAP	interface	[31].
		•			Jemboss	[32]	is	a	graphical	user	interface	for	the	European	Molecular	Biology	
Open	Software	Suite	(EMBOSS)	[33].	EMBOSS	is	an	Open	Source	analysis	software	
suite	 that	 contains	 over	 200	 bioinformatics	 applications.	 Jemboss	 consists	
of	 a	 client	 and	 server	 both	written	 in	 Java.	 The	 client	 communicates	 using	
SOAP	with	a	Tomcat	server	that	passes	requests	onto	the	Jemboss	server.	The	
Jemboss	server	can	then	indirectly	execute	EMBOSS	applications.	This	Jemboss	
server	could	easily	be	used	to	provide	access	via	SOAP	to	other	clients	than	the	
Jemboss	GUI	by	describing	and	publishing	the	interface	in	for	example	WSDL.
The	list	above	is	by	no	means	complete,	nor	is	it	meant	to	be,	but	it	illustrates	that	
for	many	frequently	used	tools	SOAP-based	web	services	are	already	available.	The	
SOAP	interfaces	make	accessing	these	tools	using	scripts	less	brittle,	but	SOAP	and	
WSDL	alone	are	not	yet	a	guarantee	that	these	services	can	easily	be	discovered,	
nor	that	they	can	easily	be	linked	to	create	pipelines.	Projects	that	focus	on	these	
latter	 subjects	 include	 BioMOBY,	 myGrid,	 Discovery	 Net	 and	 caCORE,	 and	 are	
described	below.
BioMOBY
BioMOBY	is	an	Open	Source	project	that	aims	at	providing	a	system	for	the	discovery	
and	processing	of	biological	data	using	web	services	[34,	35].	BioMOBY	is	actually	
two	projects	in	one:	there	is	Semantic	MOBY	(S-MOBY)	and	MOBY	Services	(MOBY-S).	
MOBY-S	 tries	 to	 solve	 the	 interoperability	 problem	by	 specifying	 the	 syntax	 and	
messaging layer to link clients and service providers via information in a central 
registry.	MOBY	Services	uses	SOAP	for	communication	between	client,	central	registry	
and	services.	In	order	to	discover	relevant	services,	a	client	requests	information	
from	 the	 central	 repository.	This	 central	 repository	uses	 ontologies	 to	 store	 the	
structure	of	data-types	and	services	as	well	as	the	relationships	between	them.	An	
ontology is a hierarchical data structure describing objects within a certain domain 
and	the	relationships	between	those	objects	[36].	Using	the	BioMOBY	ontology	it	
becomes	trivial	to	discover	pipelines,	because	the	relationship	between	the	input	
and	output	of	services	is	defined.	For	example	a	client	could	be	looking	for	services	
to fetch protein sequences and a service could specify that it can fetch generic 
sequence	objects	from	a	database.	Hence	the	service	can	fetch	protein	sequences,	
but	 also	DNA	 sequences,	 RNA	 sequences,	 etc.	Without	 an	 ontology	 defining	 the	
relationship between protein sequence objects and generic sequence objects the 
client	could	not	discover	the	relationship	between	them;	they	would	remain	two	
different	objects	and	the	client	would	not	discover	the	service.	In	addition	to	the	
central registry researchers can also use custom registries to store the information 
for	services	that	should	only	be	available	to	a	specific	community.	The	minimum	
Evolution of Web Services in Bioinformatics
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requirement	for	objects	in	MOBY-S	is	the	“Moby	triple”	consisting	of	an	object	tag	
with	an	identifier	and	a	namespace.	Any	other	data	is	considered	to	be	the	payload	
of	an	MOBY-S	object.
	 BioMOBY	tries	to	focus	on	data	integration	and	avoid	issues	of	data	standardisation.	
Therefore,	in	addition	to	native	BioMOBY	objects	it	also	supports	non-native	objects	
by	 embedding	 them	 as	 the	 payload	 in	 native	 objects.	 Allowing	 non-native	 data	
objects	make	BioMOBY	flexible	in	supporting	a	wide	variety	of	data	formats,	but	only	
the	structure	of	native	BioMOBY	objects	can	be	stored	in	the	ontology	of	the	central	
registry.	This	limits	the	discovery	of	services	that	use	non-native	objects.	MOBY-S	
provides	 APIs	 for	 Java,	 Python	 and	 Perl,	 but	 being	 a	web	 services	 specification	
MOBY-S	itself	is	off	course	platform	and	language	independent.	There	are	currently	
already	over	160	services	from	35	service	providers.
	 However,	 in	 its	current	 form	MOBY-S	has	also	some	weaknesses.	The	current	
specification	allows	cross-references	from	one	BioMOBY	object	to	another,	but	 it	
does	not	specify	the	relationship	that	was	used	for	the	cross-reference.	E.g.	a	gene	
might	be	cross-referenced	 to	another	one,	because	 they	are	homologs,	paralogs	
or	have	a	function	in	the	same	pathway.	There	is	currently	no	way	to	differentiate	
between	 them.	 Another	 weak	 point	 is	 the	 scalability	 of	 the	 central	 repository:	
MOBY-S	 does	 not	 deal	 with	 service	 providers	 changing	 their	 services	 without	
updating	their	registration	in	MOBY	central.	Furthermore,	service	descriptions	are	
only	 available	 in	 human-readable	 and	 not	 in	machine-readable	 form.	 Therefore,	
a client can discover services that turn some type of input into another type of 
output,	but	it	is	hard	to	figure	out	how	the	service	actually	does	that.	For	example,	
several service providers can host the same service to fetch data from a certain 
database,	 but	 not	 all	 of	 these	 instances	might	 use	 exactly	 the	 same	 version	 of	
that	database.	There	is	currently	no	standard	way	to	discover	the	most	up-to-date	
services.
	 Semantic	 MOBY	 takes	 a	 little	 different	 approach.	 It	 tries	 to	 solve	 the	
interoperability problem by providing a way to clients and providers to describe 
their	data	and	identify	the	data	relevant	to	them.	The	biggest	difference	between	
S-MOBY	and	MOBY-S	is	that	there	is	no	central	repository	where	service	providers	
have	 to	 register	 their	 services.	 S-MOBY	 service	providers	will	 simply	publish	 the	
properties	of	their	data	and	services	the	same	way	one	would	publish	a	webpage.	
Everyone is allowed to publish their own properties with regard to publicly available 
services.	 This	 can	 be	 compared	 to	 publishing	 your	 own	 view	 on	 a	 subject	 and	
hyperlinking	your	page	to	other	websites	discussing	the	same	topic.	In	such	a	way	a	
web	of	services	and	ontologies	is	constructed,	which	is	freely	accessible	to	indexing	
engines.	This	will	eventually	result	in	an	even	more	decentralised,	semantically	rich	
environment	that	can	adapt	fast	to	the	evolving	bioinformatics	community.	But	for	
the	moment	that	is	still	a	dream:	S-MOBY	currently	only	exists	as	an	analysis	of	the	
requirements	and	a	design	overview,	but	has	yet	to	materialise	in	code.
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myGrid
myGrid	 [37]	 is	 a	 project	 from	 the	 UK	 e-Science	 Programme	 funded	 by	 the	
Engineering	and	Physical	Sciences	Research	Council	(EPSRC).	All	myGrid	components	
are	developed	in	Java	and	its	code	base	is	available	as	Open	Source.	myGrid	can	
access	several	types	of	services	using	Java,	SOAP	and	the	SeqHound	API.	The	tool	
to	 create	 workflows	 for	myGrid	 is	 called	 Taverna	 [38].	 Taverna	 can	 be	 used	 to	
integrate	 several	 types	 of	 services	 including	web	 services	 described	 by	 a	WSDL	
document,	SOAPlab	services,	Talisman	scripts	and	local	applications.
	 To	 describe	 a	 workflow,	 Taverna	 uses	 a	 custom	 XML-based	 language	 called	
simple	 conceptual	 unified	 flow	 language	 (Scufl).	 A	 advantage	 of	 Taverna	 is	 that	
it	 automatically	 stores	 results,	 provenance	 metadata	 and	 application-specific	
knowledge.	The	resulting	e-labjournal	makes	sure	that	all	the	data	describing	an	
experiment	 is	 recorded	 to	warrant	 that	experiments	 can	be	 reproduced.	This	 is	
especially	important	in	a	dynamic	distributed	environment.	If	available	services	have	
changed so much that the results can not be reproduced anymore it at least allows 
researchers	to	track	down	why	the	results	differ.	In	contrast	to	BioMOBY,	myGrid	
by	itself	can	not	discover	workflows	from	a	registry	using	semantic	annotations,	but	
recently	compatibility	with	the	service	ontology	developed	by	the	BioMOBY	project	
was	implemented,	and	BioMOBY	services	can	now	be	accessed	from	within	myGrid.	
myGrid	is	already	used	for	over	20	research	projects.
Discovery Net
Discovery	Net	 [39],	 like	myGrid,	 is	 a	 project	 from	 the	UK	e-Science	Programme	
funded	 by	 the	 EPSRC.	 The	 projects	 goal	 is	 to	 develop	 middleware	 to	 create	
worksflows	 from	 tools	 that	 are	 available	 in	 grids	 or	 as	 web	 services.	 Discovery	
Net	uses	a	custom,	XML-based	language	called	Discovery	Process	Markup	Language	
(DPML)	to	create	wrappers	around	HTML	web	forms,	SOAP	services	and	Open	Grid	
Software	Architecture	(OGSA)	grid	services.	While	myGrid	specifically	focuses	on	
bioinformatics,	Discovery	Net	has	a	bit	wider	focus	on	high	throughput	discovery	
informatics.
	 At	the	IEEE	Supercomputing	2002	High	Performance	Computing	Challenge	the	
Discovery	Net	team	won	the	reward	for	most	innovative	data	intensive	application	
with	a	real	time	genome	sequencing	and	annotation	application.	This	application	
consisted	of	a	pipeline	that	could	fetch	data	from	distributed	sources,	linked	to	a	
real	time	DNA	sequencing	platform	from	DeltaDot	Ltd.	The	biggest	disadvantage	of	
the	Discovery	Net	framework	is	that	the	software	is	not	freely	available	as	Open	
Source,	resulting	in	a	lack	of	wide	community	support.					
caCORE
caCORE	[40]	is	a	project	from	the	National	Cancer	Institute	Center	for	Bioinformatics	
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(NCICB) aimed at integrating bioinformatics services to support research in cancer 
biology	and	medicine.	Although	the	project	specifically	targets	cancer	research	its	
developers	believe	that	the	caBIO	model	and	architecture,	which	is	at	the	heart	of	
caCORE	could	be	extended	to	serve	as	a	general	infrastructure	for	bioinformatics.	
The	project	uses	a	hybrid	strategy	using	both	data	centralisation	and	distribution.	
To	provide	access	to	their	services	caBIO	provides	three	APIs:	a	Java	API	that	uses	
RMI	for	communication,	an	HTTP-XML	web	interface	and	a	SOAP	web	interface.	The	
latter	two	return	data	in	XML,	but	they	differ	in	the	way	a	query	is	submitted.	For	
the	SOAP	service	the	query	is	wrapped	in	XML,	whereas	for	the	HTTP-XML	service	
the	 query	 is	 specified	 using	 options	 in	 the	 URL.	 The	 system	 itself	 can	 also	 use	
external	SOAP	web	services	like	Distributed	Annotation	System	(DAS)	servers.	
The future of web services in bioinformatics
SOAP-based	web	services	and	centralised	systems	both	have	their	strong	points	and	
therefore	both	might	face	a	bright	future,	in	which	they	can	live	happily	together.	
Large institutes and service providers can use centralised systems for their (internal) 
high	performance	computing	needs	and	provide	SOAP-based	web	service	access	to	
their	tools	and	data	for	external	clients	at	the	same	time.	A	good	example	of	such	
a	combination	strategy	is	version	8	of	SRS.	Recently	Lion	Bioscience	AG	[3]	released	
an	add-on	named	SRS	WSObjects	for	their	flagship	product.	SRS	WSObjects	allows	
developers	to	create	clients	that	communicate	with	an	SRS	server	over	HTTP	using	
SOAP.	The	package	contains	APIs	 for	 Java,	Perl,	C#	and	VBA.	The	package	even	
contains	a	plug-in	for	Microsoft	Excel	that	allows	researchers	to	connect	to	remote	
SRS	servers	using	web	services.	In	this	way	Excel	can	be	used	as	graphical	interface	
to	create	bioinformatics	pipelines.
For smaller research groups that need to create public access to a single tool or 
data	set,	web	services	with	a	SOAP	interface	will	be	sufficient.	The	most	serious	
disadvantage	of	using	XML	 is	 the	 large	amount	of	overhead	 it	 creates.	Although	
Soap-HT-BLAST	 [41]	 demonstrated	 the	 use	 of	 web	 services	 to	 create	 a	 high	
throughput	BLAST	cluster,	it	is	questionable	whether	such	an	approach	would	scale	
well.	The	original	Soap-HT-BLAST	cluster	had	only	three	computing	nodes.	Groups	
that use complete genome annotation pipelines usually have farms with hundreds of 
computing	nodes.	The	overhead	created	by	encoding	their	data	in	XML	and	moving	
it	around	the	farm	is	too	much	for	such	high	performance	systems.	To	this	end,	the	
W3C	has	created	a	XML	Binary	Characterization	Working	Group	[42]	that	is	currently	
investigating	a	binary	form	of	XML	for	high	performance	applications.	 If	a	binary	
XML	specification	will	be	developed	it	could	bridge	the	gap	between	bioinformatics	
services running on grids in a local area network and the large network of services 
distributed	all	over	the	internet.
	 Although	SOAP	services	provide	convenient	access	to	scripts	they	can	not	be	
accessed	by	humans	using	a	web	browser.	The	latter	currently	requires	an	additional	
adaptor	which	links	HTML	web	forms	to	the	SOAP	interfaces.	In	the	near	future	this	
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gap could be closed if the Xforms standard becomes more widespread implemented 
in	web	browsers.	 Xforms	 is	 another	W3C	 standard,	which	 is	 the	XML-compatible	
and	logical	successor	to	HTML	forms	[43].	Using	Xforms	the	user	input	from	a	web	
browser	can	be	used	directly	as	input	for	a	web	service.	Hence	the	same	service	
will	be	easily	accessible	for	both	humans	and	scripts.	The	output	will	need	to	be	
Xforms	compatible	as	well,	in	order	to	make	sure	that	it	can	be	used	directly	as	
the	 input	for	another	web	service.	Such	workflows	will	allow	a	user	to	view	the	
intermediate	 results	 in	 a	web	 browser	 by	 tapping	 into	 the	 data	 stream.	 This	 is	
not only convenient for developers that need to debug their services: analysis of 
use	cases	by	the	BioMOBY	project	shows	that	biologists	also	want	to	peek	at	the	
intermediate	 results	 to	 know	 why	 an	 automated	 workflow	 generated	 a	 specific	
result	[35].
	 Another	unresolved	issue	is	quality	management.	Several	groups	might	offer	the	
same	type	of	service	for	redundancy	or	load	balancing,	but	they	not	need	to	be	
equally	up-to-date.	BioMOBY	supports	an	“authorative”	flag	for	service	description,	
but	it’s	up	to	the	service	provider	who	registers	a	service	whether	or	not	to	set	the	
authorative	flag.	Hence,	there	might	be	multiple	authorative	instances	of	the	same	
type	of	service	and	there	might	be	none.	 It	 is	currently	not	possible	to	discover	
the	most-up-to	date	service	(mirror).	This	results	in	similar	problems	as	with	the	
150+	publicly	available	SRS	servers	where	 the	same	databank	 is	often	hosted	by	
several	servers.	They	may	host	different	versions	of	the	database	and	there	might	
be	changes	in	the	available	data	due	to	custom	parsers	and	views.	To	deal	with	such	
issues,	information	about	the	quality	of	services	needs	to	be	implemented	in	the	
tools	to	handle	and	query	the	service	directories.	Current	projects	like	BioMOBY	
require	 web	 service	 providers	 to	 register	 their	 services	 in	 a	 central	 repository.	
Service providers are expected to make sure that the information for their services 
is	kept	up-to-date.	Unfortunately	it	is	unlikely	that	this	will	happen.	The	Taverna	
project already contains a limited crawler to discover and index services described 
using	 WSDL,	 XScufl	 or	 Talisman	 scripts,	 but	 it	 will	 not	 discover	 services	 unless	
the	user	manually	points	the	crawler	to	specific	URLs	[38].	So	if	a	web	service’s	
description	has	changed	it	can	be	dynamically	re-analysed.	As	long	as	web	service	
descriptions	are	published	only	at	a	limited	amount	of	nodes	on	the	web,	such	a	
strategy	might	work,	 but	 it	 does	 not	 scale	 very	well.	 To	make	 SOAP-based	web	
services	just	as	successful	as	tools	based	on	HTML	interfaces,	the	bioinformatics	
community	needs	a	web	crawler	to	index	web	services	similar	to	what	Google	is	for	
web	sites.
	 Sometimes	resources	are	even	only	available	with	a	web	interface.	In	such	cases	
a	centralisation-based	strategy	is	not	an	option.	In	an	editorial	in	Bioinformatics,	
D.	Curtis	Jamison	signals	a	trend	towards	publishing	software	through	a	HTML	web	
interface	 or	 as	 a	 binary	 only	 [44].	 Service	 providers	may	want	 to	 protect	 their	
intellectual	properties	(IP)	and	provide	limited	access	to	their	data	and	tools	at	the	
same	time.	According	to	Jamison	publishing	an	algorithm	or	data	set	on	the	internet	
with a limited web interface is by far the most common used compromise between 
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protecting	IP	and	making	it	freely	available.	Service	providers	that	need	such	limited	
access	have	deliberately	hidden	their	data	or	algorithm	behind	a	difficult	to	script	
interface	and	do	not	want	bioinformaticians	to	“screen	scrape”	their	web	servers.	
They	are	therefore	not	likely	to	provide	SOAP	interfaces	to	ease	the	job.
	 Once	 services	 can	easily	 be	discovered	 it	 does	not	mean	 they	 can	easily	 be	
integrated.	 The	 extensibility	 of	 XML	 is	 both	 its	 strongest	 and	 weakest	 point.	
The extensibility makes sure there is not a piece of data in the bioinformatics 
domain	 that	 cannot	 be	 described	 in	 XML,	 but	 if	 every	 service	 provider	 chooses	
his	own	extensions	for	the	same	type	of	data,	linking	services	into	pipelines	will	
be	accompanied	by	frequently	mapping	data	from	one	XML	schema	into	another.	
Fortunately,	 tools	 that	 provide	 such	 conversions	 will	 break	 less	 easily	 for	 self-
describing	data	formats	like	XML	as	compared	to	non-self-describing	data	formats.	
Therefore the lack of standards that plagues the bioinformatics community is less 
of	a	problem	for	XML-based	web	services.	But	web	services	would	 surely	evolve	
faster if developers would stick to some code of conduct for service providers 
like	 the	 one	 proposed	 by	 Lincoln	 Stein	 [45]	 to	 prevent	 unnecessary,	 inefficient	
conversions	 between	 standards.	Web	 services	 have	 the	 potential	 to	 provide	 the	
superglue	 to	 link	data	 and	 tools	with	different	 formats.	 But	 this	will	 only	 really	
take off if the bioinformatics community can reach consensus on one or at least not 
dozens	of	standards	for	such	glue.	Otherwise	we	will	need	another	standard	to	glue	
web	service	standards	together.	There	is	a	small	risk	that	for	political	reasons	and	
funding	or	IP	issues	different	groups	will	stick	to	their	own	“standards”.
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Abstract 
Background
High throughput gene expression studies using oligonucleotide microarrays depend 
on the specificity of each oligonucleotide (oligo or probe) for its target gene. 
However, target specific probes can only be designed when a reference genome 
of the species at hand were completely sequenced, when this genome were 
completely annotated and when the genetic variation of the sampled individuals 
were completely known. Unfortunately there is not a single species for which such 
a complete data set is available. Therefore, it is important that probe annotation 
can be updated frequently for optimal interpretation of microarray experiments.
Results
In this paper we present OligoRAP, a pipeline to automatically update the annotation 
of oligo libraries and estimate oligo target specificity. OligoRAP uses a reference 
genome assembly with Ensembl and Entrez Gene annotation supplemented with a 
set of unmapped transcripts derived from RefSeq and UniGene to handle assembly 
gaps. OligoRAP produces alignments of each oligo with the reference assembly 
as well as with unmapped transcripts. These alignments are re-mapped to the 
annotation sources, which results in a concise, as complete as possible and up-to-
date annotation of the oligo library. The building blocks of this pipeline are BioMoby 
web services creating a highly modular and distributed system with a robust, remote 
programmatic interface.
 OligoRAP was used to update the annotation for a subset of 791 oligos from the 
ARK-Genomics 20K chicken array, which were selected as starting material for the 
oligo annotation session of the EADGENE/SABRE Post-analysis workshop. Based on 
the updated annotation about one third of these oligos is problematic with regard 
to target specificity. In addition, the accession numbers or IDs the oligos were 
originally designed for no longer exist in the updated annotation for almost half of 
the oligos. 
Conclusions
As microarrays are designed on incomplete data, it is important to update probe 
annotation and check target specificity regularly. OligoRAP provides both and 
due to its design based on BioMoby web services it can easily be embedded as an 
oligo annotation engine in customised applications for microarray data analysis. 
The dramatic difference in updated annotation and target specificity for the ARK-
Genomics 20K chicken array as compared to the original data emphasises the need 
for regular updates.
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Background 
DNA microarray technology has evolved rapidly to become the most popular platform 
for high throughput gene expression analysis as it allow biologists to measure the 
expression of entire transcriptomes at relatively high speed and low cost. This makes 
microarrays ideal for applications like sample clustering / fingerprinting, genome 
annotation, detection of differential gene expression, detection of polymorphisms 
and re-sequencing [1, 2]. Microarrays contain oligonucleotides (probes) that can 
hybridise with the labelled reverse complement of mRNA. Since the probes are 
immobilised on the surface of an array and it is known which probes are located 
where on the array, signal at a certain spot can be used as a measure for gene 
expression. This requires that probes are unique for their target genes and hence 
optimal microarray design requires:
  1  A completely sequenced reference genome.
  2   Complete annotation for this reference genome to know what parts may be 
expressed.
  3   Complete knowledge about the natural variation amongst the sampled 
individuals.
Unfortunately there is currently not a single species for which such complete 
information is available. Although some reference genomes are now close to 
completion, annotation of these reference genomes as well as information on 
how individuals differ from these reference genomes is far from complete. Hence, 
microarray design is currently sub-optimal even for species with a rather complete 
reference genome. Probe design based on incomplete or erroneous data can lead 
to serious problems like non-specific probes causing cross hybridisation, orphan 
probes designed for non-existing targets, missing probes and misleading probes due 
to erroneous annotation.
 Therefore, it is important to update the annotation for arrays regularly to 
improve the functional annotation of the targets as well as the reliability of probe-
target assignments. Several tools have been developed for this purpose [3-12], but 
these provide either limited annotation, require complicated local installations with 
many dependencies, do not scale well or do not support our species of interest. We 
have developed OligoRAP (Oligo ReAnnotation Pipeline) to overcome these issues.
Implementation 
The pipeline consists of 5 steps (see figure 1):
 I  Convert oligo library data into BioMoby objects
 II  Align oligos with a reference genome assembly and with a set of unmapped 
transcripts (UMTs)
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Pipeline Overview
Legend
User Inputs BioMoby Web Services OutputsDatabases
OligoRAP
UnMapped TranscriptsAlign Oligos
BioMoby
XML
&
SVGMake Graphs
Analyse Quality
Check Expression
Analyse Annotation
&
Other
Tools
Ensembl Annotation
Convert Input
Genome
Entrez Gene
Hybridisation
Potential
Filter Thresholds
Oligos Organism
Figure 1: Summarising OligoRAP flowchart.
    Blue blocks represent user input, green blocks databases, pink blocks output and 
finally orange blocks represent one or more BioMoby web services. For a more 
detailed description see additional files 1-6.
 III  Analyse oligo annotation
 IV  Analyse oligo quality
 V  Make summary charts.
Implementation details are described and illustrated in the supplemental information 
section at the end of this chapter. Here we will only focus on the key advantages 
of OligoRAP.
 Firstly, OligoRAP does not rely solely on a reference genome or solely on 
transcripts (or sequences derived thereof), but uses both where possible. For the 
genome OligoRAP uses reference assemblies and annotation as provided by the 
Ensembl [13] project. Ensembl was chosen as primary annotation source, because 
it is the largest and richest resource of its kind with support for most popular 
model species in the animal kingdom. In addition to reference assemblies OligoRAP 
uses a set of unmapped transcripts (UMTs) to get a more complete picture. The 
UMT set contains RefSeq [14] and UniGene [14] entries, which failed to map to 
OligoRAP • An Oligo Re-Annotation Pipeline
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the reference assembly. Where available annotation derived from Ensembl (for hits 
on the genome) and from RefSeq or UniGene (for hits on UMTs) can be expanded 
with links to Entrez Gene [14] and GO [15]. The combination of reference genome 
supplemented with UMTs provides optimally complete annotation for well-annotated 
species whilst keeping redundancy at a minimum. At the same time this strategy is 
flexible enough to support less well-annotated species even if there is no reference 
assembly available. In that case all of a species’ transcripts simply become part of 
the UMT set. 
45.1%
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1.9%
5.4%
2.0%
1.6%
3.5%
1.8%
16.1%
39.4%
24.8%
3.0%
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9.4%
3.5%
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Distribution of Oligos
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Totals B:
3.5 %
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8.8 %
16.9 %
3.0 %
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A. Transcriptome-based
Legend and Totals
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Figure 2:  Distribution of Oligos over Target Specificity Classes (TSCs).
    Distribution of the 791 oligos selected for the workshop over the 6 TSCs with 
transcriptome-based (A) and genome-based target specificity (B). The status of 
the link between the oligo and the accession number / identifier it was originally 
designed for is indicated by a tint difference in the colour for TSC 1, 3 and 4: 
accession/ID still present in the annotation, hence “target unchanged” (dark tint) 
or accession/ID absent, hence “target changed” (light tint). For TSC 2, 5 and 6 the 
target status is always “changed”.
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 Secondly, OligoRAP provides annotation for all hits instead of only for the best 
hit. This allows OligoRAP to provide not only updated annotation, but also oligo 
target specificity based on the amount and type of hits. OligoRAP can differentiate 
between primary hits (high hybridisation potential) and secondary hits (low 
hybridisation potential). Hybridisation potential is determined using three filters, 
which users can adjust based on their experimental setup. Based on their target 
specificity oligos are divided into six target specificity classes (TSCs):
 1  Gene-specific probes with maximum signal potential
 2  G ene-specific probes with reduced signal potential
 3  Non-specific probes with maximum signal potential
 4  Non-specific probes with mixed signal potential
 5  Non-specific probes with reduced signal potential
 6  Orphan probes with background signal potential.
Finally, each of the steps is implemented as one or more web services [16], which 
were built using the BioMoby framework [17, 18]. These web services provide 
remote programmatic access and can be glued together using a variety of BioMoby 
clients like the Taverna Workbench [19] or custom code built with the BioMoby 
Perl or Java framework. Using web services we created a highly customisable and 
modular annotation pipeline with a robust interface. This allows for OligoRAP to be 
embedded in microarray data analysis workflows for improved scalability without 
tedious, local installations suffering from complex dependencies.
Results & Discussion 
OligoRAP was used to update annotation and target specificity for the subset of 791 
oligos from the ARK-Genomics 20K chicken array (see methods in the supplemental 
information). Figure 2 shows how these oligos are divided over OligoRAP’s target 
specificity classes (TSCs) with transcriptome-based target specificity (TbTS) in 
figure 2A and genome-based target specificity (GbTS) in figure 2B.
Transcriptome-based versus genome-based target specificity
Up till recently the transcriptome of higher eukaryotes was thought to contain a 
very small subset of the genome. For example in Ensembl 50 less than 5% of the 
chicken genome is annotated as exon. Since only potentially expressed sequences 
can hybridise to probes on a microarray, most oligo design and annotation efforts 
have focused on known or predicted transcripts without taking the rest of the 
genome into account. Apart from a few structural elements like the centromeres 
and telomeres it’s still not clear what the function of the other 95% or more of DNA 
is, but slowly evidence is piling up indicating the size of the transcriptome is vastly 
underestimated. Especially the pilot phase of the ENCODE project showed that the 
OligoRAP • An Oligo Re-Annotation Pipeline
39
In
tr
od
uc
ti
on
D
is
cu
ss
io
n 
&
 C
on
cl
us
io
ns
2
1
3
4
5
•
human “genome is pervasively transcribed, such that the majority of its bases can be 
found in primary transcripts” [20]. It remains unclear whether all these transcripts 
are biologically functional or whether they just represent noise, but it is clear that 
all transcripts can potentially hybridise with the oligos on microarrays. Therefore 
it is probably more appropriate to evaluate target specificity in the context of the 
entire genome as compared to what is currently annotated as transcriptome.
 Looking at TbTS and GbTS for the 791 ARK-Genomics chicken oligos the 
total amount of gene-specific oligos differs only by 2.3% with 69.5% and 67.2%, 
respectively. Hence taking the entire genome into account as compared to looking 
only at the transcriptome does not lead to a dramatic decrease of gene-specific 
probes. Unfortunately at least one third of the probes are non-specific. For these 
problematic non-specific probes the TbTS and GbTS pictures look quite different.
Annotation quality
For most of the oligos it is extremely difficult to verify their predicted target 
specificity except for the orphan oligos of TSC 6. The 791 oligos selected as starting 
material for this EADGENE/SABRE workshop were picked, because they do show a 
high differential signal on the microarrays. Hence these oligos clearly bind labelled 
cDNA derived from one or more target genes, but OligoRAP classifies 3.5% and 16.1% 
of the oligos as orphans with GbTS and TbTS, respectively. These numbers indicate 
that OligoRAP’s TSC assignments are currently more an indicator for the relatively 
immature status of the chicken genome assembly and its annotation than for target 
specificity.
 Furthermore, for almost half of the oligos, the sequence identifier they were 
originally designed for is no longer present in their updated annotation, which 
is indicated with “target changed” in figure 2. The fact that these identifiers no 
longer link to these oligos not necessarily means that the oligo no longer represents 
expression of the same gene as before, but it does indicate at least major changes in 
the annotation. On the other hand annotation associated with certain identifiers may 
have received considerable “minor” updates keeping the sequence identifier intact. 
Hence, the large amount of oligos with changed targets is still an underestimate of 
the total amount of changed annotation.
Future work
Although the ENCODE pilot study covered only approximately 1% of the human 
genome it is clear that our view on the transcriptome will change dramatically over 
the next years. This will have a big impact on oligo annotation & target specificity 
making it more important than ever to be able to update oligo annotation quickly 
and regularly. In addition to regular updates of the data, annotation pipelines like 
OligoRAP will need to be updated too to adapt the annotation strategies to our 
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Conclusions
Microarray probes are designed on incomplete data. Therefore it is important 
to update probe annotation and estimate target specificity regularly. OligoRAP 
provides such functionality for Ensembl species and can easily be embedded in 
customised applications for microarray data analysis due to its design based on 
BioMoby web services. The rather high amount of oligos with changed targets shows 
the importance of updated annotation and reflects the limited amount and quality 
of the annotation available at the time the ARK-Genomics 20K chicken array was 
designed.
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Supplemental information
Implementation details
OligoRAP consists of 5 steps as depicted in figure 1:
 I  Convert oligo library data into BioMoby objects
 II  Align oligos
   A With a reference genome assembly
   B With a set of unmapped transcripts (UMTs)
 III  Analyse oligo annotation
 IV  Analyse oligo quality
 V  Make charts.
These steps are described here in detail followed by more information on the web 
service interfaces in general. See supplemental figure S3 for a detailed flowchart.
I  Converting oligo library data into BioMoby objects
The oligos are divided into chunks in order to distribute the load and be able 
to re-do subsets of the analysis in case something goes wrong. In case the oligo 
sequences are not available as chunks of BioMoby multi sequence FASTA objects, 
the Tab2MultiSeqFastaChunks or Fasta2MultiSeqFastaChunks services can be used 
to convert from tab delimited or FASTA format respectively. In addition to the 
oligo sequences the systematic name of the organism for which to annotate the 
sequences is required and together these inputs are forwarded to the next services.
II-A  Aligning oligos with a reference genome assembly
Firstly, the MobyBlat service is executed to align the oligos with a reference 
genome. MobyBlat uses the BLAST Like Alignment Tool (BLAT) [1], which uses an in 
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memory index to provide a huge query speed improvement over BLAST although at 
the expense of steeper memory requirements. BLAT parameters are optimised to 
minimise the risk of missing short relevant hits due to intron gaps, while keeping the 
server’s memory requirements below 2 GB (see methods). A disadvantage of BLAT 
is that it might miss hits to highly redundant parts of the genome, because it stores 
only unique or relatively rare fragments (tiles) in its index.
 Secondly, oligos without any BLAT hit are aligned with the MobyBlast service, 
which uses NCBI BLAST [2, 3]. BLAST searches are executed without the default low 
complexity region filtering to detect hits for oligos that target conserved domains 
in members of large gene families or for oligos that were accidentally designed for 
repeats (see methods in the supplemental information for additional parameters).
 Since the amount of oligos without BLAT hit is usually less than 3%, this strategy 
provides an ideal combination of speed and accuracy. Once both MobyBlat and 
MobyBlast have completed a chunk, their results are passed on to the ConcatenateFiles 
service, which simply appends MobyBlast results to those of MobyBlat.
II-B  Aligning oligos with unmapped transcripts (UMTs)
A set of UMTs is used in addition to a reference assembly, because no single assembly 
is 100% complete. This UMT set contains all RefSeq [4] RNA accessions as well as 
UniGene clusters that were not mapped on the genome by Ensembl [5] with high 
sequence identity (see construction of UMT sets below). Small imperfections are 
allowed in the Ensembl alignments to prevent accessions from being included into 
the UMT dataset due to natural variation amongst individuals of a species.
 Similar as for the alignments with the genome the oligos are first aligned with 
the UMT set using MobyBlat and only oligos without any BLAT hit are aligned using 
MobyBlast. Since UMTs don’t contain introns, there is no need to increase BLAT 
sensitivity to pick up short hits to intron-separated exons. Other parameters were 
the same as for the alignments with the genome assembly (see methods). Just as 
for alignments with the genome, results from MobyBlat and MobyBlast are combined 
per chunk with the ConcatenateFiles service.
 Figure S3:  Detailed flowchart.
     (A) OligoRAP components. User inputs are in blue, databases in green and 
results in orange. Yellow blocks represent a single synchronous web service 
or a set of two asynchronous services for a specific task (one service for job 
submission and one for requesting a job’s status). Some steps are executed 
multiple times. BLAT, BLAST, Concatenate, Analyse Annotation and Merge 
Hits and Analyse Quality are executed multiple times for multiple chunks as 
indicated by sets of three connecting lines starting with a filled circle (•). The 
Create Chart step is executed multiple times for different inputs (not chunks) 
as indicated by a set of two connecting lines starting with a filled square (▪). 
(B) Some examples of how OligoRAP can be extended or linked to downstream 
analyses tools.
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 Construction of UMT sets
For each OligoRAP supported species, the sets of unmapped transcripts (UMTs) 
contain all RefSeq [4] RNA accessions of that species that were not mapped on 
the genome by Ensembl [5] with 97% sequence identity or better and are based 
on experimental evidence (accession numbers starting with “NR” or “NM”). Since 
RefSeq does not include records for (clustered) transcript fragments if there is no 
evidence for a complete CDS and oligos are frequently designed based on ESTs, 
relying solely on RefSeq for UMTs would be needlessly incomplete. Therefore, 
member sequences of UniGene clusters [4] are also included in the UMT set if none 
of a cluster’s member sequences was aligned with the genome by Ensembl at 97% 
sequence identity or better and if the cluster didn’t contain a RefSeq accession. 
Finally, RefSeq RNAs and UniGene clusters are only included in the UMT set if they 
were “known” at the time an Ensembl data set was generated to prevent redundancy 
due to new sequences, which were simply not yet taken into account. This means 
RefSeq RNAs and UniGene clusters must exist either as “DNA align feature” and/
or “Xref” and/or “unmapped object” in the Ensembl databases. This procedure is 
necessary, as information on which versions of external databases like RefSeq and 
UniGene were used for a certain Ensembl release tends to be inconsistent and/or 
incomplete.
III   Analysing oligo annotation: parsing alignments and fetching annotation for 
individual hits
The concatenated alignment reports are then sent to the OligoAnnotationAnalyser 
web service, which uses BioPerl [6] for NCBI BLAST XML parsing. 
For hits on the genome OligoAnnotationAnalyser checks if a hit overlaps any 
sequence features annotated by Ensembl, that indicate this hit might be expressed. 
This “expression evidence” includes amongst others: Ensembl Gene IDs, Ensembl 
Transcript IDs, INSDC (DDBJ & EMBL & GenBank) RNA/cDNA accessions including full 
length sequences as well as fragments like ESTs, UniProt KB accessions, UniGene 
accessions and RefSeq RNA accessions (see annotation retrieval below for details). 
These features range from de novo in silico gene predictions to well-known, 
manually curated proteins, but OligoAnnotationAnalyser does not take reliability 
of the “expression evidence” into account. Accession numbers of the overlapping 
sequence features are added as cross-references to the corresponding oligo hit 
and as long as there is at least one such a cross-reference, hits are flagged as 
potentially expressed. Based on Ensembl Gene IDs, the cross-references for a hit 
can be expanded with Gene Ontology (GO) term IDs [7] and Ensembl homologs (see 
annotation retrieval below for details).
 After checking for expression evidence OligoAnnotationAnalyser performs an 
“intron-check” to see if there were any partial hits that together might represent 
a complete match. Such partial hits are merged into a single hit if two or more 
consecutive hits share at least one or more transcription cross-references.
For hits on the UMT set OligoAnnotationAnalyser simply adds the accession 
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number of the UMT as cross-reference and flags the hit immediately as potentially 
expressed. Redundant hits to members of the same UniGene cluster are dropped, 
keeping only the first one of the best hits.
Next, for any hit on either genome or UMT set OligoAnnotationAnalyser 
uses mapping from Entrez Gene [4] to fetch Entrez Gene and GO term IDs based 
on RefSeq, UniGene and INSDC cross-references (see annotation retrieval below for 
details). 
Finally OligoAnnotationAnalyser uses three filters to determine the 
hybridization potential of each hit: number of mismatches, longest contiguous stretch 
and percentage sequence identity. For each filter the client must specify thresholds 
depending on hybridization protocol, array type and array platform. Imperfect 
hits, whose hybridization potential is so weak they cannot be distinguished from 
background noise, are dropped. In an experiment for the empirical establishment of 
oligo probe design criteria He et al. have shown that a single filter couldn’t detect 
all cross-hybridizing probes, but a combination of several filters could [8]. Therefore 
the filters in OligoAnnotationAnalyser are complementary. Hence, only if one or 
more filters predict hybridization potential for a hit it is preserved.
 Annotation retrieval
Ensembl sequence features are retrieved from the Ensembl DNA align feature (DAF), 
protein align feature (PAF) or cross-reference (Xref) tables, which are part of the 
core, cdna (if present) and otherfeatures databases. We were able to reduce the 
query time for a complete oligo library from several weeks to several hours on our 
dedicated MySQL server by implementing speed optimizations involving partitioning 
of the data. This involves the creation of short “virtual contigs” (3000 nucleotides 
long) and remapping of features, which were originally assigned to complete 
chromosomes to these short virtual contigs. Due to the speed optimisations the 
Ensembl API cannot be used to fetch DAFs, PAFs and Xrefs. Raw SQL queries are 
used instead. In order for a DAF, PAF or an Xref to be scored as expression evidence 
these Ensembl features must align to the reference genome with 97% identity or 
better. This allows for small differences due to natural variation and/or sequencing 
errors. Furthermore an optional parameter can be used to shorten the region where 
the oligo aligned with the genome on both ends before checking if that hit overlaps 
any expression evidence. This prevents labelling hits as unexpressed due to small 
errors in gene models, small differences in alternative splicing or alignments that 
erroneously extend a few nucleotides into an intron. This optional trimming only 
affects the procedure that checks for overlapping Ensembl features and hence does 
not effect the alignment of the oligo with the genome in the final results. If there 
are not enough nucleotides available to trim maximally, hits are trimmed such that 
there will be at least 1 nucleotide left. DAF, PAF and Xref accession numbers are 
added as expression cross-references to the corresponding oligo hit.
 Ensembl Gene IDs can be used to retrieve Gene Ontology (GO) term IDs [7] 
and Ensembl homologs from the Ensembl go and compara databases, respectively. 
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Figure S4:  Relationships between filter thresholds, primary & secondary hits and 
estimated signal intensity.
     Primary hits (green) represent (near) perfect alignments of oligos with their 
targets. Secondary hits (orange) are defined as worse than primary hits, but 
still capable of generating signal above background. Relative signal intensity 
is shown on the vertical axis and the 3 filters - mismatches, sequence identity 
and longest contiguous stretch - on 3 horizontal axes. Signal intensity drops as 
the amount of mismatches increases and as the percentage sequence identity 
or the length of the longest contiguous stretch decreases. Estimated signal 
intensity above the primary hit threshold (green) is defined as “maximum 
signal”. Estimated signal below the primary and above the secondary hit 
threshold (orange) is defined as “reduced”. Finally estimated signal below the 
secondary hit threshold is defined as “background signal”.
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Target Specificity Classes
Legend
Oligo Target Specificity Classes (TSCs)
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Figure S5 :  Overview of OligoRAP’s six target specificity classes, which are defined 
by the amount of primary and secondary hits.
     Figure showing how target specificity classes are defined based on hits. 
Primary hits (green) represent (near) perfect alignments of oligos with their 
targets. Secondary hits (orange) are defined as worse than primary hits, but 
still capable of generating signal above background. Classes are named after 
the combination of probe type (gene-specific, non-specific or orphan) and 
estimated potential signal (maximum, reduced, mixed or background).
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For the latter clients can specify which homology types (as defined by Ensembl: 
ortholog_one2one, ortholog_one2many, ortholog_many2many, apparent_ortholog_
one2one, between_species_paralog and within_species_paralog) and what model 
species to retrieve homologs for. GO term IDs are appended to hits as additional 
annotation cross-references whereas Ensembl homologs are appended as homology 
cross-references.
 For alignments with UMTs, the accession number of the UMT is appended as 
transcription cross-reference to the corresponding oligo hit.
For any hit on either genome or UMT set OligoAnnotationAnalyser can fetch Entrez 
Gene IDs based on RefSeq, UniGene & INSDC (DDBJ & EMBL & GenBank) transcription 
cross-references based mapping provided by Entrez Gene [4]. The mapping is taken 
from the gene2unigene, gene2refseq and gene2accession as provided by the NCBI 
ftp-server (ftp://ftp.ncbi.nlm.nih.gov/gene/DATA/). Optionally if an Entrez Gene ID 
is available it may be used to link (additional) GO term IDs to the oligo hits using 
the gene2go file also available from the NCBI ftp-server. GO term IDs are appended 
to oligo hits as annotation cross-references, while Entrez Gene IDs are appended as 
additional transcription cross-references.
IV   Analysing oligo quality: estimating target specificity for each oligo and the 
library as a whole
The OligoAnnotationAnalyser results, containing the oligo hits and their annotation, 
are sent to the OligoMergeXML web service, which combines genome and UMT 
hits for each oligo per chunk. All merged chunks together are then sent to the 
OligoQualityAnalyser web service.
 OligoQualityAnalyser uses the same three user-definable filters as 
OligoAnnotationAnalyser to determine the hybridization potential of each hit, 
but where OligoAnnotationAnalyser only checks if a hit can generate any signal 
above background noise, OligoQualityAnalyser differentiates between primary and 
secondary hits (supplemental figure S4). Primary hits are defined as (near) perfect 
hits having optimal signal to noise ratio under the hybridization conditions. Imperfect 
hits, not qualifying as primary hit, but still causing a significant amount of noise are 
labelled secondary hits. Furthermore multiple combinations of filter settings can be 
provided in a single run to determine the effect of more lenient or more stringent 
settings on oligo target specificity. Just as in OligoAnnotationAnalyser the filters are 
complementary. So, if the filters predict different hybridization potentials for a hit 
it is labelled with the best hybridisation potential predicted. 
 OligoQualityAnalyser determines both oligo target specificity as well as the 
overall quality of the entire array. Based on the amount of primary and secondary 
hits the oligos are divided into six target specificity categories (TSCs) (supplemental 
figure S5):
 1  Gene-specific probes with maximum signal potential
 2  Gene-specific probes with reduced signal potential
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 3  Non-specific probes with maximum signal potential
 4  Non-specific probes with mixed signal potential
 5  Non-specific probes with reduced signal potential
 6  Orphan probes with background signal potential.
Gene-specific probes have only one hit, non-specific probes hit multiple targets and 
orphan probes no longer hit any targets. Maximum signal potential indicates primary 
hits, reduced signal potential indicates secondary hits, mixed signal potential is the 
result of a mix of both primary and secondary hits and finally background signal 
potential means the oligo doesn’t have any hits and hence is an orphan. When 
OligoQualityAnalyser determines target specificity it does so twice for different 
contexts: genome-based target specificity (GbTS) and transcriptome-based target 
specificity (TbTS). For GbTS all hits on genome and UMTs are taken into account 
irrespective of whether they have any evidence for potential expression or not, but 
for TbTS only hits with expression evidence are taken into account.
 Usually a single hit for an oligo means it is target specific and multiple hits 
indicate potential cross-hybridization, but there are exceptions. RefSeq might for 
example contain redundancy as result of splice variants and UniGene clustering is 
not 100% perfect. Secondly, it is also possible that an oligo hits the same target 
more than once. Therefore, OligoQualityAnalyser counts multiple hits with the same 
Entrez Gene ID or the same Ensembl Gene ID cross-references as a single hit with 
the hybridization potential of the best one. On the other hand it is also possible for 
genes to overlap on the same strand. Therefore, hits on the same strand with cross-
references to more than one Ensembl Gene ID are counted as multiple hits.
 OligoQualityAnalyser keeps track of the amount oligos in each TSC per 
combination of filter settings. In addition to these summaries the results now 
contain for each oligo: 1) Oligo accession/ID and optionally the accession/ID of the 
original target the oligo was designed for, 2) Oligo length, 3) Zero or more hits 
on genome and/or UMTs with detailed alignment information and zero or more 
cross-references linking the hit to annotation, 4) Genome- and transcriptome-
based target specificity class assignments per combination of filter thresholds. See 
supplemental figures S6 and S7 for examples of OligoQualityAnalyser output and of 
the Cigar Like Lines (CLLs) used to store alignment details. OligoRAP’s annotation 
consists of accession numbers and the database they belong to. This is a concise 
way of linking oligos to genes, transcripts and proteins, but mere accession numbers 
are not very meaningful to biologists, who are generally interested in attributes 
such as gene symbols, functional descriptions or GO terms. Retrieving all data for 
all accessions from all databases would generate a huge amount of data, which is 
not always useful and highly redundant. Therefore it was decided to store only the 
accession numbers as cross-references and leave it up to bioinformaticians to use 
the cross-references with downstream tools for their custom needs. Some example 
applications of how OligoRAP can be extended or used with additional tools are 
given in supplemental figure S3-B, but this is beyond the scope of this paper.
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BioMoby XML
Legend
OligoQualityAnalyser example output for an oligo
|BioMoby header/footer |One oligo |Two hits |Two TSC assignments |Annotation/Xrefs
<?xml version='1.0' encoding='UTF-8'?>
<moby:MOBY xmlns:moby='http://www.biomoby.org/moby' xmlns='http://www.biomoby.org/moby'>
  <moby:mobyContent moby:authority='www.bioinformatics.nl/phenolink/'>
    <moby:mobyData moby:queryID='1146'>
      <moby:Collection moby:id='CGEN_MOULIB384' moby:namespace='' moby:articleName='oligo_annotation'>
        <moby:Simple moby:articleName='oligo' moby:id='1'>
          <moby:OligoQualityRecord moby:id='CGEN_MOUSE_3000003_1|NM_008954' moby:namespace='' 
              moby:articleName='oligo_record'>
            <moby:Integer moby:id='' moby:namespace='' moby:articleName='length'>65</moby:Integer>
            <moby:OligoHit moby:id='hit1 hsp1' moby:namespace='Mus_musculus_Genome' moby:articleName='oligo_hit'>
              <moby:HitPosition moby:id='' moby:namespace='transcriptome' moby:articleName='hit_position'>
                <moby:String moby:id='' moby:namespace='' moby:articleName='seq_id'>17</moby:String>
                <moby:Integer moby:id='' moby:namespace='' moby:articleName='start'>57139132</moby:Integer>
                <moby:Integer moby:id='' moby:namespace='' moby:articleName='stop'>57139196</moby:Integer>
                <moby:Object moby:id='-' moby:namespace='' moby:articleName='strand'/>
                <moby:String moby:id='' moby:namespace='' moby:articleName='cll'>65M</moby:String>
              </moby:HitPosition>
              <moby:CrossReference>
                <moby:Object moby:id='0001658' moby:namespace='GO' moby:articleName='annotation_xref'/>
                <moby:Object moby:id='0005102' moby:namespace='GO' moby:articleName='annotation_xref'/>
                <moby:Object moby:id='0005576' moby:namespace='GO' moby:articleName='annotation_xref'/>
                <moby:Object moby:id='0005615' moby:namespace='GO' moby:articleName='annotation_xref'/>
                <moby:Object moby:id='0008083' moby:namespace='GO' moby:articleName='annotation_xref'/>
                <moby:Object moby:id='19197' moby:namespace='EntrezGene' moby:articleName='expression_xref'/>
                <moby:Object moby:id='A1L3Q1' moby:namespace='UniProt' moby:articleName='expression_xref'/>
                <moby:Object moby:id='AF040960' moby:namespace='INSDC' moby:articleName='expression_xref'/>
                <moby:Object moby:id='BC130229' moby:namespace='INSDC' moby:articleName='expression_xref'/>
                <moby:Object moby:id='ENSBTAG00000031794' moby:namespace='Ensembl' 
                  moby:articleName='Bos_taurus_homology_xref'/>
                <moby:Object moby:id='ENSG00000125650' moby:namespace='Ensembl' 
                  moby:articleName='Homo_sapiens_homology_xref'/>
                <moby:Object moby:id='ENSMUSG00000002664' moby:namespace='Ensembl' 
                  moby:articleName='expression_xref'/>
                <moby:Object moby:id='ENSMUST00000002740' moby:namespace='Ensembl' 
                  moby:articleName='expression_xref'/>
                <moby:Object moby:id='GENSCAN00000045225' 
                  moby:namespace='in silico' moby:articleName='expression_xref'/>
                <moby:Object moby:id='Mm.86487' moby:namespace='UniGene.cluster'
                  moby:articleName='expression_xref'/>
                <moby:Object moby:id='NM_008954' moby:namespace='RefSeq' moby:articleName='expression_xref'/>
                <moby:Object moby:id='O70300' moby:namespace='UniProt' moby:articleName='expression_xref'/>
              </moby:CrossReference>
            </moby:OligoHit>
            <moby:OligoHit moby:id='hit2 hsp1' moby:namespace='Mus_musculus_Genome' moby:articleName='oligo_hit'>
              <moby:HitPosition moby:id='' moby:namespace='genome' moby:articleName='hit_position'>
                <moby:String moby:id='' moby:namespace='' moby:articleName='seq_id'>11</moby:String>
                <moby:Integer moby:id='' moby:namespace='' moby:articleName='start'>3259678</moby:Integer>
                <moby:Integer moby:id='' moby:namespace='' moby:articleName='stop'>3259742</moby:Integer>
                <moby:Object moby:id='+' moby:namespace='' moby:articleName='strand'/>
                <moby:String moby:id='' moby:namespace='' moby:articleName='cll'>15S16M34S</moby:String>
              </moby:HitPosition>
            </moby:OligoHit>
            <OligoTargetSpecificity moby:namespace='' moby:id='fs1' moby:articleName='oligo_target_specificity'>
              <Object moby:namespace='' moby:id='1p:0s' moby:articleName='transcriptome'/>
              <Object moby:namespace='' moby:id='1p:0s' moby:articleName='genome'/>
            </OligoTargetSpecificity>
            <OligoTargetSpecificity moby:namespace='' moby:id='fs2' moby:articleName='oligo_target_specificity'>
              <Object moby:namespace='' moby:id='1p:0s' moby:articleName='transcriptome'/>
              <Object moby:namespace='' moby:id='1+p:1+s' moby:articleName='genome'/>
            </OligoTargetSpecificity>
          </moby:OligoQualityRecord>
        </moby:Simple>
      </moby:Collection>
    </moby:mobyData>
  </moby:mobyContent>
</moby:MOBY>
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 Figure S6:   OligoQualityAnalyser example output for Compugen oligo CGEN-
MOUSE_30000003_1.
      An example of OligoQualityAnalyser output with an OligoQualityRecord 
(blue) containing 2 hits/alignments (green) and 2 target specificity 
assignments (orange). The first hit overlaps with Ensembl features resulting 
in annotation in the form of cross-references (purple), while the second 
hit targets ‘intergenic’ space resulting in a lack of cross-references. Each 
target specificity block contains the oligo’s specificity for two contexts  - 
genome and transcriptome - and refers by id attribute to the filter settings 
(thresholds) described elsewhere in the XML (not shown). The Cigar Like 
Line (CLL) is derived from the Ensembl Cigar line [21] and is used to store 
alignment details (matches, mismatches, insertions, deletions & intron 
gaps) in a compact string. See figure additional file 6 for detailed CLL 
examples. Together with subject sequence accession/ID, start, and stop, 
the CLL provides all information necessary to reconstruct the alignments. 
It can be used for example to create UCSC “custom tracks” [22, 23] for 
visualization in the UCSC or Ensembl genome browsers.
 Figure S7:   Detailed CLL examples.
      Five example alignments with their accompanying cigar like lines (CLLs). 
A CLL is a compact way to represent the alignment of a first sequence 
(query) with a second one (subject/DB). In these examples the single 
stranded oligo is the query and the double stranded DNA the subject. 
Example with matches and substitutions of an oligo hit on the forward 
DNA strand (1). Similar example of an oligo hit on the reverse DNA strand 
(2). Note that the CLL describes the alignment from the perspective of the 
oligo in terms of insertions and deletions, but is always read from left to 
right with the forward strand of the subject written from 5’ on the left to 
3’ on the right side. Hence in the case of example 2 the CLL corresponds 
to 3’ on the left to 5’ on the right for the oligo sequence. Examples of 
insertions & deletions (3) and of an intron gap (4). In this context introns 
are special cases of deletions and usually the result of merging multiple 
smaller hits into one larger alignment. Example of mixed case nucleotides 
(5): a number followed by 2 or more characters (m/s/i/d/n) indicates 
this amount of nucleotides can be a mix of the corresponding classes. 
In this case there are 25ns nucleotides, which corresponds to a mix of 
substitutions with an intron gap. Due to the substitutions it’s not possible 
to determine exactly where the intron gap starts and ends in the oligo 
sequence. Hence alignments corresponding to 7m5s20n9m, 7m3s20n2s9m 
(shown) and 7m20n5s9m can al be written as 7m25ns9m.
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V   Making charts
The summaries with the amount of oligos in each TSC are sent on to the MobyPieChart 
service, which generates several pie charts in SVG format. These pie charts provide 
an overview of the target specificity of all probes of the oligo-nucleotide library for 
a certain combination of filter settings.
Web services
Unfortunately, sending big datasets as part of the payload of a web service 
is problematic for most popular SOAP libraries (used for service execution). 
Therefore, we use “pass-by-reference”, which means that an URL replaces results 
in case large output can be expected for a service (table 1). A client or the next 
service in the pipeline can then download and parse the data using alternative 
Alignments with their corresponding CLLs
Legend
M = Matches S = Substitutions I = Insertions D = Deletions N = iNtrons (Special case of D)
Detailed cigar-like line (CLL) examples
1. Oligo + 5' gtaaggcacagaaggtggcagcaagtctgtcggtgatca 3'
                     ||||||||||||||||||    ||||||||||     CLL 7s18m4s10m
   DNA   + 5' tggctttacagaaggtggcagcaagaacatcggtgatca 3'
   DNA   - 3' accgaaatgtcttccaccgtcgttcttgtagccactagt 5'
2. DNA   + 5' tggctttacagaaggtggcagcaagaacatcggtgatca 3'
   DNA   - 3' accgaaatgtcttccaccgtcgttcttgtagccactagt 5'
                     ||||||||||||||||||    ||||||||||     CLL 7s18m4s10m
   Oligo + 3' gtgaggttgtcttccaccgtcgttcagacagccactagt 5'
3. Oligo + 5' gtaaggcacagaaggtggcagcaag-----cggtgatca 3'
                     |||||||  |||||||||     |||||||||     CLL 7s7m2i9m5d9m
   DNA   + 5' tggctttacagaag--ggcagcaagaacatcggtgatca 3'
   DNA   - 3' accgaaatgtcttc--ccgtcgttcttgtagccactagt 5'
4. Oligo + 5' tggcttt-----------------------cggtgatca 3'
              |||||||                       |||||||||     CLL 7m23n9m
   DNA   + 5' tggctttacagaaggtggcagcaagaacatcggtgatca 3'
   DNA   - 3' accgaaatgtcttccaccgtcgttcttgtagccactagt 5'
5. Oligo + 5' tggctttgat------------------cgcggtgatca 3'
              |||||||                       |||||||||     CLL 7m23ns9m
   DNA   + 5' tggctttacagaaggtggcagcaagaacatcggtgatca 3'
   DNA   - 3' accgaaatgtcttccaccgtcgttcttgtagccactagt 5'
 Figure S7:   Detailed CLL examples.
     See previous page for figure caption. 
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mechanisms. Although pass-by-reference works well as a workaround with the 
current BioMoby 1.0 standard, BioMoby has not yet standardised on a mechanism 
for pass-by-reference, but this will change soon as it is a key feature of Taverna 2 
and the BioMoby community is actively discussing an extension to make it part of 
the standard.
 Some of the OligoRAP services are asynchronous, because they can easily take 
more than the default timeout on the Internet (5 minutes) to do their job (table 1). In 
these cases functionality is divided over two services: one to submit a job returning 
a link to retrieve the results and one to request the job status. Asynchronous 
services dispatch jobs internally to a small Grid Engine (GE) [9] cluster. Their results 
can be downloaded from a link provided by the submission service once their jobs 
have completed. Hence all asynchronous services use pass-by-reference.
Web service Asynchronous Uses pass-by-reference
Tab2MultiSeqFastaChunks No Yes
Fasta2MultiSeqFastaChunks No Yes
MobyBlat No Yes
MobyBlast Yes Yes
ConcatenateFiles No Yes
OligoAnnotationAnalyser Yes Yes
OligoMergeXML No Yes
OligoQualityAnalyser Yes Yes
MobyPieChart No No
Table 1:  OligoRAP web services, whether their execution is asynchronous and whether 
they use pass-by-reference.
Availability & requirements
Project name: OligoRAP
Project home page: https://www.bioinformatics.nl/phenolink/home/
The web services were designed for remote programmatic access, which is freely 
available for all within limits of our computing facilities. (Restrictions on use by non-
academics: BLAT used in the MobyBlat service requires a license for commercial 
use and hence access to MobyBlat requires a license for commercial use too. The 
pipeline can be used without MobyBlat without any loss of functionality although 
at the expense of a much longer runtime.) All services are registered in the public 
BioMoby Central repository under service authority www.bioinformatics.nl. Remote 
programmatic access only requires a BioMoby compatible client.
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The web services of the pipeline have many dependencies making them unsuitable 
for easy portability. Source code is nevertheless available upon request from the 
authors. The underlying databases are currently updated for even numbered 
Ensembl releases and OligoRAP supports Bos taurus, Danio rerio, Homo sapiens, 
Gallus gallus, Mus musculus and Rattus norvegicus. Other Ensembl species can be 
indexed on request.
Clients:
Operating system(s): platform independent / various depending on client.
Programming language: various depending on client.
Other requirements: internet access, some clients require the BioMoby Perl and/or 
Java framework available from www.biomoby.org. 
License: various
Web services:
Operating system(s): Linux
Scripting language: Perl
Other requirements: BLAT, BLAST, Ensembl databases, Entrez Gene database, 
RefSeq database, UniGene database, BioMoby Perl modules, BioPerl, many Perl 
modules available from CPAN (dependencies for the former two), Saxon-B, Java, 
MySQL, Apache and Grid Engine (GE)
License: GNU GPL v2
Methods
Updating annotation
All web services were running on servers with SuSE Linux Enterprise Server (SLES) 
9. Asynchronous services dispatched jobs to a 10 node SLES 9 cluster with Grid 
Engine 6u10. The genome assembly (WASHUC2) was downloaded from Ensembl. 
UMT sequences were derived from RefSeq 30 and UniGene Gga 40. Expression 
evidence for oligo hits was derived from the Ensembl 50. Mapping from UniGene, 
RefSeq and INSDC (DDBJ & EMBL & GenBank) to Entrez Gene was downloaded from 
the NCBI ftp server on 26-08-2008. GO terms were derived from both Ensembl 50 as 
well as from Entrez Gene d.d. 26-08-2008. Databases were stored on local servers 
running SLES 9 with MySQL 4.1. 
Web service specifics
MobyBlat: BLAT suite version 34 [1]; gfServer: tileSize = 12 nucleotides, minMatch 
= 1 tile, stepSize = 6 nucleotides; gfClient - all alignments: q = rna, gfClient - 
additional parameters only for alignments with a genome assembly: maxIntron 
= 1.000.000 nucleotides, minScore = 0; Other optional parameters: out  = blast7 
(BLAST XML). MobyBlast: NCBI BLAST 2.2.13 [2, 3]; blastall: p = blastn, m = 7, 
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S = 3 for alignments with the genome assembly or S = 1 for alignments with 
UMT sequences, F = F. OligoAnnotationAnalyser: BioPerl 1.5.2 [6] except for 
blastxml.pm, for which we used an outdated version from CVS (10-05-2007) as 
later releases were either broken or didn’t scale well. (This problem should be 
fixed now and recent versions of BioPerl can be used again with recent versions of 
BLAST (Personal communication with BioPerl developer Chris Fields.)); Thresholds 
for dropping hits: mismatches = 45, contiguous stretch = 16, percentage 
identity = 30. Optional parameters: fetch_go_from_ensembl = 1, fetch_go_
from_Entrez Gene = 1, ortholog_one2one = 1, apparent_ortholog_one2one = 0, 
ortholog_one2many = 1, ortholog_many2many = 1, between_species_paralog 
= 0, within_species_paralog = 0, fetch_ensembl_bos_taurus_homolog = 1, 
fetch_ensembl_gallus_gallus_homologs = 1, fetch_ensembl_homo_sapiens_
homologs = 1, fetch_ensembl_mus_musculus_homologs = 1, fetch_ensembl_
rattus_norvegicus_homologs = 1, expression_evidence_overlap_mismatch = 
5. OligoQualityAnalyser hybridisation filter thresholds (primary/secondary): 
mismatches* = 1/2; longest contiguous stretch* = 55/20; percentage identity* = 
95/85; * = Filter thresholds derived from He et al. [8] except for the mismatches 
filter which is basically disabled with these thresholds to make the OligoRAP filters 
as close as possible similar to those of two other oligo annotation pipelines for a 
comparison of annotation strategies described in chapter 3. MobyPieChart: Uses 
Saxon-B 8.8J from Saxonica [10] with an XSLT to transform the BioMoby XML into 
SVG; Optional parameters: three_dimensional = 1, throw_shadow = 1, series_
clustering_threshold = 1, clustered_series_label = Others, clustered_series_color 
= #AAAAAA.
Microarray
The microarray used is the ARK-Genomics Chicken 20K array consisting of 20.460 
probes ranging in length from 60 to 75 nucleotides with the majority of the probes 
70 nucleotides long [11]. It was designed in 2005 based on: 1) INSDC (DDBJ/EMBL/
GenBank) ESTs/cDNAs including the UMIST ChESTs, 2) Ensembl 30 with gene models 
based on various sources ranging from highly reliable chicken UniProtKB/Swiss-Prot 
proteins to relatively unreliable ab initio in silico gene predictions, 3) miRBase micro 
RNAs and 4) a small set of contributed sequences. Probe annotation was updated 
with OligoRAP. For the EADGENE and SABRE workshop data was provided from an 
experiment where the ARK-Genomics Chicken 20K array was used to determine gene 
expression levels in chickens 8 and 24 hours after infection with several parasites 
[12]. From this experiment a subset of 791 highly differentially expressed probes 
based on the MM8-MM24 contrast was selected for in depth analysis.
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Supplemental Files
Supplemental file S7:  OligoRAP annotation for the 791 oligos selected for this 
workshop.
        ZIP-archive containing the final results of the OligoRAP pipeline 
run as well as all intermediate results. See included README for 
details. https://www.bioinformatics.nl/phenolink/home/OligoRAP/
datasets/Ensembl50_RefSeq30/OligoRAP_RIGG791_20081222_
BMC_Proceedings.zip
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Abstract
Background
Reliable	 annotation	 linking	 oligonucleotide	 probes	 to	 target	 genes	 is	 essential	
for	 functional	 biological	 analysis	 of	microarray	 experiments.	We	used	 the	 IMAD,	
OligoRAP	and	sigReannot	pipelines	to	update	the	annotation	for	the	ARK-Genomics	
Chicken	20K	array	as	part	of	a	joined	EADGENE/SABRE	workshop.	In	this	manuscript	
we	compare	their	annotation	strategies	and	results.	Furthermore,	we	analyse	the	
effect	of	differences	in	updated	annotation	on	functional	analysis	for	an	experiment	
involving	Eimeria	 infected	chickens	and	finally	we	propose	guidelines	for	optimal	
annotation	strategies.
Results
IMAD,	 OligoRAP	 and	 sigReannot	 update	 both	 annotation	 and	 estimated	 target	
specificity.	The	3	pipelines	can	assign	oligos	to	target	specificity	categories	although	
with	varying	degrees	of	resolution.	Target	specificity	is	judged	based	on	the	amount	
and	 type	of	 oligo	 versus	 target-gene	alignments	 (hits),	which	are	determined	by	
filter	 thresholds	 that	 users	 can	 adjust	 based	 on	 their	 experimental	 conditions.	
Linking	oligos	to	annotation	on	the	other	hand	is	based	on	rigid	rules,	which	differ	
between	pipelines.	
	 For	 52.7	 %	 of	 the	 oligos	 from	 a	 subset	 selected	 for	 in	 depth	 comparison	 all	
pipelines	linked	to	one	or	more	Ensembl	genes	with	consensus	on	44.0	%.	In	31.0	
%	 of	 the	 cases	 none	 of	 the	 pipelines	 could	 assign	 an	 Ensembl	 gene	 to	 an	 oligo	
and	for	the	remaining	16.3	%	the	coverage	differed	between	pipelines.	Differences	
in	 updated	 annotation	were	mainly	 due	 to	 different	 thresholds	 for	 hybridisation	
potential	filtering	of	oligo	versus	target-gene	alignments	and	different	policies	for	
expanding	annotation	using	 indirect	 links.	The	differences	 in	updated	annotation	
packages	had	a	significant	effect	on	GO	term	enrichment	analysis	with	consensus	
on	only	67.2	%	of	the	enriched	terms.
Conclusions
In	addition	to	flexible	thresholds	to	determine	target	specificity,	annotation	tools	
should	 provide	 metadata	 describing	 the	 relationships	 between	 oligos	 and	 the	
annotation	assigned	to	them.	These	relationships	can	then	be	used	to	judge	the	
varying	 degrees	 of	 reliability	 allowing	 users	 to	 fine-tune	 the	 balance	 between	
reliability	 and	 coverage.	 This	 is	 important	 as	 it	 can	 have	 a	 significant	 effect	 on	
functional	microarray	analysis	as	exemplified	by	the	 lack	of	consensus	on	almost	
one	third	of	the	terms	found	with	GO	term	enrichment	analysis	based	on	updated	
IMAD,	OligoRAP	or	sigReannot	annotation.
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Background 
High	throughput	gene	expression	experiments	using	microarrays	are	based	on	the	
principle	of	hybridising	strands	of	nucleotides	to	form	a	duplex.	For	each	gene	(the	
target)	a	microarray	contains	many	copies	of	one	or	more	short	strands	(the	probes)	
in	small	regions	on	the	array	called	spots.	In	a	microarray	experiment	expressed	
sequences	or	sequences	derived	thereof	are	labelled	and	allowed	to	hybridise	to	
the	probes	making	the	amount	of	label	at	each	spot	an	indicator	for	the	amount	of	
gene	expression.	Since	all	spots	are	processed	simultaneously,	it	is	essential	that	
all	probes	have	optimal	target	specificity	under	the	same	experimental	conditions.	
Therefore,	optimal	microarray	design	requires	1)	a	completely	sequenced	reference	
genome,	2)	complete	annotation	for	this	reference	genome	to	know	what	parts	may	
be	expressed	and	3)	complete	knowledge	about	the	natural	variation	amongst	the	
sampled	individuals.
	 Unfortunately	there	is	currently	not	a	single	species	for	which	such	complete	
information	 is	 available.	 Although	 some	 reference	 genomes	 are	 now	 close	 to	
completion,	the	recently	published	first	results	of	the	ENCODE	project	indicate	that	
our	knowledge	of	what	is	expressed	is	vastly	underestimated	[1].	Hence,	certainly	
when	a	reference	genome	is	not	available	and	array	design	is	primarily	based	on	
expressed	sequence	tags	(ESTs),	but	also	for	species	with	a	rather	complete	reference	
genome,	microarray	design	 is	 sub-optimal.	Probe	design	based	on	 incomplete	or	
erroneous	data	can	lead	to	serious	problems	like	non-specific	probes	causing	cross	
hybridisation,	orphan	probes	designed	for	non-existing	targets,	missing	probes	and	
misleading	probes	due	to	erroneous	annotation.
	 Previous	 re-annotation	 studies	 have	 shown	 that	 up	 to	 half	 of	 the	 probes	 for	
popular	microarrays	 can	 be	 problematic	 as	 they	 suffer	 from	 cross	 hybridisation,	
from	detecting	 something	else	 than	what	 they	were	designed	 for,	or	both	 [2-7].	
The	 scale	of	 the	problem	differs	 for	each	microarray	design	and	usually	 reflects	
differences	in	probe	design	criteria	and	in	completeness	of	the	data	used	for	the	
array	 design.	 Erroneous	 probe	 to	 gene	 assignments	 at	 such	massive	 scale	 were	
shown	to	have	a	dramatic	effect	on	 lists	of	differentially	expressed	genes	 [2,	6,	
8]	and	clustering	of	genes	based	on	co-expression	[6,	9].	Surprisingly,	Lu	and	Zang	
found	that	it	had	hardly	an	effect	on	sample	clustering	[6].
		 Other	 evidence	 that	 current	 probe	 annotation	 is	 often	 suboptimal	 comes	
from	 microarray	 reproducibility	 studies.	 Although	 reproducibility	 of	 modern	
arrays	 using	 the	 same	 array	 platform	 and	 version	 is	 usually	 good	 to	 very	 good,	
reproducibility	 between	different	 array	 versions	even	on	 the	 same	platform	can	
be	very	poor	[10-14].	Re-annotation	of	the	probes	using	updated	data	sets	and/or	
using	alternative	strategies	for	probe-gene	assignment	was	shown	to	improve	the	
correlation	 co-efficient	 dramatically	 [10-14].	 This	 suggests	 that	 the	 lack	 of	 cross	
platform	reproducibility	is	mainly	caused	by	poor	annotation	of	probes.	Alternative	
splicing	was	shown	to	effect	cross	platform	reproducibility	as	well	as	probes	from	
two	different	vendors	might	detect	the	same	gene,	but	not	necessarily	the	same	
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splice	variants	of	that	gene	[15].
	 Summarising,	 it	 is	 important	to	update	the	annotation	for	arrays	regularly	to	
improve	 the	 reliability	 of	 probe-target	 assignments.	 Three	 tools	 to	 update	 oligo	
annotation	 for	 microarrays	 -	 IMAD,	 OligoRAP	 and	 sigReannot	 -	 are	 described	
elsewhere	in	this	issue	of	BMC	Proceedings	[16-18].	In	this	manuscript	we	compare	
their	underlying	annotation	strategies	and	the	differences	 in	updated	annotation	
for	 the	 ARK-Genomics	 Chicken	 20K	 array	 to	 illustrate	 the	 challenges	 associated	
with	updating	annotation	and	target	specificity.	We	also	analyse	the	effect	of	the	
differences	in	updated	annotation	on	functional	analysis	of	an	experiment	involving	
Eimeria	infected	chickens,	which	was	selected	as	starting	material	for	the	joined	
EADGENE	[19]	and	SABRE	[20]	workshop	on	microarray	data	analysis	in	November	
2008.	Finally	we	propose	guidelines	for	optimal	annotation	strategies	based	on	the	
lessons	learned	from	this	workshop.
Methods
Microarray
The	microarray	used	is	the	ARK-Genomics	Chicken	20K	array	consisting	of	20.460	
probes	ranging	in	length	from	60	to	75	nucleotides	with	the	majority	of	the	probes	
70	nucleotides	long	[21].	It	was	designed	in	2005	based	on:	1)	INSDC	(DDBJ/EMBL/
GenBank)	ESTs/cDNAs	including	the	UMIST	ChESTs,	2)	Ensembl	30	with	gene	models	
based	 on	 various	 sources	 ranging	 from	 highly	 reliable	 chicken	 UniProtKB/Swiss-
Prot	proteins	to	relatively	unreliable	ab	initio	in	silico	gene	predictions,	3)	miRBase	
micro	RNAs	and	4)	a	small	set	of	contributed	sequences.	Microarray	data	from	an	
experiment	with	Eimeria	 infected	chickens	and	using	 this	array	was	provided	as	
starting	material	for	the	EADGENE/SABRE	post-analyses	workshop	[22].	From	this	
experiment	a	subset	of	791	differentially	expressed	probes	based	on	the	MM8-MM24	
contrast	sample	was	selected	for	in	depth	comparison	of	the	annotation.	For	the	GO	
term	[23]	enrichment	analysis	all	20K	oligos	were	used.
Updating annotation
IMAD,	 OligoRAP	 and	 sigReannot	 were	 used	 to	 update	 annotation	 as	 described	
elsewhere	in	this	issue	[16-18].	At	the	time	of	analysis	the	following	database	versions	
were	used:	SigReannot:	Ensembl	50	and	UniGene	Gga	41;	OligoRAP:	Ensembl	50,	
Entrez	Gene	d.d.	2008-08-26,	UniGene	Gga	40	and	RefSeq	30;	IMAD:	Ensembl	50,	
UniGene	Gga	39	and	DFCI	chicken	gene	indices	11.
Hybridisation	 filter	 thresholds	were	 synchronised	 based	 on	He	 et	 al.	 [24]	where	
possible.	This	means	the	minimum	percentage	sequence	identity	over	the	complete	
length	of	oligo	was	set	to	85	%	and	the	minimum	length	of	the	longest	contiguous	
stretch	was	set	to	20	nucleotides	for	OligoRAP	and	SigReannot	or	a	minimum	HSP	
size	of	20	matching	nucleotides	(not	necessarily	a	contiguous	stretch.)	OligoRAP’s	
mismatches	filter	was	set	to	such	low	values	that	it	was	effectively	not	used.
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GO term enrichment
Different	custom	array	annotation	packages	based	on	Ensembl	Gene	IDs	were	made	
using	 the	 updated	 annotation	 provided	 by	 the	 IMAD,	 OligoRAP	 and	 sigReannot	
pipelines.	These	custom	annotation	packages	were	made	with	Bioconductor	 [25]	
using	the	AnnotationDbi	package	[26].	Three	conditions	each	with	a	set	of	up-	and	
a	 set	 of	 down-regulated	 genes	 resulted	 in	 a	 total	 of	 six	 gene	 lists	 as	 described	
elsewhere	in	this	issue	[27].	Gene	lists	were	tested	for	GO	term	enrichment	using	a	
conditional	hypergeometric	test	algorithm	from	the	Bioconductor	package	GOstats	
[28].	The	significance	threshold	 for	 this	 test	was	set	to	p	values	smaller	 than	or	
equal	to	0.05	and	only	GO	terms	from	the	Biological	Process	(BP)	ontology	were	
used.
Results & Discussion
Figure	1	shows	a	consensus	flowchart	with	five	steps	that	all	three	pipelines	perform	
in	order	to	annotate	an	oligo-nucleotide	library.	
Oligo Sequences & Species
Align Oligos with Genes ReferenceGenome
Other Sequence 
Sources
Retrieve Annotation
From Alignments
Retrieve Annotation
From Other Annotation
Filter AlignmentsFilter Thresholds
Format Annotation DatabaseDisplay
Documents
Documents
Documents
Other Annotation 
SourcesEnsembl
Other Annotation 
SourcesEnsembl
1
2
5
4
3
Figure 1:  Consensus Pipeline Overview
	 	 	 	Procedures	 used	 by	 IMAD,	 OligoRAP	 and	 sigReannot	 to	 update	 oligo	 library	
annotation	can	be	grouped	in	5	steps	(yellow),	with	user	inputs	(blue),	external	
data	sources	(green)	and	results	(red).	
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Annotation strategies compared
The	first	 step	 requires	 the	oligo	 sequences	 and	 species	 of	 interest	 as	 input	 and	
aligns	the	oligos	with	potential	targets.	An	overview	of	datasources	used	for	the	
alignments	 is	provided	 in	figure	2A.	The	primary	 source	of	probe	 targets	 for	all	
three	pipelines	 is	 Ensembl	 [29,	 30].	OligoRAP	uses	 the	entire	 reference	 genome	
assembly	for	a	given	species,	while	IMAD	and	sigReannot	only	focus	on	the	parts,	
which	are	annotated	as	Ensembl	transcripts.	There	are	two	exceptions	though.
	 Firstly,	 IMAD	 ignores	 strand	 information	 and	 hence	might	 link	 to	 annotation	
derived	from	features	located	on	the	opposite	strand	of	a	hit.	SigReannot	is	strand-
aware,	but	can	link	to	annotation	from	the	opposite	strand	if	no	annotation	was	
found	on	the	hit	strand.	Most	array	platforms	only	detect	a	single	strand	and	under	
normal	conditions	a	gene	produces	only	RNA	from	a	single	strand.	But	there	can	
be	exceptions	like	in	the	case	of	viral	reverse	transcriptases,	some	of	which	can	
switch	 templates	 resulting	 in	chimeric	cDNA	molecules	 [31].	 IMAD	was	originally	
designed	for	arrays	used	in	experiments	 involving	viral	 infections,	which	reflects	
the	design	choice	to	include	annotation	from	both	strands.	So,	depending	on	array	
type,	sample	preparation	protocol	and/or	sample	type,	linking	oligos	to	genes	on	
the	opposite	strand	can	either	be	a	feature	or	a	flaw.
	 Secondly,	sigReannot	uses	UTR/intron	extension	in	case	no	hits	were	found	on	
Ensembl	 transcripts.	The	 latter	means	 that	 sigReannot	 searches	UniGene	 [32]	as	
secondary	source	for	alignments.	If	a	hit	is	found,	the	Ensembl	API	is	used	to	fetch	
Ensembl	genes	linked	to	the	found	UniGene	cluster	accessions.	For	these	Ensembl	
genes	 the	 entire	 sequence	 including	 introns	 is	 fetched	 and	 extended	with	 1000	
nucleotides	both	up-	and	downstream.	When	the	oligo	can	be	aligned	with	these	
extended	sequences,	 it	 is	 linked	to	the	corresponding	Ensembl	genes.	 In	general	
Ensembl	is	relatively	conservative	in	annotating	genes	and	sigReannot’s	UTR/intron	
extension	is	a	smart	feature	to	boost	the	coverage	of	probes	linked	to	Ensembl	gene	
IDs.	On	the	other	hand	stretching	the	boundaries	of	conservative	Ensembl’s	gene	
models	will	also	 increase	the	risk	of	 introducing	false	positive	probe	to	Ensembl	
gene	 assignments.	 Moreover,	 linking	 probes	 to	 Ensembl	 gene	 IDs	 based	 on	 rare	
splice	variants	can	be	misleading.	If	no	signal	was	observed	it	means	that	rare	splice	
variant	was	not	expressed,	but	that	doesn’t	mean	the	gene	was	not	expressed	at	
all.
	 IMAD	 and	 OligoRAP	 also	 use	 additional	 sources	 for	 probe-target	 alignments	
to	increase	the	coverage	of	annotated	probes.	In	addition	to	Ensembl	transcripts	
IMAD	aligns	probes	with	UniGene	[32]	and	DFCI	Gene	Indices	(formerly	known	as	
TIGR	Gene	 Indices)	 [33]	and	OligoRAP	aligns	with	UniGene	[32]	and	RefSeq	[32].	
The	big	difference	 is	that	 IMAD	searches	the	entire	databases	whereas	OligoRAP	
searches	only	a	sub-set	of	RefSeq	accessions,	which	are	not	reliably	represented	
by	 the	 reference	 assembly	 and	 a	 sub-set	 of	 UniGene	 accession	 neither	 reliably	
represented	by	the	reference	assembly	nor	by	the	RefSeq	sub-set.	Hence	IMAD	hits	
to	the	different	databases	can	be	highly	redundant	while	OligoRAP	tries	to	minimise	
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 Figure 2:  Comparison of Target and Annotation Sources
	 	 	 	 	Data	 sources	 as	 used	by	 the	 corresponding	 annotation	 pipelines	 for	 linking	
probes	to	target	genes	(A)	and	for	annotation	retrieval	(B):	green	checkmark	
=	used,	red	cross	=	unused	and	orange	checkmark/cross	=	partially	used.	*)	
IMAD	ignores	strand	information	and	therefore	might	contain	hits	to	intergenic	
space	with	Ensembl	exons	annotated	on	the	opposite	strand.	**)	sigReannot	
can	report	hits	to	intergenic	space	and	introns	using	its	UTR/intron	extension	
feature.	This	requires	a	hit	on	a	UniGene	cluster	 located	 in	a	gene’s	 intron	
or	in	a	region	of	1000	nucleotides	up-	or	downstream	of	a	gene.	UTR/intron	
extension	is	only	performed	with	sigReannot	if	there	were	no	hits	on	Ensembl	
Genes.	OligoRAP	on	 the	other	hand	 takes	all	 intergenic	 space	 into	account	
irrespective	of	whether	there	are	hits	on	Ensembl	Genes	or	not.	***)	To	prevent	
redundancy	OligoRAP	takes	only	a	subset	of	UniGene	and	RefSeq	accessions	
into	account:	those	that	do	not	map	with	high	confidence	onto	the	reference	
assembly.
redundancy.
The	second	step	is	to	filter	the	hits	based	on	the	quality	of	the	alignments,	which	
relates	to	the	hybridisation	potential	of	a	hit.	All	three	pipelines	can	filter	alignments	
on	 the	 percentage	 of	 sequence	 identity.	 Low	 quality	 hits	 that	 do	 not	 pass	 this	
filter,	but	which	do	contain	 small	 stretches	of	uninterrupted	matches	might	 still	
contribute	to	signal	on	a	microarray.	Therefore,	OligoRAP	and	sigReannot	feature	a	
second	filter	for	the	minimum	size	of	what	is	called	the	longest	contiguous	stretch	or	
continuous	block,	respectively.	Finally,	OligoRAP	has	a	third	filter	for	the	maximum	
total	amount	of	mismatches.	When	the	probes	are	not	all	equally	long	this	filter	will	
produce	different	results	as	compared	to	the	percentage	identity	filter.
	 In	 contrast	 to	 sigReannot	 and	 IMAD,	 OligoRAP	 applies	 the	 filter	 step	 not	
immediately	after	aligning	oligos	with	targets,	but	after	all	annotation	is	retrieved	
instead	(after	step	4).	This	allows	OligoRAP	to	check	if	two	or	more	short	hits	were	
derived	from	intron-separated	exons	of	the	same	gene.	If	such	hits	are	found	they	
are	merged	into	a	larger	hit,	which	is	necessary	for	OligoRAP,	because	it	aligns	with	
reference	 genomes	 as	 compared	 to	 IMAD	 and	 sigReannot,	which	 only	 align	with	
transcripts.
	 Based	on	the	amount	and	type	of	hits	oligos	can	be	assigned	to	target	specificity	
classes	(TSCs).	An	overview	of	how	TSCs	overlap	or	differ	between	the	3	pipelines	
is	given	in	figure	3A.	IMAD	focuses	on	the	big	picture	the	way	most	biologists	are	
interested	in	oligo	annotation:	Are	my	oligos	gene	specific	or	not?	This	results	 in	
three	TSCs:	gene-specific,	non-specific	and	orphan	oligos.	OligoRAP	and	sigReannot	
on	the	other	hand	provide	more	resolution	by	differentiating	between	high	quality	
(HQ)	and	low	quality	(LQ)	alignments	resulting	in	7	and	6	TSCs,	respectively.	OligoRAP	
uses	two	thresholds	per	filter	-	one	for	LQ	and	one	for	HQ	hits	-	to	assign	oligos	
to	TSCs.	A	different	approach	is	used	by	sigReannot	as	the	percentage	sequence	
identity	 is	 used	 exclusively	 to	 filter	 for	 HQ	 hits	 and	 the	 length	 of	 the	 longest	
contiguous	stretch	for	LQ	hits.	Figure	3B	shows	how	the	more	specialised	TSCs	of	
Chapter 3
68
5
•
Introduction
D
iscussion &
 Conclusions
2
1
3
4
B. Sources for annotation retrieval
A. Sources for linking probes to targets 
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Figure 2:  Comparison of Target and Annotation Sources
	 	 	 See	previous	page	for	figure	caption
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B. Detailed TSCs grouped into base TSCs
A. Detailed TSCs 
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Figure 3:  Comparison of Target Specificity Classes (TSCs)
	 	 	 	Overview	of	how	the	TSCs	 -	as	defined	by	 the	3	pipelines	 -	 (partially)	overlap	
or	are	divided	 into	 smaller	 sub-categories	 (A).	O	=	OligoRAP,	S	=	 sigReannot,	 I	
=	 IMAD.	 Numbers	 indicate	 the	 corresponding	 TSCs.	 LCS	 =	 Longest	 Contiguous	
Stretch.	IMAD	does	not	differentiate	between	different	hit	types.	OligoRAP	and	
sigReannot	differentiate	between	High	Quality	alignments	(HQ	hits,	called	“hits”	
by	sigReannot	and	“primary	hits”	by	OligoRAP)	and	Low	Quality	alignments	(LQ	
hits,	called	“noise”	by	sigReannot	and	“secondary	hits”	by	OligoRAP).	Figure	B	
shows	how	more	detailed	TSCs	can	be	grouped	into	3	base	TSCs	for	comparison	
of	the	results:	one	hit	(I1	=	O1+O2	=	S1+S3+S4),	multiple	hits	(I2	=	O3+O4+O5	=	
S2+S5+S7)	or	no	hits	at	all	(I3	=	O6	=	S6).
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OligoRAP	and	sigReannot	can	be	combined	into	the	more	generic	TSCs	of	IMAD	for	
easier	comparison	of	the	results	produced	by	IMAD,	OligoRAP	and	sigReannot.
	 OligoRAP	and	sigReannot	use	comparable	TSCs	in	case	there	was	only	one	HQ	
hit	(TSC	O1	&	S1),	there	were	multiple	LQ	hits	(TSC	O5	&	S5),	or	there	were	no	hits	
at	all	(TSC	O6	&	S6).
	 When	there	was	only	1	LQ	hit,	OligoRAP	puts	these	oligos	in	a	single	TSC	(O2),	
but	sigReannot	differentiates	between	LQ	hits	with	longest	contiguous	stretches	of	
30	nucleotides	and	more	(S3)	and	with	stretches	of	less	than	30	nucleotides	(S4).	The	
latter	TSC	contains	gene-specific	oligos,	which	are	less	reliable	for	detecting	lowly	
expressed	genes,	because	they	have	the	worst	signal	to	noise	ratio.	By	providing	
an	extra	TSC	for	these	oligos,	users	can	choose	to	drop	them	from	further	analysis	
or	at	 least	can	see	quickly	they	are	 less	 reliable.	OligoRAP	handles	this	problem	
differently	by	allowing	users	to	specify	multiple	combinations	of	filter	thresholds	per	
run.	This	allows	them	to	analyse	for	example	the	effect	of	more	lenient	or	stricter	
thresholds	for	HQ	and/or	LQ	hits	and	covers	all	TSCs	instead	of	just	the	oligos	with	
only	one	LQ	hit.	Analysing	different	combinations	of	filter	thresholds	is	also	possible	
with	IMAD	and	sigReannot,	but	this	a	bit	more	work	as	it	requires	a	user	to	run	the	
pipeline	with	the	most	lenient	hybridisation	potential	filter	thresholds	followed	by	
post-processing	of	the	results	to	generate	results	for	more	stringent	thresholds.
	 In	 the	 case	 of	multiple	 HQ	 hits	 or	 a	mix	 of	 HQ	 and	 LQ	 hits	 sigReannot	 and	
OligoRAP	classify	them	differently.	SigReannot	differentiates	between	cases	with	
one	HQ	hit	accompanied	with	one	or	more	LQ	hits	(TSC	S2)	and	cases	with	multiple	
HQ	hits	with	or	without	LQ	hits	(TSC	S7).	OligoRAP	on	the	other	hand	differentiates	
between	multiple	HQ	hits	 (TSC	O3)	and	a	mix	of	HQ	and	LQ	hits	 (TSC	O4).	The	
reason	 sigReannot	differentiates	between	S2	and	S7	while	OligoRAP	assigns	 such	
oligos	all	to	O4	is	a	difference	in	annotation	retrieval	policy	(see	below).	TSC	O3	
is	 interesting,	because	 in	 theory	 these	oligos	 target	 shared	domains	or	different	
highly	similar	genes.	Therefore	these	oligos	could	still	be	informative	as	such	genes	
are	usually	involved	in	similar	biological	processes	just	like	different	splice	variants	
derived	from	the	same	gene.	In	practice	however	many	of	the	oligos	in	TSC	O3	have	
multiple	HQ	hits	due	to	redundancy	and	this	is	usually	the	result	of	assembly	and/
or	annotation	problems.	Either	way	it	makes	sense	to	differentiate	between	these	
oligos	and	ones	that	target	a	mix	of	HQ	and	LQ	hits	as	the	latter	can	suffer	from	
cross-hybridisation	with	transcripts	from	highly	dissimilar	targets	and	hence	are	not	
informative.
Steps	three	and	four	consist	of	annotation	retrieval	directly	from	the	alignments	
or	 indirectly	 from	 previously	 fetched	 annotation,	 respectively.	 There	 are	 many	
differences	 in	 annotation	 features	 retrieved	 by	 the	 different	 pipelines,	 but	 all	
pipelines	 provide	 links	 to	 Ensembl	 gene	 IDs,	 Ensembl	 Transcripts	 IDs,	 UniGene	
cluster	accessions	and	GO	terms	IDs	derived	from	Ensembl	genes	(figure	2B).	The	
largest	differences	between	the	pipelines	can	be	found	in	the	data	sources	used	
for	annotation	expansion	using	database	cross-references.	Such	indirect	 links	are	
Effect of Annotation Strategies on Downstream Analysis
71
In
tr
od
uc
ti
on
D
is
cu
ss
io
n 
&
 C
on
cl
us
io
ns
2
1
3
4
5
•
convenient,	but	differences	here	are	less	important	as	users	can	fetch	these	links	
themselves	from	the	direct	 links	using	other	tools	 like	for	example	BioMart	[34].	
The	annotation	present	in	the	final	results	can	depend	on	the	target	specificity	of	
an	oligo.	Both	 IMAD	and	 sigReannot	provide	at	most	only	one	gene	 ID/accession	
per	database	 linked	to	each	oligo.	This	 is	accomplished	 in	 IMAD	by	fetching	only	
annotation	 for	 the	 best	 hit	 found	 in	 each	 of	 the	 databases	 used	 for	 alignment	
searches.	 SigReannot	on	 the	other	hand	 fetches	annotation	 for	 the	 single	HQ	or	
LQ	hit	found	(TSC	S1,	S3	and	S4)	or	for	the	HQ	hit	in	case	it	was	accompanied	by	
additional	LQ	hits	(TSC	S2).	Hence,	in	case	there	were	multiple	HQ	hits	(TSC	S7)	or	
multiple	LQ	hits	in	absence	of	HQ	hits	(TSC	S5),	sigReannot	provides	no	annotation	
at	all	as	there	is	no	clear	best	hit.	Although	this	is	an	oversimplification	it	can	be	
an	advantage	as	most	downstream	analysis	tools	are	limited	to	accepting	only	one	
ID/accession	number	per	oligo	and	hence	that	is	what	most	users	want.	OligoRAP	
provides	all	annotation	for	all	hits	-	both	HQ	and	LQ	-	it	can	find.	In	case	there	were	
multiple	hits	this	means	the	users	will	have	to	decide	for	themselves	what	hits	to	
take	 into	account.	This	gives	users	more	control	of	what	annotation	 to	use,	but	
might	require	additional	parsing	of	OligoRAP	annotation.
Finally,	the	fifth	step	involves	formatting	and	storing	the	results	in	various	ways.	
SigReannot’s	annotation	is	provided	as	collection	of	tab-delimited	flat	files.	IMAD	
on	the	other	hand	uses	a	MySQL	database	to	store	its	results	and	OligoRAP’s	native	
output	format	is	BioMoby	[35]	XML,	but	both	provide	tab-delimited	flat	files	upon	
request.	In	addition	to	data	dumps,	IMAD	provides	web-based	access	to	query	the	
updated	annotation	using	a	CGI	script.	SigReannot	does	not	provide	web-based	access	
yet,	but	the	data	is	stored	in	a	BioMart	compliant	MySQL	database	with	installation	
of	the	web-based	BioMart	front-end	planned	for	a	future	release.	OligoRAP	does	
not	 provide	 a	 web-based	 interface	 to	 query	 the	 generated	 annotation,	 but	 the	
annotation	pipeline	consists	of	BioMoby	web	services	allowing	users	to	execute	the	
pipeline	remotely	themselves	instead.
Effect of differences in annotation strategies on coverage and 
consensus
A	subset	of	791	oligos	was	selected	from	the	experimental	data	provided	for	the	
workshop	to	assess	the	effect	of	the	different	annotation	strategies	on	coverage.	
These	 oligos	 were	 selected,	 because	 they	 showed	 differential	 gene	 expression	
signals.	Hence	these	probes	clearly	bind	transcripts	and	any	orphan	oligos	in	the	
updated	 annotation	 produced	 by	 sigReannot,	 OligoRAP	 and	 IMAD	 indicate	 false	
negatives	 due	 to	 incomplete	 data	 sources,	 incomplete	 annotation	 strategies	 or	
both.	The	focus	for	this	comparison	is	on	Ensembl	gene	ID	assignments	as	all	three	
pipelines	provide	these	and	hence	they	can	be	easily	compared.	Figure	4A	shows	a	
Venn	diagram	representing	the	amount	of	oligos	covered	with	at	least	one	Ensembl	
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Figure 4:  Ensembl Annotation Assigned to Oligos: Coverage & Consensus
	 	 	 	Venn	diagram	representing	oligos	linked	to	Ensembl	gene	IDs	by	the	3	annotation	
pipelines	(A).	Colours	represent	oligos	linked	to	at	least	one	Ensembl	gene	by	all	
3	pipelines	(417:black),	not	linked	to	any	Ensembl	genes	by	any	of	the	3	pipelines	
(245:white),	linked	to	at	least	one	Ensembl	gene	only	by	IMAD	(26:red),	only	by	
OligoRAP	(2:blue),	only	by	sigReannot	(13:yellow),	by	IMAD	&	OligoRAP	(3:purple),	
OligoRAP	&	sigReannot	(6:green)	or	by	IMAD	&	sigReannot	(79:orange).
	 	 	 	When	an	oligo	is	linked	to	at	least	one	Ensembl	gene	by	all	3	pipelines	this	not	
necessarily	means	it	is	linked	to	the	same	Ensembl	genes,	which	is	depicted	as	
consensus	 in	 a	pie	 chart	 (B).	Agreement	between	all	 3	pipelines	 is	 subdivided	
in	 agreement	 on	 the	 presence	 or	 on	 the	 absence	 of	 links	 to	 Ensembl	 genes.	
Where	only	2	pipelines	agree	this	is	not	subdivided	and	hence	represents	a	mix	of	
consensus	on	presence	or	absence	of	annotation.	Pipeline’s	initials	indicate	the	
corresponding	pipelines	share	consensus;	a	dash	instead	of	an	initial	indicates	the	
corresponding	pipelines	lack	consensus.
	 	 	 	Reasons	for	a	lack	of	consensus	are	sorted	by	impact	(C)	and	were	counted	per	
oligo:	++	=	extra	hits	were	found	because	of	this	reason,	--	=	hits	were	missing	
because	of	this	reason.	If	an	oligo	had	multiple	hits,	multiple	reasons	can	apply,	
but	multiple	occurrences	of	the	same	reason	were	counted	only	once.
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gene	ID	versus	probes	without	any	links	to	Ensembl	genes.	Slightly	more	than	half	
(52.7	%)	of	the	oligos	is	linked	to	at	least	one	Ensembl	gene	by	all	three	pipelines.	
Unfortunately	with	31.0	%	the	second	largest	group	consists	of	the	oligos,	which	could	
not	be	linked	to	any	Ensembl	gene	by	any	pipeline.		Although	IMAD	and	OligoRAP	
can	fetch	annotation	for	additional	sources	to	boost	annotation	coverage,	this	tends	
to	be	less	informative,	because	-	apart	from	assembly	gaps	-	had	there	been	a	lot	of	
high	quality	annotation	available	for	a	hit,	this	would	have	resulted	in	an	Ensembl	
gene	model.	When	there	was	not	enough	convincing	experimental	evidence	for	an	
Ensembl	gene	model	this	often	means	the	hit	is	only	covered	by	just	a	few	or	even	
a	single	EST.	For	the	remaining	16.3	%	of	the	oligos	the	coverage	differs.	The	bulk	
of	these	(10.0	%)	are	represent	oligos	linked	to	Ensembl	only	by	IMAD+sigReannot.	
Probes	linked	to		Ensembl	only	by	IMAD	or	only	by	sigReannot	correspond	to	3.3	%	
and	1.6	%,	respectively.	Finally,	OligoRAP	appears	to	be	the	most	conservative	in	
linking	oligos	to	Ensembl	genes	as	the	amounts	of	oligos	linked	to	Ensembl	only	by	
OligoRAP,	only	by	IMAD+OligoRAP	and	only	by	OligoRAP+sigReannot	are	all	less	than	
1	%.	
In	case	an	oligo	was	not	linked	to	any	Ensembl	genes	by	any	of	the	pipelines,	they	
clearly	all	agree,	but	in	case	two	or	more	pipelines	link	to	Ensembl	genes,	that	does	
not	necessarily	mean	they	link	to	the	same	Ensembl	genes	for	the	corresponding	
oligos.	Therefore,	the	consensus	between	the	pipelines	in	linking	oligos	to	Ensembl	
genes	was	determined	(figure	4B).	For	44.2	%	all	pipelines	link	to	the	same	Ensembl	
gene(s).	 Together	with	 the	 31.0	 %	 of	 the	 probes	without	 any	 Ensembl	 gene	 link	
in	 any	 of	 the	 updated	 annotation	 datasets,	 this	 means	 the	 pipelines	 agree	 in	
approximately	three	quarters	of	the	cases.	In	2.3	%	of	the	cases	all	three	pipelines	
link	to	Ensembl	gene	IDs,	but	these	are	not	(all)	the	same.	Finally,	two	pipelines	
agree	on	either	the	presence	or	absence	of	annotation	in	1.9	%	(IMAD+OligoRAP),	
12.1	%	(OligoRAP+sigReannot)	and	8.7	%	(IMAD+sigReannot)	of	the	cases.
Reasons for a lack of consensus
In	case	the	annotation	pipelines	did	not	agree	on	the	Ensembl	genes	linked	to	an	
oligo	 the	 reason	 for	 this	 lack	 of	 consensus	was	 determined	 (figure	 4C).	Multiple	
reasons	can	apply	in	case	an	oligo	had	multiple	links,	but	if	the	same	reason	applied	
to	multiple	hits	of	the	same	oligo	this	was	counted	only	once.	In	86	cases	additional	
hits	were	present	 in	 the	 IMAD	annotation	due	 to	 lower	 thresholds.	Although	we	
tried	 to	 synchronise	 hybridisation	 filter	 thresholds	 for	 this	 pipeline	 comparison	
(see	 methods),	 this	 was	 not	 completely	 possible,	 because	 IMAD	 doesn’t	 have	 a	
longest	contiguous	stretch	filter	making	it	more	difficult	to	filter	for	relevant	short	
hits.	To	mimic	the	longest	contiguous	stretch	filter,	short	stretches	(BLAST	HSPs)	
were	considered	to	be	positive	hits	in	IMAD	when	they	had	a	minimum	amount	of	
matches	equal	to	the	longest	contiguous	stretch	size	for	OligoRAP	and	sigReannot.	
Hence	the	matches	in	these	short	HSPs	are	not	necessarily	a	contiguous	stretch,	
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which	explains	why	some	of	these	hits	are	missing	from	OligoRAP	and	sigReannot.	
It	is	questionable	whether	these	extra	IMAD	hits	will	be	able	generate	signal	in	a	
microarray	experiment,	but	this	will	depend	heavily	on	the	chosen	experimental	
conditions.
In	the	vast	majority	of	the	remaining	cases	where	consensus	is	lacking,	the	pipelines	
initially	find	the	same	hits,	but	judge	them	differently	when	deciding	whether	to	
link	 to	Ensembl	genes	based	on	 these	hits	or	not.	 In	88	and	66	cases	oligos	are	
linked	to	Ensembl	genes	located	on	the	opposite	strand	of	the	hit	with	IMAD	and	
sigReannot,	respectively.	The	difference	is	the	result	of	sigReannot	not	linking	to	
annotation	from	the	opposite	strand	if	there	was	also	annotation	on	the	strand	of	
the	hit.	Furthermore,	sigReannot	only	takes	annotation	from	the	opposite	strand	into	
account	for	HQ	hits	and	hence	ignores	such	annotation	for	LQ	hits.	So	sigReannot	is	
a	bit	more	conservative	in	linking	to	annotation	from	the	opposite	strand.
OligoRAP	only	links	a	hit	to	annotation	if	there	is	(near)	perfect	overlap	between	
the	hit	(oligo	-	genome	alignment)	and	the	annotation	(annotated	feature	-	genome	
alignment).	For	IMAD	and	sigReannot	this	does	not	apply	as	they	only	align	the	oligos	
with	transcripts.	In	case	a	hit	extended	beyond	the	borders	of	a	transcript	on	the	
genome,	 IMAD	and	sigReannot	will	find	a	shorter	hit	covering	only	 the	part	 that	
overlaps	with	the	transcript.	This	results	in	24	oligos	with	extra	links	to	Ensembl	
genes	with	IMAD	and	17	with	sigReannot	as	compared	to	OligoRAP.	The	difference	
between	IMAD	and	sigReannot	is	the	result	of	partial	overlap	combined	with	lower	
thresholds	for	IMAD	either	because	of	the	lack	of	a	contiguous	stretch	filter	in	IMAD	
(2	cases)	or	because	the	annotation	was	derived	from	the	opposite	strand	and	the	
hit	didn’t	pass	sigReannot’s	HQ	hit	thresholds	(5	cases).
SigReannot’s	UTR/intron	extension	 feature	 generates	 additional	 links	 to	Ensembl	
genes	 for	 16	 oligos	 with	 hits	 in	 the	 vicinity	 of	 Ensembl	 transcripts.	 IMAD	 and	
OligoRAP	cannot	link	to	annotation	located	in	the	vicinity	of	a	hit	on	the	genome	
and	this	explains	their	absence.
If	a	BLAST	result	contains	overlapping	HSPs	these	were	all	ignored	by	IMAD	resulting	
in	7	oligos	where	links	to	Ensembl	genes	are	missing	as	compared	to	OligoRAP	and	
sigReannot.	Further	inspection	of	these	7	probes	revealed	they	contained	repeats	
and	IMAD	has	been	adjusted	to	include	hits	from	overlapping	HSPs.
Finally,	the	“other”	leftover	category	contains	9	rare	cases.	In	one	of	these	IMAD	
missed	a	hit,	because	it	uses	BLAST	[36,	37]	with	the	default	low	complexity	filter	
switched	on,	whereas	OligoRAP	and	sigReannot	have	this	switched	off.	Three	oligos	
had	dozens	of	links	to	Ensembl,	which	were	only	partially	shared	by	the	updated	
annotation	sets	due	to	limits	on	the	amount	of	processed	hits.	These	differences	
can	be	considered	insignificant,	because	these	oligos	were	far	from	target	specific	
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and	a	 few	hits	more	 or	 less	 does	 not	 change	 that.	 In	 another	 3	 cases	OligoRAP	
missed	an	additional	 link	 to	Ensembl,	because	a	 short	 alignment	was	below	 the	
detection	thresholds	for	BLAT	[38],	which	is	a	faster	alternative	for	BLAST	and	only	
used	by	OligoRAP.	One	of	these	included	a	case	where	OligoRAP’s	intron	gap	splicing	
feature	could	not	help	to	retrieve	the	larger	alignment	with	the	transcript,	because	
the	partial	hits	were	too	short.	Finally	in	2	cases	OligoRAP	used	intron	gap	splicing	
to	merge	shorter	hits	into	longer	ones	linking	to	Ensembl	genes,	which	are	absent	
from	IMAD	and	sigReannot	annotation.	In	these	cases	Ensembl	gene	models	do	not	
support	the	intron	gaps,	but	in	one	case	additional	annotation	from	ESTs	does.
It	must	be	noted	 that	 IMAD	and	 sigReannot	normally	provide	maximally	a	 single	
link	 to	 an	 Ensembl	 gene	 per	 oligo.	 In	 case	 there	 are	multiple	 hits	 for	 an	 oligo	
these	pipelines	will	try	to	find	a	best	one	and	if	this	fails	not	link	to	Ensembl	at	
all.	For	this	workshop	the	IMAD	and	sigReannot	teams	provided	additional	data	for	
oligos	with	multiple	hits,	so	they	could	all	be	taken	into	account	and	compared,	but	
would	users	compare	standard	IMAD	and	sigReannot	data,	they	might	find	additional	
differences	due	to	different	prioritisation	of	hits	to	find	the	best	one.
	 In	 most	 cases	 the	 oligos	 with	 multiple	 hits	 are	 non-specific,	 but	 further	
investigation	 revealed	9	extreme	cases	of	 oligos	with	numerous	hits	 (up	 to	200)	
on	transcripts	representing	 large	gene	families	or	sharing	domains	such	as	genes	
coding	 for	MHC	proteins,	 olfactory	proteins,	 homeobox	proteins,	 protein	 kinases	
and	potassium	voltage-gated	channel	proteins.	Although	it	was	clearly	not	possible	
to assign a best hit in these cases linking the oligo to the gene family or shared 
domain	could	still	be	highly	informative	despite	the	lower	resolution.
Effect of differences in annotation on  
GO term enrichment analysis  
GO	term	enrichment	analysis	was	chosen	as	an	example	to	investigate	the	results	
of	 differences	 in	 updated	 annotation	 on	 functional	microarray	 analysis.	 For	 this	
analysis	all	probes	of	the	ARK-Genomics	20K	chicken	array	were	taken	into	account,	
annotation	was	updated	with	IMAD,	OligoRAP	&	sigReannot	and	enrichment	of	GO	
terms	in	the	lists	of	significantly	up-	or	down	regulated	genes	was	performed	as	
described	by	Haisheng	et	al.	[27].	Three	conditions	with	each	a	list	of	up-	and	a	list	
of	down-regulated	genes	resulted	in	a	total	of	six	gene	lists.	For	each	of	these	the	
lists	of	enriched	GO	terms	derived	from	the	3	sets	of	annotation	were	compared	
and	summarised	in	a	single	Venn	diagram	(figure	5).	With	172	GO	terms	or	67.2	%,	
the	majority	of	the	significantly	enriched	GO	terms	(p	<=	0.05)	were	the	same	in	the	
analysis	based	on	the	three	updated	annotation	sets.	That	also	means	that	there	
was	no	consensus	on	84	or	almost	one	third	of	the	terms	enriched	in	up-	or	down-
regulated	genes.	This	clearly	shows	that	differences	 in	annotation	strategies	can	
have	a	significant	effect	on	functional	analysis.	
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Optimal annotation strategies
IMAD	only	differentiates	between	oligos	with	1	hit,	multiple	hits	or	no	hits	at	all	
and	uses	a	 single	hybridisation	potential	filter	 for	 sequence	 identity.	This	 is	 less	
advanced	 than	 OligoRAP	 and	 sigReannot,	 which	 differentiate	 between	 LQ	 and	
HQ	hits	and	introduce	a	second	hybridisation	potential	filter	for	short	contiguous	
stretches	 of	matching	 nucleotides.	 Despite	 these	 differences,	 basically	 all	 three	
pipelines	can	divide	the	oligos	into	several	TSCs	giving	users	an	indication	of	the	
target	specificity	of	the	oligos.	Furthermore,	depending	on	experimental	conditions,	
users	can	customise	the	parameters	for	the	hybridisation	potential	filters.
	 After	 the	 pipelines	 have	 aligned	 oligos	 with	 potential	 targets	 they	 have	 to	
decide	whether	or	not	to	link	to	certain	annotation	based	on	these	alignments	and	
this	is	where	they	differ	the	most.	Should	the	pipelines	be	very	conservative	and	
link	only	to	annotation	derived	from	other	sequences	that	(near)	perfectly	overlap	
the	alignment	of	the	oligo	with	the	potential	target,	like	OligoRAP	does?	Or	should	
the	annotation	strategy	be	more	lenient	and	include	annotation	from	indirect	links	
like	sigReannot	does	when	it	uses	UTR/intron	extension	to	link	indirectly	to	Ensembl	
via	UniGene?	 	 The	question	basically	 boils	 down	 to	whether	 to	prefer	 reliability	
over	coverage	or	the	other	way	around.	After	some	discussion	during	the	workshop	
the	 biologists	 present	 decided	 they	 couldn’t	 choose	 between	 optimal	 coverage	
and	optimal	reliability.	 Instead	they	would	prefer	to	have	as	much	annotation	as	
possible	and	have	metadata	attached	to	the	annotation	indicating	the	reliability	of	
the	link	between	the	oligo	and	for	example	an	Ensembl	gene.	Similar	to	the	target	
specificity	categories	one	can	think	of	a	few	annotation	link	reliability	categories	
Consensus
GO Term Enrichment
Shared
GO Terms
Enriched
with updated
Annotation
IMAD
sigReannot
OligoRAP
Figure 5:  Consensus on GO Term Enrichment Analysis
	 	 	 	Venn	 diagram	 representing	 consensus	 on	 the	 GO	 terms	 retrieved	 from	 term	
enrichment	analysis	with	updated	annotation	from	IMAD,	OligoRAP	or	sigReannot.	
Colours	represent	terms	found	with	annotation	from	all	pipelines	(172:black),	from	
IMAD	only	(10:red),	from	OligoRAP	only	(8:blue),	from	sigReannot	only	(19:yellow),	
from	IMAD	&	OligoRAP	(7:purple),	from	OligoRAP	&	sigReannot	(26:green)	or	from	
IMAD	&	sigReannot	(14:orange).
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that	would	allow	the	biologists	to	filter	their	results	in	downstream	analysis	and	see	
the	effect	of	in-	or	excluding	less	reliable	annotation	in	addition	to	the	effect	of	
in-	or	excluding	potential	non-specific	oligos.	We	propose	the	following	categories:
		1	 	Direct	sequence-based	links:
	 annotation	was	derived	from	alignment	of	the	oligo	with	a	target	sequence.
  2  Indirect links
	 		a	 	Sequence-based	 and	 with	 (near)	 perfect	 overlap	 of	 the	 oligo-target	
alignment	with	the	alignment	of	the	target	with	the	other	sequence	from	
which	the	annotation	is	derived.
	 		b	 	Sequence-based	 and	 with	 partial	 overlap	 of	 the	 oligo-target	 alignment	
with	the	alignment	of	the	target	with	the	other	sequence	from	which	the	
annotation	is	derived.
	 		c	 	Sequence-based	 and	 without	 any	 overlap	 of	 the	 oligo-target	 alignment	
with	the	alignment	of	the	target	with	the	other	sequence	from	which	the	
annotation	is	derived.
	 	 		i	 	Oligo-target	alignment	is	located	up-	or	downstream	in	the	vicinity	of	
the	gene	from	which	the	annotation	is	derived.
	 	 		ii	 	Oligo-target	alignment	is	located	in	an	intron	of	the	gene	from	which	the	
annotation	is	derived.
	 	 		iii		Oligo-target	 alignment	 is	 located	 on	 the	 opposite	 strand	 of	 the	 gene	
from	which	the	annotation	is	derived.
	 		d	 	Non	sequence-based	links.	For	example	in	the	case	of	expanding	annotation	
using	text	mining.
	 		e	 	Non	gene-specific	link.	For	example	to	a	gene	family	or	shared	domain.	
These	categories	can	be	easily	expanded	where	necessary.	For	category	2cii	one	
could	 flag	 for	 example	 whether	 there	 was	 other	 sequence-based	 evidence	 that	
makes	the	link	more	reliable.	This	would	be	the	case	if	an	oligo	aligns	with	an	intron	
and	if	there	are	ESTs	that	align	with	both	the	gene’s	exons	and	the	intron	suggesting	
the	gene	model	was	too	conservative	and	intron	retention	splice	variants	do	exist.
Conclusions 
Approximately	four	years	after	the	design	of	the	ARK-Genomics	20K	chicken	array	
almost	one	third	of	the	probes	could	no	longer	or	still	not	be	linked	to	high	quality	
annotation	in	the	form	of	a	link	to	an	Ensembl	gene	with	neither	IMAD	nor	OligoRAP	
nor	sigReannot.	This	indicates	that	keeping	annotation	as	well	as	target	specificity	
up-to-date	is	important	to	make	most	of	microarray	experiments.
	 IMAD,	OligoRAP	and	sigReannot	can	assign	oligos	 to	 target	 specificity	classes	
(TSCs)	although	with	different	 levels	of	resolution.	These	TSCs	are	based	on	the	
amount	of	target	each	oligo	hits	and	users	can	specify	thresholds	for	hybridisation	
potential	filter	used	to	determine	the	impact	of	these	hits.	Thereby	the	hybridisation	
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potential	 filters	 combined	with	 the	 TSCs	 give	 users	 the	 flexibility	 to	 adjust	 the	
target	specificity	estimates	to	their	experimental	conditions.	In	addition	it	allows	
them	to	play	 safe	by	discarding	potential	 cross-hybridising	probes	or	 live	on	 the	
edge	to	get	higher	annotation	coverage.	In	contrast	to	target	specificity	users	have	
no	control	over	the	annotation	that	is	fetched	based	on	the	hits	of	the	oligos	with	
potential	 targets.	Fetching	annotation	 from	 indirect	 relationships	between	oligos	
and	potential	targets	can	help	to	boost	coverage,	but	will	also	result	in	varying	levels	
of	reliability	of	the	updated	annotation.	Not	only	have	users	currently	no	control	
over	which	annotation	is	retrieved,	they	currently	also	cannot	see	the	difference	
between	annotation	from	more	reliable	direct	links	and	from	less	reliable	indirect	
links.	Based	on	the	feedback	from	the	EADGENE/SABRE	post-analysis	workshop	we	
therefore	 suggest	 annotation	 link	 reliability	 categories	 be	 added	 to	 indicate	 the	
type	of	relationship	between	oligos	and	their	annotation.	Adding	such	indicators	for	
the	reliability	of	the	annotation	will	be	an	important	step	in	the	future	development	
of	IMAD,	OligoRAP	and	sigReannot	and	allow	users	to	fine	tune	the	balance	between	
reliability	 and	 coverage.	 This	 is	 important	 as	 it	 can	 have	 a	 significant	 effect	 on	
functional	 analysis	 of	 microarray	 data	 as	 exemplified	 by	 the	 lack	 of	 consensus	
on	almost	one	third	of	 the	terms	found	with	GO	term	enrichment	analysis	using	
updated	annotation	generated	with	IMAD,	OligoRAP	and	sigReannot.
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Further information and supplemental data
Links	 to	 supplemental	files	with	annotation	as	used	 for	 the	workshop	as	well	as	
presentations	as	presented	at	the	workshop	are	available	from	the	EADGENE	portal:
http://www.eadgene.info/NewsandEvents/EADGENEEvents/
EADGENEandSABREPostanalysesWorkshop/AnnotationWorkshopResults/tabid/345/
Default.aspx
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Updated annotation reveals discrepancy between 
commonly used experimental conditions for 
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target specificity for high throughput gene 
expression experiments.
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Abstract 
Background
High throughput gene expression studies using oligonucleotide microarrays depend 
on the specificity of each oligonucleotide (probe) for its target gene. However, 
target specific probes can only be designed when a reference genome of the species 
at hand were completely sequenced, when this genome were completely annotated 
and when the genetic variation of the sampled individuals were completely known. 
Unfortunately there is not a single species for which such a complete data set is 
available. Furthermore detailed information about the experimental conditions is 
required to determine the effect of natural variation on hybridisation potential 
as well as the cross-hybridisation thresholds for the similarity of oligos with non-
targets.  
 Using updated annotation and target specificity for a typical long oligo array 
we could determine if hybridisation potential thresholds to measure differential 
gene expression in mouse based on this annotation are compatible with previously 
established thresholds that would fit the experimental characteristics of long oligo 
arrays best. 
Results
Analysis of a typical long oligo (65-mer) mouse array originally designed in 2000-
2001 indicates optimal signal potential is achieved with rather lenient thresholds for 
probe-target alignments, whereas optimal target specificity is achieved with rather 
stringent thresholds as compared to thresholds previously established as optimal 
based on the biochemical properties of long oligo arrays. Especially for short 
contiguous stretches of matching nucleotides the discrepancy between the two 
is alarmingly large with the annotation suggesting a maximum longest contiguous 
stretch of 32 nucleotides whereas experiments have shown that a longest contiguous 
stretch of 15-20 would be required as threshold for alignments of oligos with non-
targets to prevent cross-hybridisation.
Conclusions
As micro arrays are designed on incomplete data, it is important to update 
probe annotation and check target specificity regularly. Evolution of the mouse 
genome annotation over the past 6 years reveals optimal hybridisation conditions 
for differential gene expression experiments using long oligo arrays can be quite 
different from what is commonly used based on experimentally established 
relationships between probe-target alignments and hybridisation potential.
Hybridisation filter thresholds for optimal target specificity
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Background 
DNA micro array technology [1, 2] has become a popular platform for high throughput 
gene expression analysis. Micro arrays allow biologists to measure the expression of 
entire transcriptomes at relatively high speed and low cost making them potentially 
ideal for applications like sample clustering / fingerprinting, genome annotation, 
detection of differential gene expression, detection of polymorphisms and re-
sequencing [3, 4]. A key concept of micro array technology is hybridisation of 
target sequences representing a gene’s RNA product with oligonucleotides (probes). 
Therefore, depending on array platform a probe must be a small sub-sequence of 
either its target gene or of the reverse complement of its target gene and to make 
sure a probe is unique for a certain target, optimal micro array design requires 
1) a completely sequenced reference genome, 2) complete annotation of this 
reference genome to know what parts may be expressed, 3) complete knowledge 
about the natural variation amongst the sampled individuals and 4) knowledge of 
the experimental conditions that determine the thresholds at which amount of 
dissimilarity probes will no longer hybridise with non-targets.
 Unfortunately there is currently not a single species for which such complete 
information is available. Although some reference genomes are now close to 
completion, the recently published first results of the ENCODE project indicate that 
our knowledge of what is expressed is vastly underestimated [5]. Hence, certainly 
when a reference genome is not available and array design is primarily based on 
expressed sequence tags (ESTs), but also for species with a rather complete reference 
genome, micro array design is sub-optimal. Probe design based on incomplete or 
erroneous data can lead to serious problems like non-specific probes causing cross 
hybridisation, orphan probes designed for non-existing targets, missing probes and 
misleading probes due to erroneous annotation.
 Furthermore, our knowledge on optimal experimental conditions for long oligo 
arrays is based on a limited amount of relatively small-scale experiments [6-9]. In 
these experiments conditions for optimal signal to noise ratios were determined 
first. Next, the maximum permissible amount of similarity probes can share with 
non-targets without resulting in cross-hybridisation was determined under these 
experimental conditions. Currently these experimental conditions are widely used 
for array hybridisation and the corresponding cross-hybridisation thresholds for 
probe design.
 It remains unclear though whether these experimentally established parameters 
based on relatively small-scale experiments scale to whole genome gene expression 
studies. Therefore, we have used OligoRAP [10] to update the annotation and target 
specificity for a typical long oligo mouse array - Compugen’s MOULIB384 - using a 
wide range of thresholds for probe-target alignments. Using this parameter sweep 
the optimal annotation-based thresholds for both signal to noise ratio and cross-
hybridisation can be established for the application of studying differential gene 
expression in mice with this oligo library. Finally, we can compare these annotation-
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they are compatible.
OligoRAP’s target specificity classes (TSCs)
OligoRAP is a pipeline of BioMoby web services to update annotation and target 
specificity for oligonucleotides. One of these services is OligoQualityAnalyser, which 
uses three user-definable filters to determine the hybridisation potential of each 
oligo-target alignment: 1) minimum percentage sequence identity, 2) maximum 
amount of mismatches and 3) minimum length of the longest contiguous stretch. 
OligoQualityAnalyser differentiates between primary and secondary hits (figure 
1). Primary hits are defined as (near) perfect hits having optimal signal to noise 
ratio under the hybridisation conditions. Imperfect hits, not qualifying as primary 
hit, but still causing a significant amount of noise are labelled secondary hits. The 
hybridisation potential filters are complementary. So, hits are considered to be 
secondary if one or more filters predict secondary hybridisation potential unless 
one of the filters predicts primary hybridisation potential in which case the hit is 
considered to be a primary hit. If a hit is not able to trigger any of the thresholds 
for a combination of filter settings it is ignored for that filter settings combination. 
 Based on the amount of primary and secondary hits the oligos are divided into 
six target specificity categories (TSCs, see figure 2):
  1 Gene-specific probes with maximum signal potential
  2 Gene-specific probes with reduced signal potential
  3 Non-specific probes with maximum signal potential
  4 Non-specific probes with mixed signal potential
  5 Non-specific probes with reduced signal potential
  6 Orphan probes with background signal potential.
Gene-specific probes have only one hit, non-specific probes hit multiple targets 
and orphan probes no longer hit any target gene. Maximum signal potential 
indicates primary hits, reduced signal potential indicates secondary hits, mixed 
signal potential is the result of a mix of both primary and secondary hits and finally 
background signal potential means the oligo doesn’t have primary nor secondary 
hits and hence is an orphan. Target specificity is determined twice: for genome-
based target specificity (GbTS) and for transcriptome-based target specificity 
(TbTS). In the context of GbTS all hits are counted irrespective of whether they 
had any evidence/annotation indicating they might be expressed or not. For the 
TbTS context on the other hand only hits with expression evidence are taken into 
account. OligoQualityAnalyser keeps track of the amount oligos in each TSC per 
combination of filter settings and per context. 
Hybridisation filter thresholds for optimal target specificity
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Figure 1:  Relationships between filter thresholds, primary & secondary hits and 
estimated signal intensity.
    Primary hits (green) represent (near) perfect alignments of oligos with their 
targets. Secondary hits (orange) are defined as worse than primary hits, but still 
capable of generating signal above background. Relative signal intensity is shown 
on the vertical axis and the 3 filters - mismatches, sequence identity and longest 
contiguous stretch - on 3 horizontal axes. Signal intensity drops as the amount 
of mismatches increases and as the percentage sequence identity or the length 
of the longest contiguous stretch decreases. Estimated signal intensity above the 
primary hit threshold (green) is defined as “maximum signal”. Estimated signal 
below the primary and above the secondary hit threshold (orange) is defined as 
“reduced”. Finally estimated signal below the secondary hit threshold is defined 
as “background signal”.
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Results & Discussion
OligoRAP was used to update annotation and target specificity for the Compugen 
mouse array (MOULIB384 standard + extension). This typical long oligo library contains 
a total of 21.766 oligos without controls. All MOULIB384 oligos are 65 nucleotides 
long and were designed based on GenBank 121 (standard) or 126 (extension) in 2000 - 
2001. Different combinations of filter thresholds were used to determine their effect 
on target specificity more than 6 years after the initial design. Primary hit threshold 
(PHT) / secondary hit threshold (SHT) values for the mismatches filter range from 
0/1 to 40/45 mismatches. For the length of the longest contiguous stretch values 
range from 65/64 to 18/16 nucleotides and for the percentage sequence identity 
from 100/98 to 40/35 percent. Three-dimensional graphs showing the distribution 
of probes over target specificity classes are available as supplementary material 
(figures S1-S6).
Transcriptome-based versus genome-based target specificity
Up till recently the transcriptome of mammals was thought to contain a very small 
subset of the genome. For example in Ensembl 50 less than 5 % of the mouse 
genome is annotated as exon. Since only potentially expressed sequences can 
hybridize to probes on a micro array, most oligo design and annotation efforts 
have focused on known and/or predicted transcripts without taking the rest of the 
genome into account. Apart from a few structural elements like the centromeres 
and telomeres it’s still not clear what the function of the other 95 % or more of 
DNA is, but slowly evidence is piling up indicating the size of the transcriptome is 
vastly underestimated. Especially the findings of pilot phase of the ENCODE project 
showed that the human “genome is pervasively transcribed, such that the majority 
of its bases can be found in primary transcripts” [5]. It remains unclear whether 
all these transcripts are biologically functional or whether they just represent 
noise, but it is clear that all transcripts can potentially hybridize with the oligos 
on micro arrays. Although the ENCODE pilot study covered only approximately 1 % 
of the human genome it is clear that our view on the transcriptome will change 
dramatically over the next years. This will have a big impact on oligo annotation & 
target specificity. Therefore, it is more important than ever to be able to update 
oligo annotation quickly and regularly.
 OligoRAP provides estimated target specificity based both on the transcriptome 
and genome and we investigated how big the difference between these two different 
contexts is for the MOULIB384 oligo library. For each combination of primary and 
secondary hit thresholds the amount of probes in each target specificity class (TSC) 
was calculated per filter. Table 1 shows the correlation between genome-based 
target specificity (GbTS) and transcriptome-based target specificity (TbTS).
 For the mismatches filter and a SHT of up to 40 mismatches the correlation is 
extremely high with an average of 0.99. This indicates that the trend of how oligos 
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Figure 2:  Overview of OligoRAP’s six target specificity classes, which are defined by 
the amount of primary and secondary hits.
    Figure showing how target specificity classes are defined based on hits. Primary 
hits (green) represent (near) perfect alignments of oligos with their targets. 
Secondary hits (orange) are defined as worse than primary hits, but still capable 
of generating signal above background. Classes are named after the combination 
of probe type (gene-specific, non-specific or orphan) and estimated potential 
signal (maximum, reduced, mixed or background).
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Figure 3:  Cumulative graph showing the balance between gene-specific (TSC 1+2), 
non-specific (TSC 3+4+5) and orphan oligos (TSC 6).
    When target specificity classes (TSCs) are combined in this way, the primary 
hit threshold has no effect on the combined classes. The amount of oligos per 
combined TSC as percentage of the total amount of oligos in the library is 
shown on the vertical axis and the secondary hit threshold in nucleotides on 
the horizontal axis. (A) Effect of the length of the longest contiguous stretch 
on target specificity. (B) Effect of the total amount of mismatches on target 
specificity.
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are distributed over the TSCs as result of different PHTs & SHTs is virtually the 
same for GbTS and TbTS. Although trends are the same, this does not mean that the 
absolute amount of oligos in a certain TSC is the same for GbTS and TbTS. Therefore 
we also calculated the mean difference of the number of oligos in a certain TSC as 
percentage of the total amount of oligos for GbTS compared to TbTS (delta). For 
example with the mismatches filter the delta for TSC 1 is -1.0 %. This means there 
is on average 1 percent less gene-specific oligos with an estimated maximum signal 
potential (TSC 1) when all hits are taken into account as compared to taking only 
hits annotated as potentially expressed into account. The largest differences are a 
decrease of 2.5 % in orphan oligos (TSC 6) and an increase of 2.3 % in non-specific 
oligos with estimated mixed signal potential (TSC 4). So compared to TbTS, GbTS 
results in a small decrease of gene-specific and orphan oligos compensated by an 
increase in non-specific oligos, but overall the differences are marginal. In the light 
of the results of the ENCODE study it is safer to use GbTS and fortunately this does 
not result in a dramatic decrease of gene-specific oligos.
 The situation for the percentage identity filter is virtually the same as for 
the mismatches filter. Any small differences are the result of rounding or slightly 
different combinations of thresholds sampled. This makes perfect sense, as all 
oligos in the MOULIB384 library are equally long. Hence the relative amount of 
mismatches (percentage identity) should be the same as the absolute amount of 
mismatches. Therefore the percentage identity filter will not be discussed further 
in the next sections. For libraries of oligonucleotides with different sizes it can be 
useful though to have a filter for relative in addition to one for the absolute amount 
of mismatches.
 In contrast to the mismatches filter the situation is different for the longest 
contiguous stretch filter. Looking at the complete range of SHT values (64-16 
nucleotides) there is less correlation between GbTS & TbTS with an average of 
0.91.  There is also a relatively large shift from gene-specific oligos with estimated 
maximum signal potential (TSC 1) to non-specific oligos with estimated mixed signal 
potential (TSC 4) with delta values of -8.1 % and 10.6 % respectively. As indicated 
by the 3D graphs in the supplemental material this breakdown of correlation occurs 
for SHT values below 24 nucleotides. Therefore correlation and delta were also 
calculated separately for filter threshold combinations with SHTs ranging from 64-
24 nucleotides and from 22-16 nucleotides. With the former average correlation 
is extremely high at 0.99 with very low delta values just like for the mismatches 
filter, but below 24 nucleotides the average correlation drops to 0.88 and delta for 
TSC1 and TSC 4 increases to ~ 30 %. Hence below 24 nucleotides the chance that 
an oligo aligns with additional regions of the genome increases rapidly resulting in 
a breakdown of correlation accompanied with a steep decrease of oligos in TSC 1 
and an increase in TSC 4. (When SHT values > 40 nucleotides or < 40 % sequence 
identity would be allowed for the mismatches and percentage identity filter 
respectively, a similar breakdown of correlation would be visible for these filters, 
but such values are so far of the scale for realistic experimental conditions that they 
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are not further discussed here. See also “Can annotation-based optimal thresholds 
be combined with realistic experimental conditions?”) So with the results of the 
ENCODE project still in mind, it’s safer to use GbTS compared to TbTS, but with 
the longest contiguous stretch filter this will result in a dramatic decrease of gene-
specific oligos if experimental conditions allow a hybridizing stretch of less than 24 
nucleotides to generate significant noise.
Annotation-based thresholds for  
optimal oligonucleotide target specificity
Most micro arrays are used for differential gene expression experiments, resulting 
in relative gene expression values. Hence, in such experiments it’s not important 
to determine absolute gene expression values. As long as the probe is specific for 
its target and the signal to noise ratio high enough, it doesn’t matter whether the 
signal potential is maximum or reduced due to a sub-optimal alignment. Therefore 
the following combined categories are the most important for differential gene 
expression experiments: gene-specific (TSC 1+2), non-specific (TSC 3+4+5) and 
orphan (TSC 6). The amount of oligos per combined TSC is solely dependent on the 
SHT with these combinations. So for a certain SHT, the PHT only affects how the 
oligos are distributed over the TSCs making up the combined gene-specific or non-
specific combined TSCs. Figure 3 shows the effect of the SHT on the distribution 
of oligos over the combined gene-specific, combined non-specific and orphan oligo 
TSCs. 
 For the longest contiguous stretch filter there is a clear optimum of ~ 82 % gene-
specific oligos at a secondary hit threshold of 32 nucleotides with GbTS (figure 3A). 
This corresponds with ~ 11 % non-specific and ~ 7 % orphan oligos. The breakdown of 
correlation between GbTS & TbTS, as previously described for the individual TSCs, 
is also clearly visible for the combined TSCs: Below a secondary hit threshold of 
24 nucleotides, the amount of orphan oligos steadily declines with both contexts, 
but with GbTS the amount of non-specific oligos explodes at the expense of gene-
specific probes. Eventually the amount of non-specific oligos even exceeds the 
gene-specific oligos. The optimum of gene-specific oligos with TbTS is the same at ~ 
82 % with a SHT of 32 nucleotides. At this threshold ~ 8 % of the oligos is non-specific 
and ~ 10 % is orphan, which is a slight shift from non-specific to orphan oligos as 
compared to with GbTS.
 The situation for the mismatches filter is quite different (figure 3B). Since the 
correlation between GbTS & TbTS for the individual TSCs was extremely high, the 
trends in the pictures for the combined TSCs are also virtually the same. However, 
in contrast to the longest contiguous stretch filter, the optimum for gene-specific 
oligos protrudes less clearly. The highest amount of gene-specific oligos is ~ 79 % or ~ 
80 % with GbTS or TbTS and a SHT between 16-35 or 20-35 nucleotides, respectively. 
But the differences are very small with minimal gene-specific oligo percentages of 
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~ 76 % and ~ 75 % for the two contexts. Hence, in case of the mismatches filter the 
SHT mostly affects the balance between non-specific and orphan oligos.
 Now that we have established the optimal SHTs based on the annotation, figure 
4 shows how the PHT affects the distribution of oligos over TSCs with maximum, 
mixed or reduced signal potential at the optimal secondary hit threshold. When a 
gene-specific probe’s signal potential is reduced due to a sub-optimal alignment 
with its target, the probe might still be useful to detect highly and differentially 
expressed genes, but the signal might get lost in the background when genes are 
differentially expressed at relatively low expression levels. Hence, the optimal 
primary hit threshold is the one with the most maximum signal potential oligos 
and the least reduced signal potential oligos. The trends for the longest contiguous 
stretch filter (figure 4A) are slightly different than the trends for the mismatches filter 
(figure 4B), but in both cases the optimal PHT is the one closest to the SHT. Hence 
optimal PHT/SHT combinations based on the annotation are 32/34 for the longest 
contiguous stretch and 20/25 for the mismatches filter with the 2 and 5 nucleotide 
sampling intervals used around the optimal thresholds in this experiment. If the 
sampling intervals would be smaller the optimal PHT would probably be even closer 
to the SHT.
Can annotation-based optimal thresholds be combined with 
realistic experimental conditions?
The annotation shows there is an optimal amount of gene specific oligos with rather 
lenient PHTs and rather stringent SHTs. In addition to the former, the amount of 
orphan oligos even with GbTS can be as high a ~ 20 % with the most stringent 
thresholds. This indicates there is quite a bit of natural variation between the 
sequences used to design the oligos years ago and the “reference” sequences 
used to update the annotation today. So if one would use a long oligo array for 
differential gene expression and the individuals sampled are different from the 
individuals used to design the oligos, which is usually the case, researchers should 
look for hybridisation conditions that fit lenient PHTs to get the most maximum 
signal potential oligos. This could be achieved for example with relatively low 
hybridisation temperatures.
 If stringent hybridisation conditions were to be used, highly expressed genes 
might give a differential signal as result of differences in the sequences of the 
target genes in the different samples, as result of differential gene expression or 
as a result of a mix of both. The problem is that there is no way to distinguish 
between these two. Furthermore, a lack of signal on the array might indicate a 
lowly expressed gene with differences between the “reference” target gene used 
for probe design and the sampled target gene instead of a lack of gene expression. 
Again there is now way to distinguish between these two based on the array data.
 Although lenient PHTs increase the total amount of maximum signal potential 
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oligos, it will be very hard to prevent cross-hybridisation especially for highly 
homologous genes. So researchers who are specifically interested in the small 
subset of genes with highly similar sequences are better off with stringent PHTs, 
but they should realize this will be sub-optimal for the vast majority of the probes. 
At the same time the annotation suggests rather stringent SHTs to prevent cross-
hybridisation for optimal amounts of gene-specific probes. This would require for 
example higher hybridisation temperatures, but that is incompatible with the lower 
hybridisation temperatures required for optimal amounts of oligos with maximum 
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Figure 4:  Cumulative graph showing the effect of the primary hit threshold on the 
distribution of oligos over the TSCs at the optimal secondary hit threshold
    The amount of oligos per TSC as percentage of the total amount of oligos in the 
library is shown on the vertical axis and the primary hit threshold in nucleotides 
on the horizontal axis. (A) Effect of the length of the longest contiguous stretch 
on target specificity. (B) Effect of the total amount of mismatches on target 
specificity.
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signal potential.
 Experimental data remains scarce, but Kane et al. have shown for 50-mers 
that imperfect oligo - target matches with more than 75 % sequence identity or 
contiguous stretches of 15 nucleotides or more can cause detectable noise [7]. 
Liebich et al. on the other hand found for 50-mers a maximum longest contiguous 
stretch of 20 nucleotides and a maximum percentage identity of 90 % as thresholds 
for detectable noise [9]. Finally He et al. investigated both 50-mers and 70-mers. 
They found maximum longest contiguous stretches of 15 nucleotides (50-mers) or 
20 nucleotides (70-mers) and a maximum sequence identity percentage of 85 % 
for alignments with non-targets as optimum thresholds for gene specific probes to 
prevent cross-hybridisation [6]. It is difficult to compare these experiments due to 
the differences in hybridisation conditions. Hybridisation temperature for example 
was 42º C [7], 45º C [6] and 50º C [9]. 
 Nevertheless all of these experimental optimal thresholds for micro array probe 
design are incompatible with optima as suggested by the updated annotation for the 
MOULIB384 oligos. For example the optimum SHT for the longest contiguous stretch 
filter was 32 nucleotides. Hence stretches < 32 nucleotides should not produce 
significant noise, but Kane et al. found ~ 30 % and ~ 50 % signal compared to perfect 
matching probes for imperfect matches with stretches of 30 or 35 nucleotides, 
respectively. Similarly, He et al. found ~ 30 % and ~ 55 % signal for stretches of 25 
and 35 nucleotides with 50-mers or ~ 26 % and ~ 32 % with stretches of 30 and 35 
nucleotides with 70-mers. Finally, Liebich et al. detected ~ 40 % for stretches of 
30 nucleotides. Kane et al. specifically mention that increasing the hybridisation 
temperature to over 50º C reduced cross-hybridisation noise in some cases, but 
simultaneously reduced the signal for all data points resulting in reduced sensitivity 
[7]. This is also visible in the study of Letowski et al., who investigated the effect 
of mismatches at 42º, 47º and 53º C as well as differences in GC percentage for 
50-mers [8]. Depending on GC %, temperature and location of the mismatches, 
contiguous stretches of 30 nucleotides were able to generate anywhere between 
~ 10 up to 100 % signal intensity. Increasing the temperature would decrease the 
signal produced by contiguous stretches of 30 nucleotides, but it was not possible to 
get the relative signal intensity from contiguous stretches of 30 nucleotides below 
10 % without a drop in relative signal intensity for perfect match probes to ~ 50 %.
 When hybridisation conditions similar to the ones used in the experiments 
described above would be used with a MOULIB384 array, less than 70 % of the oligos 
would be gene-specific with TbTS. In case our understanding of the transcriptome is 
vastly underestimated as indicated by the ENCODE study and GbTS would be a more 
realistic measure, the amount of gene-specific probes could even drop dramatically 
to << 50 %.  Further experiments are required to investigate if conditions that fit our 
current understanding of transcriptomes and their natural variation optimally will 
be possible at all.
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Conclusions
Micro array probes are designed on incomplete data and hence under sub-optimal 
conditions. Therefore it is important to update probe annotation and estimate 
target specificity regularly. OligoRAP analysis of the Compugen MOULIB384 long 
oligo array shows that - based on current genome annotation - rather lenient filter 
thresholds for the alignment of the oligos with their targets are required to cope 
with the natural variation between the sequences used to design the oligos and the 
current reference sequences / assemblies. At the same time the OligoRAP analysis 
indicated rather stringent thresholds are required to prevent cross-hybridisation. The 
optimal thresholds for signal / noise ratios and for target specificity as determined 
with OligoRAP based on the current annotation appear to be incompatible with 
experimentally determined cross-hybridisation thresholds commonly used for array 
design. Using more stringent hybridisation conditions like a higher temperature can 
be used to prevent cross-hybridisation, but will have a dramatic negative effect on 
signal to noise ratios. Furthermore, under conditions stringent enough to prevent 
cross-hybridisation a difference in signal between samples will no longer be the 
result of differential gene expression alone, but also of polymorphisms between 
the sampled individuals. This is bad news for those who explicitly want to measure 
differential gene expression for example as result of different environmental factors 
or different treatments. But for those investigating the effect of different genetic 
backgrounds on phenotypes, the good news is that these polymorphisms might be 
actually even more interesting than the difference in gene expression as the former 
can be the cause of the latter. Further research will be required to investigate if 
the chemistry on the array can be modified in a way that will fit differential gene 
expression experiments more optimally. 
Methods
Microarray annotation was updated with OligoRAP web services as previously 
described [10] unless explicitly stated otherwise below. Genome assemblies were 
downloaded from Ensembl (NCBIM37 for Mus musculus and NCBI36 for Homo 
sapiens). UMT sequences were derived from RefSeq 30 and UniGene 174 for Mus 
musculus or UniGene 214 for Homo sapiens. Expression evidence for oligo hits was 
derived from the Ensembl 50 core, otherfeatures and cdna databases. Mapping from 
UniGene, RefSeq and INSDC (DDBJ & EMBL & GenBank) to Entrez Gene was taken 
from gene2unigene, gene2refseq and gene2accession as provided by the NCBI ftp 
server on 26-08-2008. GO terms were derived from both the Ensembl 50 compara 
database as well as from the Entrez Gene gene2go file of 26-08-2008. 
Web service specifics
OligoAnnotationAnalyser: Thresholds for dropping hits: mismatches = 45, contiguous 
stretch = 16, percentage identity = 30. OligoQualityAnalyser: Mismatch thresholds* 
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= 0, 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 25, 30, 35, 40 and 45; Longest contiguous 
stretch thresholds** = 65, 64, 62, 60, 58, 56, 54, 52, 50, 48, 46, 44, 42, 40, 38, 36, 
34, 32, 30, 28, 26, 24, 22, 20, 18, and 16; Percentage identity thresholds** = 100, 98, 
96, 94, 92, 90, 85, 80, 75, 70, 65, 60, 55, 50, 45, 40 and 35; * = all combinations 
as long as: primary hit threshold < secondary hit threshold; ** = all combinations as 
long as: primary hit threshold > secondary hit threshold.
Microarray
The MOULIB384 library - both the standard (STD) and extension (EXT) - contains 
a total of 21766 probes excluding positive controls. Positive controls were left out 
of the analysis as these are expected to be non-specific and generate a lot of un-
informative hits. Probe sequences were downloaded from www.labonweb.com as 
provided by Compugen (Adjuvant Global Advisors 7101, Wisconsin Avenue, Suite 
1001 Bethesda, MD 20814, USA). 
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Supplementary material
Figures S1-S6:  Distribution of oligos over TSCs
     The 3D surface plots on the next pages show the amount of oligos 
per target specificity class on the vertical axis versus the thresholds 
for primary and secondary hits on the other two axis. The sub graphs 
1-6 in each figure correspond with the 6 target specificity classes: 
sub graph 1 shows only TSC 1, the other sub graphs show TSC1 for 
reference at the top and TSC 2, 3, 4, 5 or 6 at the bottom.
     When TSC 1 is shown for reference in sub graphs 2-6, data for some 
of worst alignments (lowest contiguous stretches, lowest percentage 
identity, or highest number of mismatches) is left out, because the 
drop in TSC 1 oligos is so dramatic it would otherwise obscure the 
view on the other TSC shown at the bottom of the graph. Sub graphs 
2,4 and 5 are rotated 180º around the vertical axis compared to sub 
graphs 1, 3 and 6 for a better viewing angle on the corresponding 
TSC.
     Figures S1-S3 show genome-based target specificity, whereas figures 
S4-S6 show transcriptome-based target specificity. Figures S1 
+ S4 are for the longest contiguous stretch filter, S2 + S5 for the 
mismatches filter and S3 + S6 for the percentage identity filter. In 
order to make any biological sense, primary hits must always have 
higher hybridisation potential than secondary hits. This explains the 
triangular shape of the 3D surfaces. 
Hybridisation filter thresholds for optimal target specificity
103
Effect of the longest contiguous stretch on genome-based oligo target specificity.
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Figure S1: see start of the supplementary material section for legend
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Effect of mismatches on genome-based oligo target specificity.
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Figure S2: see start of the supplementary material section for legend
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Effect of percentage identity on genome-based oligo target specificity.
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Figure S3: see start of the supplementary material section for legend
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Effect of the longest contiguous stretch on transcriptome-based oligo target specificity.
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Figure S4: see start of the supplementary material section for legend
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Effect of mismatches on transcriptome-based oligo target specificity.
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Figure S5: see start of the supplementary material section for legend
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Effect of percentage identity on transcriptome-based oligo target specificity.
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Abstract 
Background
R is the statistical language commonly used by many life scientists in (omics) 
data analysis. At the same time, these complex analyses beneﬁt from a workﬂow 
approach, such as used by the open source workﬂow management system Taverna. 
However, Taverna had limited support for R, because it supported just a few data 
types and only a single output. Also, there was no support for graphical output and 
persistent sessions. Altogether this made using R in Taverna impractical.
Findings
We have developed an R plugin for Taverna: RShell, which provides R functionality 
within workﬂows designed in Taverna. In order to fully support the R language, 
our RShell plugin directly uses the R interpreter. The RShell plugin consists of a 
Taverna processor for R scripts and an RShell Session Manager that communicates 
with the R server. We made the RShell processor highly conﬁgurable allowing the 
user to deﬁne multiple inputs and outputs. Also, various data types are supported, 
such as strings, numeric data and images. To limit data transport between multiple 
RShell processors, the RShell plugin also supports persistent sessions. Here, we will 
describe the architecture of RShell and the new features that are introduced in 
version 1.2:
 i)  Support for R up to and including R version 2.9
 ii)  Support for persistent sessions to limit data transfer
 iii)  Support for vector graphics output through PDF
 iv)  Syntax highlighting of the R code
 v)  Improved usability through fewer port types.
Our new RShell processor is backwards compatible with workﬂows that use 
older versions of the RShell 1 processor. We demonstrate the value of the RShell 
processor by a use-case workﬂow that maps oligonucleotide probes designed with 
DNA sequence information from Vega onto the Ensembl genome assembly.
Conclusion
Our RShell plugin enables Taverna users to employ R scripts within their workﬂows 
in a highly conﬁgurable way.
RShell
113
In
tr
od
uc
ti
on
D
is
cu
ss
io
n 
&
 C
on
cl
us
io
ns
2
1
3
4
5
A
Findings
Background 
The open source workﬂow system Taverna [1] provides access to and integration of 
many life science web services. However, not all desired data-analysis procedures 
are available as web services. Therefore, support for scripting is essential and by 
default, Taverna provides scripting in Java. Many scientists are not familiar with 
Java and prefer other languages, such as R, a statistical language commonly used 
by many life scientists [2]. Taverna had limited support for R. We developed an R 
plugin for Taverna: RShell, which removes the limitations of R support in Taverna 
workﬂows. RShell can be incorporated in a Taverna workﬂow as a processor for 
executing R scripts. Although RShell was already sketchily introduced in Li et al. [3], 
here we present a detailed description of the RShell functionality and architecture. 
This was also motivated by several requests from Taverna and R users. Additionally, 
we introduce new functionality of our current RShell version 1.2.
Implementation
RShell is based on a client-server architecture. It requires a local or remote 
installation of the R-interpreter with the Rserve library [4] installed. The Rserve 
library turns the R-interpreter into a server, which enables other applications to 
communicate with the R-interpreter by means of a socket connection. From here on, 
the R-interpreter with the Rserve library installed will be denoted as the R server. 
RShell uses the Java library named REngine to establish and maintain connection 
between Taverna and R server. To execute R scripts, the RShell processor sends 
the script and the input data via the RShell session manager to the R server, which 
delegates the script to the R-interpreter and sends the results back to RShell (Figure 
1). This new version is fully compatible up to and including R 2.9.2
Conﬁguring the RShell processor 
The RShell processor is highly conﬁgurable: the user can deﬁne the script to be 
executed, the input ports to feed the relevant data, and the output ports to 
extract the created data. The user can conﬁgure the RShell processor by invocating 
the RShell processor in Taverna’s “advanced model explorer”. This will show a 
conﬁguration dialog containing four tabs for the script, the input ports, the output 
ports and the connection settings.
 Syntax highlighting is available in the scripting tab, to help the user write 
correct R code. The keywords are highlighted in blue; the inputs and outputs of the 
RShell are highlighted in pink.
 RShell supports multiple input and output ports. Each port has a name, 
corresponding to the variable name it represents, as well as a type, corresponding 
to the type of data it holds. RShell uses the data type to determine how to exchange 
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data with Taverna. RShell supports booleans, numeric values (both integers and 
ﬂoating point numbers), strings, and, vector of numerics and strings. Inputs and 
outputs of these data types can directly be used as variables in the R script. RShell 
provides the text-ﬁle data type to handle large data. Ports of this type can be read 
and written as normal R tables. The PNG and, since version 1.2, the PDF data type 
are available for graphical output. PNG can be used bitmap graphics; PDF for vector 
graphics. PNG and PDF outputs are handled as graphics devices in the standard 
R fashion. Input ports and output ports can be deﬁned using the input ports and 
output ports tab.
 RShell can execute any R script as long as the required libraries are installed in 
the R server. By default, the RShell processor is conﬁgured to use a locally installed 
R server serving at address localhost, port 6311. It can be conﬁgured to use a remote 
installation of R instead, using the connections tab. This can be useful when, the 
user is not able to install R, a central installation of R with a speciﬁc set of installed 
libraries is used, or R is installed in a grid environment. Multiple R servers can be 
accessed within the same workﬂow.
Persistent sessions 
RShell supports persistent sessions to prevent unnecessary data transfer. The user 
can enable persistent sessions in the connection tab. When these are enabled, 
all input data, output data and script variables will be kept in memory of the 
R-interpreter until the whole workﬂow execution is ﬁnished. Multiple RShell 
processors in the same workﬂow are able to use the data provided by previously 
used processors, without requiring data links between these processors. Although 
persistent sessions can be very useful, they do have some limitations:
 i)  Sessions can only be used among RShell processors.
 ii)  RShells devoted to a different session can access other R servers, but RShell 
processors involved in a single persistent session have to use the same R 
server.
 iii)  It takes extra effort to keep a provenance log of data kept at the R 
interpreter.
Taverna manages all data consumed and produced by processors. By using persistent 
sessions, Taverna is not aware of the data generated by one RShell processor and 
used by another RShell processor. If the user wants to record data generated by an 
RShell processor, he/she can do that by deﬁning an output port for that variable.
Use-case: mapping oligonucleotides to a genome DNA-sequence
We used RShell in the design process of a zebraﬁsh microarray (see ﬁgure 2 for a 
summary and supplementary ﬁgure S4 for the complete workﬂow). A microarray 
with 15k probes of 60-mer oligonucleotides has been designed on gene sequences 
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from Vega (http://vega.sanger.ac.uk/Danio_rerio) and Ensembl (http://www.
ensembl.org/Danio_rerio/) that are also known in genome assembly available from 
the Zebraﬁsh Information Network (http://zﬁn.org). For zebraﬁsh, the VEGA set is 
not a subset of the Ensembl set. To judge the agreement that exists between the 
different assembly annotations, we mapped the Vega-designed probes onto the 
Ensembl assembly in the following way. All probe sequences are aligned to the 
Ensembl assembly. Hits with an e-value below 1.5e-4 are considered to be able to 
contribute to the hybridization signal on the microarray [5]. Next, for each hit, a 
query is performed to check which genes and/or transcripts are present at the hit 
location in the genome. Finally, each probe with at least one hit is further classiﬁed 
based on the number of hits, genes and transcripts (see supplementary table S5). 
Figure 2: The use case workﬂow 
    Backbone of the workﬂow that maps oligonucleotides to an assembly. The RShell 
processor is the ﬁnal task in the workﬂow, used to analyse the oligo mapping. For 
a detailed ﬂowchart see supplementary ﬁgure S4
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For this classiﬁcation, an additional lower cut-off is applied (e-value below 
1e-12) and the possibility of the occurrence of intron-spanning probes has been 
considered. Therefore, probe sequences that show two or more hits located close 
together on the genome and that constitute a continuous stretch of more than 57 
nucleotides on the probe, are labeled intron-spanning probes. For the alignment, 
BioMoby Blat and Blast services at WUR (http://www.bioinformatics.nl/) are used. 
Gene and transcript ﬁnding is performed by the Ensemble 51 Genes BioMart service 
(http://www.ensembl.org/biomart). The RShell processor is used to implement the 
classiﬁcation and the visualisation in the workﬂow.
 In Figure 3, one can see that 38.3% of the Vega designed probes have a single hit 
on the Ensembl assembly (class 1), whereas 3.0% are linked to multiple transcripts 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Relative distribution of probes among the classes
Classes
%
 o
f p
ro
be
s
0
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Figure 3:  Plot of the use-case results 
    Number of probes per class. For a description of the classes see supplementary 
table S5
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of a single gene (class 5–7). The Ensembl and Vega annotations clearly disagree 
for 5.6% of the probes, because they have hits to multiple Ensembl genes with 
an e-value below 1e-12 (class 11). For 46.5% of the probes no transcript is found 
although they have a hit on the genome assembly below 1e-12 (class 12). These 
probes target Vega transcripts that are absent in the Ensembl annotation.
 With RShell, we have been able to implement the use-case as a workﬂow 
including the statistical analysis. The complete workﬂow and the input data as well 
as a test set can be downloaded from http://www.myexperiment.org/packs/45. 
The workﬂow was run on a 3GHz Linux PC with 1.5 GB internal memory and took 
approximately six hours to complete.
Conclusions
With the introduction of our RShell plugin, scripting in R is now available for 
Taverna. RShell has a conﬁgurable processor that is able to execute any R script 
that can be executed by the available installation of the R-interpreter. The client-
server architecture enables a centralised installation of the R-interpreter containing 
all frequently used libraries used by an organisation. The support for persistent 
sessions in RShell 1.2 helps to prevent data transfer overload. RShell 1.0 comes with 
the standard installation of Taverna. RShell 1.2 can be downloaded as a plugin for 
Taverna and contains several improvements, such as support for vector graphics 
and persistent sessions.
Availability and requirements 
Pro ject name: RShell v1.2 
Pro ject home page: http://ewi.utwente.nl/~biorange/rshell/ 
Operating system(s): Any (Java) 
Programming language: Java 
Other requirements: Java 1.6, Taverna 1.3+ and R with the Rserve library installed. 
Taverna, R and Rserve are all open source and freely available. 
Licence: GNU GPL 
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 Figure S4:  Complete workﬂow 
      The expanded version of the workﬂow designed for the use-case. 
(Single ﬂowchart spanning 2 pages.)
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 Table S5: Table of the use-case results 
     Table describing the probe classes and the number of probes in each class.
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Summary
MADMAX services provide quality control and normalization for Affymetrix arrays 
via BioMoby web service interfaces. This allows for remote programmatic access 
making it easy to embed such functionality in automatic procedures without the 
need to install and maintain a dedicated Bioconductor/R environment.
Availability
Description of the web service interfaces, example Perl client code and detailed 
instructions how to import the required SSL certificates is available from:
 https://www.bioinformatics.nl/phenolink/home/
Additional example workflows for Taverna are published on myExperiment (www.
myexperiment.org). The BioMoby web services have been registered in the official 
public BioMoby Central repository (www.biomoby.org) and access to the services is 
free to all.
Requirements
Any BioMoby compatible client or custom code written using the BioMoby Java or 
Perl frameworks (www.biomoby.org). The services can only be accessed over a 
secure connection, which requires importing SSL certificates.
Contact
pieter.neerincx@gmail.com; philip.degroot@wur.nl.
Introduction 
Over the past years Bioconductor (www.bioconductor.org) [1] has become the de 
facto standard for microarray data analysis, because it is open source, is based 
on the R language for statistical computing (www.r-project.org) and has gained 
wide community support. Quality control and normalization are key aspects of 
microarray data analysis and many Bioconductor packages are available to facilitate 
these fundamental procedures.
 Maintaining a Bioconductor environment is not a trivial task and normalization 
of measurements from dozens up to hundreds of microarrays in one run usually 
requires more memory than available in a commodity workstation. Therefore, 
we have developed two web services [2], named AffyArrayNormalization and 
AffyArrayQualityAnalysis, to provide remote, robust and programmatic access to 
the quality control and normalization pipelines on our dedicated R-server. These 
web services were originally designed for the microarray LIMS and analysis tool 
MADMAX (A. Gavai, personal communication), but can be embedded easily in 
custom pipelines due to their remote programmatic interfaces. For example, a 
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GenePattern [3] module was developed for NuGO (www.nugo.org) based on the 
AffyArrayQualityAnalysis service [4].
 The web service interfaces were built using the BioMoby libraries [5]. In 
addition to providing libraries for mere web service execution, BioMoby facilitates 
service discovery using a repository called BioMoby Central, containing ontologies 
for service types, service inputs, service outputs, etc., through which clients can 
discover compatible web services automatically [5].
 One of the most successful clients with BioMoby support is the open source and 
cross platform Taverna Workbench [6]. In addition to support for several types of 
web service standards like BioMoby, SoapLab and WSDL-based services, Taverna has 
extensive R-support using the RShell processor [7], which can access an R-server 
through Rserve [8]. The RShell - Rserve combination allows “power-users” to run 
their own R-scripts, but for users who can do without the complexity of scripting in 
R and maintaining an Rserve installation, the MADMAX services provide a convenient 
alternative with example Taverna workflows available from myExperiment [9].
 The MADMAX services focus on the Affymetrix platform with currently support 
for human, mouse, rat, C. elegans, Arabidopsis, Medicago, tomato and customised 
arrays for the European NutriGenomics Organisation (NuGO). Other Affymetrix 
arrays can be added upon request.
Methods
MADMAX services run on a dedicated Linux server with 32 GB of memory (SuSE Linux 
Enterprise Server 9). Grid Engine (GE, http://gridengine.sunsource.net/) software is 
used for scheduling and resource management.
Quality Control
The AffyArrayQualityAnalysis web service requires CEL-files as input and returns 
a high resolution PDF-document containing a set of informative images and plots 
that help biologists in assessing the quality of a microarray experiment. Based on 
this information users can decide whether arrays pass quality standards and can be 
used in further analysis or not. AffyArrayQualityAnalysis uses several libraries from 
http://www.bioconductor.org/ as detailed below.
 Firstly, the Affymetrix quality control criteria as described in Affymetrix’s 
“Data Analysis Fundamentals” manual (www.affymetrix.com/support/downloads/
manuals/data_analysis_fundamentals_manual.pdf) are visualised in plots generated 
with the simpleaffy library [10]. The simpleaffy package is extended to include 
quality control definition files (qcdef-files) for NuGO, tomato and Arabidopsis 
arrays. These qcdef-files contain the quality parameters as defined by Affymetrix 
for their Command Console software package and described in the “Data Analysis 
Fundamentals” manual.
 Secondly, the Bioconductor affy [11] and affyPLM libraries are used to create 
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images of the array data. The affy package creates raw images “as is”, while affyPLM 
uses normalized data instead. The latter makes it easier to detect artefacts like 
stains and scratches. Additionally, affyPLM provides Relative Log Expression (RLE) 
and Normalized Unscaled Standard Error (NuSE) boxplots, which help in identifying 
potential outliers. Other plots created with the affy package include: probe density 
and probe boxplots both before and after normalization, an RNA digestion plot 
(providing information on the quality of the labeling and hybridization procedures) 
and a selection of MVA plots (providing information on the reproducibility of 
replicates). 
 Thirdly, correlation images of all analyzed arrays before and after normalization 
are created using the affyQCReport library. This results in an overview of which 
arrays are most similar or dissimilar. For the last plot, hierarchical clustering on the 
samples is executed and a dendrogram is created showing the similarity between 
the microarrays. If the replicates cluster together and the control and treatment 
groups cluster separately, one can safely assume that the microarray experiment 
contains the required information to distinguish between controls and treatments.
 Finally, the normalized intensities and annotation for the experiment (gene 
name, gene description, UniGene accession numbers, chromosomal location, and 
GO accessions) are stored in a tab-delimited file. The annotation is generated using 
the Bioconductor AnnotationDbi library. All generated files are compressed in a 
ZIP archive, which can be downloaded once the R-job has finished. Note that no 
R-object containing normalized data is generated. For this purpose a second web 
service is available, which is discussed next.
Normalization
Bioconductor provides lots of tools for (follow-up) microarray analysis and many 
of these require an “ExpressionSet”, which contains normalized data in a “natural 
R-object”. The AffyArrayNormalization service provides such an R-object, which is 
always stored in a file named “Normalized_Data.RData” and provided in a ZIP archive. 
This archive also includes a log file and a “species.txt” file. The latter contains the 
species as detected based on the supplied CEL-files. In addition to the CEL-files a 
client must specify which normalization method as well as whether Affymetrix or 
custom MBNI CDF files should be used. In MBNI custom CDF-files probe annotation 
is updated, probes are mapped to new probesets and poor quality probesets are 
removed [12]. This results in significantly improved microarray measurements with 
annotation based on Entrez Gene identifiers. The following normalization methods 
are available: MAS5 [13], RMA [14], VSN [15] and gcRMA [16].
 The R-object can be loaded easily into R using the load (file = “Normalized_
Data.RData”) command and it contains the variables as listed in Table 1. It is 
recommended to load the data using the same R-version as the one used by the web 
service, which is specified in the logs and frequently updated to the latest stable 
releases.
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Abstract
An important consequence of this genomic era is the accumulation of vast genomic 
data and the propensity of gene nomenclature ambiguity leading to confusion in 
annotation. We present a tool, GeneIlluminator that can highlight the multiple 
biological functions assigned to a gene within or across species exhibiting an 
ambiguous name or gene symbol. Additionally our tool is able to annotate a gene 
symbol of a given species based on prior knowledge of its closest taxonomic 
relative. This is an asset for any annotation pipeline as well as document-pivoted 
and category-pivoted text categorization where the symbol or abbreviation of a 
gene name is ambiguous. GeneIlluminator also proposes unambiguous gene symbol 
synonyms to the initial abbreviation of interest for a biological function. The 
proposed sets of unambiguous synonyms and biological entities of the category are 
used in a Boolean or vector model to effectively retrieve PubMed abstracts through 
GoPubMed, thus actively disambiguating PubMed abstracts. GeneIlluminator is freely 
available for academic use at: http://www.bioinformatics.nl/gi/. For automated 
querying via custom software, four BioMOBY web services are available for remote 
programmatic access.
Introduction
A consequence of the recent application of computational techniques life sciences is 
a vast increase in available data and publications. Naturally this provides a new and 
important source of valuable information, but it is presented in a very challenging 
format: natural language text. Several tools have been already developed to 
help researchers to extract and mine data in scientific literature [1-6]. However, 
extensive lexical variation, preventing terms to be recognized in a free text, gene 
name synonymy and gene name homonymy are hampering successful selection and 
identification of gene names. Homonymy creates uncertainties regarding the exact 
identity of a term. Furthermore, the biological field is mined with a constantly 
changing and expanding terminology. A related problem is the lack of a stringent 
nomenclature in the majority of gene and protein databases. For example the 
guidelines for FlyBase, the primary database for the Drosophila genome, hardly put 
any restrictions on what can be used as a gene symbol [7]. FlyBase favours a rather 
descriptive nomenclature, which makes an automated identification of gene names 
very difficult. In contrast, term conventions for yeasts are more stringent, thus 
allowing for easier gene name identification.
 In addition to this problem of rather technical ambiguity there is also often 
a conflict of interest between researchers, as scientist might rather share their 
toothbrush than the same gene name [8].
 Applications such as manual literature search, automated text-mining, name 
entity identification, gene or protein annotation, and linking of knowledge from 
different information sources require the knowledge of all names referring to a 
GeneIlluminator
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given gene or protein [9]. In this context it is important to realize that biomedical 
and biological terms often appear in abbreviated forms, so-called acronyms. 
Although several methods have been developed to capture the different acronyms 
in the literature [10-19], they are not sufficient in selecting the proper acronym 
that unambiguously belongs to the concept of interest, e.g. the biological function. 
That means that to date current text mining tools cannot guide users toward the 
effective term selection to achieve a meaningful query.
 This paper addresses the ambiguity at the gene nomenclature abbreviation or 
acronym level. How does one efficiently and unambiguously tap the huge knowledge 
base of literature to make sense of the vast amount of high-throughput data 
generated in experiments? Good interpretation is key to generate new hypothesis for 
further experimentation and validation. Thus, we propose a tool, GeneIlluminator 
(GI) that addresses various aspects of text mining:
  1  It addresses and displays the multiple aspects of the biological functions of 
ambiguous gene symbols. 
  2  These multiple aspects can be used independently to partition PubMed 
Abstracts based on a similarity profile between abstracts and different concepts 
of ambiguous gene symbols. 
  3  It can be used as a gene symbol ambiguity-checker for data from the UniProtKB. 
  4  The tool categorizes ambiguous gene symbols, their synonyms and species 
with respect to the distinct biological concept of the primary symbols used 
for the searches. Furthermore there is an option to check the quality of the 
categorization task as well as the feature space used.
  5  GI can be seen as an interactive curation tool, which supports the curator of 
databases and eventually learns from him. In addition it represents a functional 
annotation approach that combines data from linguistic and bioinformatics 
sources.
Implementation and design
Data preparation and processing
GeneIlluminator (GI) interrogates a MySQL repository of ambiguous gene symbols 
taken from a quantitative survey of ambiguous acronyms in UniProtKB. Our database 
was constructed with a methodology [20] based on UniProtKB release 12.2. UniProtKB 
integrates protein information from various sources, resulting in a central, stable, 
comprehensive and accurate protein sequence database with extensive annotation 
including cross-references to other data sources. The expectation of the UniProt 
project is that the UniProtKB (protein oriented) and Entrez Gene (gene oriented) 
databases will increasingly share nomenclature with the advantage that the mapping 
between databases will become more complete and less ambiguous. This will aid in 
facilitating the generation of gene name dictionaries, which in turn will represent a 
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Interface description
The GI interface requires as minimum input a gene symbol or acronym optionally 
supplemented with a species of interest (figure 1). Our interface is powered with 
Asynchronous Java and XML (Ajax) technology to make data entry easier by auto-
completion of known gene symbols and species.
 Tools such as aiSee, a graphic layout software (www.aisee.com) and CLUTO 
(http://glaros.dtc.umn.edu/gkhome/views/cluto) are used to enhance the 
visualization of GI gene symbol analysis. GI graph exploits aiSee’s force-directed 
layout to display a gene symbol and its synonyms linked in a network to the most 
descriptive terms of its biological function and different taxonomic levels (figure 2a). 
Parameters for force-directed placement are set to 180, 180, 0.0, 254 and 0.0 for 
attractive forces, repulsive forces, gravitational forces, maximal temperature and 
minimum temperature, respectively. The nodes of the generated graph represent 
the gene symbol, its synonyms and associated biological terms and taxonomy. 
Different shapes and colors are used to facilitate easy interpretation of this graph. 
All nodes are interactive and by clicking on the node a set of related PubMed 
abstracts will be displayed. The graph is created in scalar vector graphic (SVG) 
format providing unlimited resolution for publication quality images. Furthermore, 
CLUstering TOolkit (CLUTO) is used for clustering of descriptive features of the 
ambiguous symbol under investigation complementary to the graph layout of aiSee 
(figure 2b).
 In case a user submitted a gene symbol, which could not be mapped directly to 
the species of interest using a query in UniProtKB, GI will assign the meaning of the 
gene symbol to the species based on their last common ancestor in the taxonomy. 
The latter assignment is realized with a Naïve Bayes classification algorithm, which is 
Figure 1:  GeneIlluminator web interface.
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 Figure 2a:  GeneIlluminator main screen output for ALK1
     The Aisee graph on the right requires a larger page size than this thesis was 
printed on to be readable, but does give an impression of the type of graph 
GeneIlluminator constructs. The query gene symbol (red) and any synonyms 
found (purple) are shown in the center. Lines show how the gene symbols 
are related to 4 clusters of functional terms or concepts (green). Clusters of 
functional terms are linked to certain parts of the tree of life (taxonomy) as 
indicated by kingdoms (blue), species (grey), last common ancestors (red) and 
other taxonomic ranks (yellow).
 Figure 2b:  GeneIlluminator 
CLUTO clusters
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based on the following: most assignments of annotation for molecular function rely, 
at least partially, on the assumption that genes with similar sequences also display 
similar biological functions. This implies, that similar sequences are evolutionary 
related to a certain extent, which denotes a last common ancestor prior to the 
speciation event. Thus, species of a certain taxonomic rank most probably have the 
same biological function for a specific gene, which is used in our approach to link 
the gene symbol to a biological function for species, for which the corresponding 
protein was not yet annotated in UniProt.
 In addition to the web interface, four BioMOBY [21] web services were developed, 
providing remote programmatic access to GI:
 •  GeneIlluminator_GetGraph
 •  GeneIlluminator_GetClusters
 •  GeneIlluminator_AssignSpeciesToCluster
 •  GeneIlluminator_GetPubMedQuery
These web services allow users to incorporate GI in workflows for automated 
disambiguation of gene symbols. All services require a gene symbol as minimum 
input, but GeneIlluminator_AssignSpeciesToCluster and GeneIlluminator_
GetPubMedQuery require a species name in addition. The first two services provide 
an overview of all synonyms and homonyms for a gene symbol together with clusters 
of taxonomic clades showing the gene symbol pertaining to a certain function. 
GeneIlluminator_GetGraph provides this overview as an image in SVG format, 
whereas GeneIlluminator_GetClusters provides the same information in a textual 
format (raw BioMOBY XML). GeneIlluminator_AssignSpeciesToCluster provides the 
same textual information as GeneIlluminator_GetClusters, but supplemented with 
a Naïve Bayes probability indicating the likelihood that a gene symbol belongs to a 
certain cluster given the input species. Finally, GeneIlluminator_GetPubMedQuery 
generates a Boolean query, which can be used to search PubMed for a given gene 
symbol and species and retrieve unambiguously documents that describe the gene 
of interest. It is noteworthy that GeneIlluminator_GetPubMedQuery provides the 
query terms, but does not perform the actual query. To retrieve the query’s results 
other tools like for example GoPubMed [22] must be used.
 Documentation, example workflows and example inputs for the Taverna 
workflow management system [23] are available in the online material.
Exampe application: analysis of the ambiguous gene symbol ALK1
To illustrate our approach, we selected the gene symbol ALK1, which has entries in 
UniProtKB for human, mouse, fungi and bacteria. Figure 2b shows the existence of 
two distinct groups in fungi, described as cytochrome P450 and permease-peptidase, 
whereas in bacteria ALK1 refers to a helix-hairpin-helix superfamily based excision 
DNA repair protein. Furthermore, a list comparison of ALK1 synonyms and taxonomy 
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association to its multiple senses (figures 2c, 2d and 2e) shows that unlike synonyms, 
the taxonomic units are unambiguous per biological function. For instance, species 
of the rank Ascomycota show unambiguously the function described as cytochrome 
and monoxygenase. All species of the taxonomic rank Aspergillus unambiguously 
have the function described as protease and peptidase, and last but not least 
Bacillus cereus, Homo sapiens and Saccharomyces cerevisiae unambiguously have 
the function described as kinase receptor. This clearly exemplifies the issue of 
intra-species and inter-specie gene nomenclature ambiguity encountered in text 
mining of current molecular biological databases. 
 Using the Naïve Bayes taxonomy-based disambiguation (figure 2a) shows that for 
the species Aspergillus flavus and the gene symbol ALK1 the function “proteinase 
22.3%, elastolytic 5.6%, peptidase 5.6%” is assigned with a 100 % confidence 
based on the fact that all Aspergillus spp. already exhibited that function (latest 
common ancestor). The percentage ascribed to each functional biological term of a 
category, e.g. 22.3% proteinase, explains that the cluster is made up of “proteinase, 
elastolytic, peptidase, secreted protein, alkaline” to the extent of the given 
percentage. Currently predefined queries are generated from a list of synonyms 
as shown in figures 2a, 2c, 2d and 2e. A click on the cluster label ‘Cytochrome 
monooxygenase cluster’ retrieved a total of 157 abstracts listed in PubMed with the 
majority of them referring to or related to fungi.
Development platform
GeneIlluminator is implemented in Perl as a web-based service, running on an apache 
2.0 webserver using a Linux platform (SuSE linux Enterprise Server 9 with MySQL 5.0). 
GI’s interface (figure 1) is a wrapper on several independent applications that uses 
a Naïve bayes algorithm for categorizing previously unseen instances of ambiguous 
gene symbols of a given species and subsequently plotting a graph of gene symbols, 
their synonyms and associated biological functions. The web interface preserves 
platform independence across multiple operating systems and allows the user 
to interact with the different GI programs without prior knowledge of computer 
programming skills. Figure 3 summarizes a global overview of GI workflow. 
 The GI web interface was tested on Windows XP, Mac OS X and several types of 
Linux OS browsers with good results. However, some problems where noticed with 
the interactive usage of the scalar vector graphic (SVG) due to incompatibility of 
some browsers with this graphic display as some browsers still require the Adobe 
SVG plug-in, downloadable from the Adobe site (http://www.adobe.com/svg/
viewer/install/main.html). The latest versions of the Mozilla Firefox, Opera and 
Safari have already native (built-in) SVG support and it is reasonable to expect that 
more browsers will follow soon.
Chapter 5
140
5
C
Introduction
D
iscussion &
 Conclusions
2
1
3
4
Figures 2c,2d and 2e (from top to bottom):  The 3 different genes with symbol ALK1, 
their synonyms and their taxonomic 
distribution.
              Genes are functionally described with the 
terms cytochrome + monooxygenase (c), 
proteinase + peptidase (d) and kinase + 
receptor (e). 
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CFuture plans
In the near future we plan to allow users to select terms of categories and gene 
symbols to be used in a GI query, so the analysis can be tailored to pecific user 
needs. Furthermore, we plan to provide a suitable interactive summary report 
of the different abstracts retrieved as well as association maps of all abstracts 
pertaining to each of the functional aspects of a gene symbol. Moreover we believe 
it to be beneficial to implement an ensemble of classifiers to assign a function to an 
ambiguous gene symbol for a given species. 
Conclusion
GeneIlluminator (GI) is a text-mining tool that is able to display the multiple aspects, 
i.e. biological functions, of an ambiguous gene symbol. GI uses the latest common 
ancestor of a species assuming the same biological function for an ambiguous gene 
symbol to infer the function in those species where the function is irretrievable 
through direct database query.  Given a document, GI searches and retrieves all 
Figure 2f:  GO PubMed.
    Screenshot for an example GO PubMed search for the GI “cytochrome 
monooxygenase” ALK1 cluster.
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categories under which it should be filed, which is known as a document-pivoted 
categorization. Alternatively, given a specific category, GI searches and retrieves 
all the documents that should be filed under this specific category, which is known 
as a category-pivoted categorization.
 GeneIlluminator can be easily accessed through its web interface or its 
programmatic interfaces (web services) and represents a user-friendly tool 
indispensable for up-to-date text mining in life sciences.
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General Discussion & Conclusions
Is OligoRAP’s annotation “complete”?
Microarray experiments require complete a priori knowledge of the target genes 
under investigation for proper probe design. Unfortunately, there is not a single 
species for which such complete data is available resulting in sub-optimal microarray 
probe design and annotation. To make the picture as complete as possible OligoRAP 
does not rely solely on a reference genome assembly or on a collection of expressed 
sequences, but uses both. Since such datasets will be highly redundant, OligoRAP 
takes only those expressed sequences into account, which are not represented by 
a species’ reference genome. This combination is more complete than using only 
one or the other and by removing the redundancy also allows OligoRAP to estimate 
target specificity.
 Updating probe annotation just a few years after the initial array design can 
already result in a significant amount of change in both the annotation linked to 
probes as well as in the number of gene-specific probes as shown in chapter two. 
As our knowledge of genomes and their expression keeps increasing rapidly and 
regular updates of estimated probe annotation and target specificity with tools like 
OligoRAP will improve the reliability of microarray experiments. Nevertheless even 
updated OligoRAP annotation will not be complete and the requirement of a priori 
knowledge on complete transcriptomes for proper array design remains one of the 
Achilles’ heels of microarray technology.
Which oligo annotation pipeline performs best?
Several tools to update annotation and target specificity for oligo libraries have 
been published, but not all tools are equally suitable for all microarray platforms 
or for all species. Therefore, OligoRAP was not compared to all of these tools, 
but as part of the November 2008 EADGENE/SABRE workshop it was compared to 
sigReannot and IMAD (chapter three). These tools were chosen for the workshop, 
because all three were developed by EADGENE partners to overcome the lack of 
support for farm animals like chicken. “Which tool performed best?” would be an 
obvious question to ask, but the answer is not part of this thesis for the simple 
fact that it would require an experimentally validated benchmark dataset or “gold 
standard” and to the best of our knowledge such dataset does not exist.
 The in-depth comparison of chapter three did show that relatively small 
differences in annotation strategies resulted in relatively large differences in 
functional analysis by means of GO term enrichment analysis. It must be noted 
that despite the updated annotation the coverage of GO terms for the probes was 
relatively low, making the analysis susceptible to “runaway statistics”. (Runaway 
refers in this context to a system where insignificant differences explode into 
absurd differences as result of unlimited feedback loops, eventually leading to sub-
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optimal results just like with runaway selection in evolution.) So the low p-values 
for enriched GO terms, suggesting reliable results, may have been misleading. For 
species with more completely annotated genomes like human or mouse this would 
be less of a problem, but there are much more model species whose genome is less 
well annotated than the chicken genome. Hence, the important message here is 
that biologists should be careful when interpreting such analyses.
What hybridisation filter thresholds to choose?
In fact the situation could be a lot worse than described in chapter three. IMAD, 
OligoRAP and sigReannot feature filters to determine which probe-target alignments 
have a high enough hybridisation potential to be able to generate a signal on an 
array and which ones have not. The thresholds for these filters can be configured 
by the users, who should adjust them based on their experimental conditions like 
temperature, salt concentrations et cetera. For the comparison in chapter three 
the filter thresholds were synchronised where possible, to make a fair comparison 
of annotation strategies without additional differences in annotation due to 
differences in filter thresholds. What is not mentioned in chapter three is that 
it was actually the second attempt to compare the results from IMAD, OligoRAP 
and sigReannot. In a first attempt the filter thresholds were not synchronised with 
OligoRAP using a longest contiguous stretch (LCS) threshold of 20 nucleotides as per 
He et al. [1] compared to sigReannot using an LCS of 15 nucleotides as per Kane 
et al. [2]. Using the more lenient threshold sigReannot’s coverage of Ensembl gene 
IDs was much higher as compared to OligoRAP’s. IMAD does not have a longest 
contiguous stretch filter and scored somewhere in between. Approximately 24 % 
of sigReannot’s additional Ensembl gene IDs was assigned to oligos based on low 
quality hits with longest stretches of less than 30 nucleotides. The vast majority 
of these will be the result of the lower threshold and not of the differences in 
annotation strategy. Such a large difference in coverage of annotation resulted in 
an even more dramatic difference in the GO term enrichment analysis.
 The problem is that both the thresholds established by He et al. and the ones by 
Kane et al. are reasonable guesses. These studies - and there are a few others [3-5] 
- all investigate limited amount of probe-target and probe-non-target interactions 
under a limited set of experimental conditions. To the defence of the authors it 
must be noted that these publications cover a lot of time-consuming work, but 
these studies neither cover the wide range of experimental conditions used for 
hybridisation of arrays nor do they scale to the size of a complete microarray. 
Therefore these studies provide a valuable indication of the range of thresholds 
that should be used for initial probe design or updating probe annotation,  but the 
important question of which thresholds would fit certain experimental conditions 
best remains unsolved.
 Because we could not answer this question we turned the problem around 
in chapter four. Instead of determining the optimal thresholds given certain 
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experimental conditions and updating the annotation based on these thresholds, 
we established optimal thresholds for the Compugen MOULIB384 long oligo mouse 
array based on the annotation. Hence, given the mouse genome and its annotation 
we looked for the thresholds that would provide most gene-specific oligos. This 
will allow wet-lab biologists to search for experimental conditions that fit these 
thresholds best.
 In addition to turning the problem around there is another essential difference 
between these approaches. The experimental conditions for the experimentally 
established thresholds were optimised for optimal signal-to-noise ratios for 
perfect probe-target alignments before the thresholds for cross-hybridisation were 
determined. With our annotation-based optimal thresholds on the other hand we 
optimised for minimal cross-hybridisation. Unfortunately, the annotation-based 
optimal thresholds do not fall within the range of optimal thresholds experimentally 
established by He et al., Kane et al., Liebich et al., Letwoski et al. and Hughes 
et al. [1-5]. In fact they are not even close. The annotation shows rather lenient 
filter thresholds for probe-target alignments are required to cope with the natural 
variation between the sequences used to design the oligos and the current reference 
sequences. At the same time the OligoRAP analysis indicated rather stringent 
thresholds are required to prevent cross-hybridisation. With current microarray 
chemistry as described by He et al., Kane et al., Liebich et al., Letwoski et al. 
and Hughes et al. it is not possible to tweak conditions for both optimal signal-to-
noise ratios and optimal target specificity. For example, increasing the temperature 
to prevent oligos from cross-hybridising with non-targets will at the same time 
decrease the signal-to-noise ratio for hybridisation with the target dramatically. In 
addition a higher temperature will make the signal intensity more susceptible for 
small differences between the sequences used to design the array and the ones 
of the sampled individuals. This may result in a lower signal that may no longer 
exclusively represent lower gene expression, but could also indicate polymorphisms 
or a mix of both differential gene expression and polymorphisms. Hence for mouse 
we may question whether microarray technology as we know it is suitable for 
differential gene expression experiments.
 Due to the computationally intensive nature of the analysis in chapter four it 
was only performed for a mouse array, but for species with similar genomes like 
human and other mammals the situation will not be any different. For species with 
a significantly different genome size or composition on the other hand the situation 
might be different, because genome size and composition will influence the chance 
that a short stretch of a certain length can cross-hybridise to non-targets. Further 
research will be required to investigate if the array chemistry can be modified in 
a way that will fit differential gene expression experiments more optimally. The 
lack of sufficient experimentally validated data to determine thresholds for both 
probe-target and probe-non-target alignments when designing or annotating arrays 
is another Achilles’ heel of current microarray technology.  
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Reliability of target specificity estimates
When “target specificity” is mentioned in this thesis it is almost always immediately 
followed by “estimates” indicating it is not possible to determine target specificity 
precisely. The lack of completely annotated reference transcriptomes is not the 
only reason for describing OligoRAP’s target specificity assignments exclusively as 
estimates. In addition to exhaustive data on the transcriptomes under investigation 
OligoRAP needs to determine the hybridisation potential of oligos with potential 
targets. 
Factors influencing hybridisation potential
The factors influencing hybridisation potential can be divided into four groups: 
probe- target interactions, probe-probe interactions, target-target interactions and 
steric hindrance. OligoRAP was designed as a tool to update oligo information. 
Therefore it takes only probe-target interactions into account as these may have 
changed due to new insights with respect to the targets. OligoRAP assumes that 
oligo-oligo interactions and steric hindrance were taken care of properly at the 
time of array design. Target-target interactions are extremely complex as not all 
targets are known and they are not immobilized like the oligos, but free in solution. 
Therefore they are ignored in microarray design and this will probably not change 
in the near future. 
Probe-target interactions
It is known that sequence composition, position and distribution of mismatches, 
dangling ends, bulges, loops, salt concentrations, formamide concentrations, 
temperature and strand concentrations, hybridisation time and presence of linkers 
all have an impact on the hybridisation potential of probes with potential targets 
[1-4, 6-17]. Most of these factors are not taken into account by OligoRAP’s 3 
hybridisation potential filters. Only the longest contiguous stretch filter takes the 
distribution of mismatches into account although in a rather crude way. Knowledge 
of thermodynamic properties of DNA and RNA duplexes has increased rapidly 
over the last two decades, but it is not yet possible to calculate the hybridisation 
potential reliably for all oligo - target interactions, especially not for the imperfect 
matches [18]. Nevertheless a thermodynamics filter to calculate free energy would 
take position and distribution of mismatches better into account than the current 
longest contiguous stretch filter. This could lead to more accurate hybridisation 
potential estimates for specific probe-target alignments, but it’s questionable 
whether this will provide more useful oligo annotation.
The effect of natural variation on target specificity 
Depending on context, the stabilising effect of dangling ends on hybridisation can 
be significant and more than the destabilizing effect of certain mismatches, but on 
average the impact of dangling ends on the free energy of a DNA-DNA duplex is less 
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than that of a single mismatch [10]. So a single nucleotide polymorphism (SNP) in 
the sequence of a sampled target gene as compared to the target gene’s reference 
sequence used to design/annotate the oligo can already have a larger impact 
than the improved accuracy of taking dangling ends into account for hybridisation 
potential calculations. With a few SNPs and/or indels, taking the exact position 
of mismatches into account for the alignment of oligos with reference sequences 
becomes pointless.
 When oligos overlap with the borders of genomic inversions, re-arrangements 
and copy number variations this can have an even more dramatic effect easily 
resulting in tens of nucleotides in a row no longer matching the target. If the 
amount of natural variation amongst individuals would be very limited this would 
not be a problem for microarray technology as only a limited number of probes 
would be affected. So an important question is to what extend do the genomes of 
sampled individuals vary on average due to natural variation and are microarray 
probes robust enough to cope with that amount of variation?
 It is not yet possible to answer this question precisely, but a quick look at the 
release statistics of for example dbSNP indicates that the variation described in 
literature and databases has increased rapidly over the past years and that the 
end of this growth is not in sight. The current version of dbSNP (version 130 of 
May 2009) for example contains already 17,8 • 106 reference SNPs for human. On a 
total genome size of about 3.2 • 109 base pairs (bp), that equates to approximately 
1 SNP in every 180 bp. With a length for typical long oligos ranging from 60 to 80 
nucleotides that would still be less than one known SNP-site per oligo on average 
and off course the individuals sampled in a microarray experiment not necessarily 
have to differ at each known SNP-site, but on the other hand the distribution of 
these reference SNPs reveals that the picture is far from complete. More than 40 
% of the human reference SNPs is annotated in dbSNP as “located in a gene”. With 
currently still only a marginal fraction of genomes annotated as genes and the 
fact that sequences coding for genes - even the UTRs and introns - are on average 
more conserved than intergenic regions, one would expect much more SNPs in the 
intergenic regions as compared to in genes.
 The only reasonable explanation for the relatively large amount of SNPs in 
genes is that the sequences currently annotated as genes historically received much 
more attention from the research community. Hence the SNPs in intergenic regions 
are underrepresented in dbSNP. If intergenic regions would not be expressed 
that would not be a problem for microarrays, but the ENCODE project published 
extensive experimental evidence showing that “the majority of the human genome 
is pervasively expressed, such that the majority of its bases are present in primary 
transcripts” [19]. There had been earlier reports arguing that the idea that the 
majority of our genome is “junk” DNA does not make sense [20], but ENCODE 
made it crystal clear that our definitions of genes and intergenic regions need 
a major revision [21]. Hence there are much more potential targets with more 
genetic variation than estimated when microarray technology became popular at 
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the end of the previous century. Even without additional potential targets and 
currently unknown SNPs, analysis of popular human AffyMetrix arrays by Dai et al. 
in 2005 revealed that ~ 30 - 40 % of the probe sets contained at least one probe with 
a known SNP in the critical central 15th nucleotide, which is used to measure the 
difference in signal between a perfect match (PM) and mismatch (MM) probe [22].
 Other types of variation like copy number variations (CNVs), inversions and re-
arrangements can have an even more dramatic effect on target specificity and 
signal-to-noise ratios. Genomes can appear very similar on a global scale (high 
macro synteny), but if the order of sequence fragments is extensively re-shuffled 
(low micro synteny) oligos no longer match their targets well if they overlap the 
borders of the re-shuffled regions. In this regard the reports of the Human Genome 
Variation meetings provide an interesting picture. The trend is that each year the 
amount of variation appears to be larger than previously reported [23-26]. For 
example the latest meeting report describes “an explosion in reports of variants in 
the range of 100 bp to 1 kb” due to enhanced resolution for detection of short CNVs 
[26].  Maybe a reasonable estimate for the average amount of natural variation 
amongst individuals can be established in the near future, when the first results of 
the 1000 genomes project become available. This project, which started in January 
2008, aims to fully sequence more than 1000 human genomes. Hence the tagline “A 
Deep Catalog of Human Genetic Variation” [27]. 
The effect of splicing on target specificity 
In addition to natural genomic variation the splice machinery provides another 
major source for variation. Therefore, splice variants can also have a significant 
effect on how well oligos can hybridise with their targets.
 Firstly, oligos can have a lower hybridisation potential if they target a region, 
which partially overlaps sequences that are not conserved in all splice variants. This 
can happen for example when the oligo aligns with an intron-exon boundary. Intron 
retention, exon skipping or splicing at an alternative splice site can then produce 
transcripts that will not bind as strong to the oligo. If an oligo’s target sequence 
lies completely within an exon, splice variants lacking that exon will even have a 
hybridisation potential that is reduced to that of a-specific binding.
 Secondly, predicting splice sites is notoriously difficult and therefore that part of 
gene models is rather error prone. As a result the category of probes whose design 
is based on ab initio predicted genes is doomed to have a large portion of orphan 
oligos targeting ghost transcripts. Finally, the ENCODE project also showed that 
variation in transcripts due to splicing is larger than expected up until recently with 
many transcripts joining exons of genomic regions previously annotated as distinct 
“genes” [19]. Especially alternative upstream transcription start sites appear to be 
abundant. Although these alternative transcripts can code for the same protein 
sequences as previously annotated transcripts, their untranslated regions (UTRs) 
will be different, which can affect hybridisation on microarrays.
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Microarrays and the difference between natural variation and 
splicing versus gene expression
More research will be required to get a better understanding of to what extend 
natural variation and splicing affect target specificity of microarray probes, but 
both provide a logical explanation for the relatively lenient primary hit thresholds 
required for optimal signal-to-noise ratios found in chapter four: given the mouse 
reference genome and the Compugen mouse array with oligos of 65 nucleotides 
long, the optimal threshold for longest contiguous stretches in probe-target 
alignments was 34 nucleotides. Hence probes binding with a contiguous stretch of 
34 nucleotides should still be able to generate high signal-to-noise ratios in order to 
get the highest amount of gene-specific oligos with good signal-to-noise ratios. In 
other words that means that experimental conditions should allow stretches of up 
to 31 mismatches in a row for the largest amount of reliable probes.
 It is very unlikely that a probe was designed for an erroneously annotated - 
maybe even non-existing - target A, therefore no longer matches A, but happens 
to align with 34 nucleotides to a completely different, previously unknown target B 
located elsewhere on the genome. With a genome size of approximately 2.700 MB 
the mouse genome simply is not large enough for many stretches of 34 nucleotides 
to occur due to chance. A more likely scenario is that a probe was designed for 
target A based on the sequence of individual X and that it still targets gene A, 
but that the updated annotation is based on either sequences from individual Y, 
sequences from other splice variants or sequences with improved gene models all 
leading to a shorter stretch of aligning nucleotides.
 Either way, the improved accuracy of hybridisation potential calculations based 
on thermodynamics is insignificant compared to effects of natural genomic variation, 
splicing and erroneous gene models. The fact that both natural variation and 
splicing are more abundant and more complex than estimated up until a few years 
ago and that these biological phenomena have an effect on microarray signals is not 
necessarily a problem. On the contrary, these are interesting biological processes 
and technology to measure them will allow us to get a better understanding of 
how genotypes affect phenotypes, but the limitation of microarrays is in the fact 
that the technology cannot distinguish between the two. Like differences in gene 
expression, differences in splice variants and polymorphisms all result in more 
or less of the same fluorescent signal. Although Achilles had only two heels, the 
inability of microarray technology to tell the difference between differential gene 
expression, polymorphisms and splice variants can be considered a third Achilles’ 
heel.
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The future of microarrays and high throughput gene expression 
experiments
Detection of gene expression using hybridisation of transcripts with probes will 
always require a priori knowledge on the sequences. This will remain problematic 
even if the other two Achilles’ heels can be patched. Other techniques to measure 
gene expression and which do not require the sequences of potentially expressed 
genes tot be known already exist for many years. For example one can think of 
serial analysis of gene expression (SAGE) and “classic” sequencing. Nevertheless, 
microarrays became more popular, because sequencing and SAGE are outperformed 
by microarrays both on speed and cost.
 But SAGE evolved into SuperSAGE and in addition to “classical” sequencing 
so-called “second-generation” sequencing techniques have been developed. The 
latter is a collection of techniques that use a sequencing-by-synthesis approach like 
Illumina’s “Illumina sequencing”, Applied Biosystems “Solid” and 454 Life Sciences 
“454”. These second-generation sequencing platforms differ in many ways, but they 
share the possibility to generate several million sequence reads in a single run. In 
case of the first two platforms this does come at expense of shorter read lengths 
(50 nucleotides for Solid and 106 for Illumina) as compared to first generation 
sequencing (up to ~ 750 nucleotides). This means that determining which genes 
were expressed by mapping these short sequences back onto a reference genome 
will cause more or less the same problems as mapping microarray probes onto 
a reference assembly to update the annotation. The third second-generation 
sequencing platform - 454 - currently seems to have the best cards as it evolved 
quickly to allow for reliable read lengths of up to 500 nucleotides. This should be 
long enough to map the vast majority of transcripts reliably to the genes they 
were derived from. By providing a new scale for the definition of “high” in high 
throughput gene expression experiments, second-generation sequencing is rapidly 
becoming more popular as the length of sequence reads increases and cost goes 
down. Currently, second-generation sequencing is still more expensive compared to 
microarray experiments, but it does not require the sequence of the transcripts to be 
known a priori. In addition, second-generation sequencing can measure expression 
of previously unknown genes and detect the difference between differential gene 
expression and polymorphisms as result of natural variation. As soon as second-
generation sequencing becomes equally “cheap” as hybridisation of microarrays, 
the days of the latter will be counted, which might even happen before the ink of 
this thesis is dry. Therefore, software dedicated to analysis of microarray data is 
expected to become obsolete rather sooner than later.
 Although the software packages as a whole will become obsolete that does 
not mean all their individual components will be obsolete too. Many of the lessons 
learned from microarrays are still valuable for the analysis of data from other high 
throughput experiments. Transcriptomics using second-generation sequencing still 
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requires the mapping of sequence fragments to reference sequences to figure out 
which transcripts were present in the samples. In a broader perspective all high 
throughput “omics” techniques share the fact that the amount of data points is 
much larger than the amount of replicates. Hence statistical methods originally 
developed for transcriptomics to deal with such data can be very valuable for 
proteomics and metabolomics too. In addition strategies in software development 
to handle scalability issues are another example of technology that will find its way 
to software for analysis of future generation high throughput molecular biological 
experiments. Finally, services, which for example focus more on analysis of biological 
key principles than on specific experimental details of a certain technology, will 
remain just as useful, even when microarray technology becomes obsolete.
 For the services described in this thesis this means that the microarray 
specific MADMAX services will become obsolete, whereas RShell will remain an 
important tool to provide remote access to statistical methods developed to handle 
omics data in general. The GeneIlluminator services focus on the annotation of 
genes in general and hence are in no way limited to any specific technology or 
experimental protocol. For OligoRAP it means that the pipeline as a whole will 
become obsolete, but also that some of its web services components may easily 
outlive microarray technology. This is where the remote programmatic interfaces 
of the web services provide an additional advantage. If the modules that make up 
OligoRAP were to have interfaces written for a specific combination of hard- and/or 
software, it would have been more difficult to migrate them to new systems as the 
bioinformatics community moves along to new challenges. But due to the language-
independent, internet protocol-independent and firewall-proof nature of the web 
service interfaces, some of OligoRAP’s web services may easily be recycled in new 
workflows. 
Update on the evolution of web services in Bioinformatics
Since the publication of chapter one in 2005, important milestones have been 
reached in the development of web service technology for Bioinformatics. The 
BioMoby project for example published its 1.0 version of the BioMoby standard 
with corresponding JAVA and Perl software libraries [28]. BioMoby 1.0 delivered 
amongst others improved error handling and support for asynchronous services. 
In addition MoSeS (Moby Services Support) was developed for both Java and Perl. 
This tool can generate service and data type skeletons based on the information 
in a BioMoby Central registry. Hence instead of developing a service followed by 
registration of the service with its input and output objects in BioMoby Central, 
developers can now register services and data types first to generate software 
templates. Using MoSeS developers no longer have to write the code to deal with 
the transport of data back and forth between client and the service. They can now 
focus completely on the “business logic” or in this case “bio logic” of their services. 
In case the bio logic is handled by an existing command-line tool or software library, 
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wrapping these tools to turn them into BioMoby services becomes straightforward. 
With MoSeS Experienced developers can turn existing tools into web services in just 
a few minutes, rivalling the speed of Soaplab [29], but with the added bonus of the 
BioMoby ontologies to aid in service discovery. Soaplab itself was largely rewritten 
for version 2, which is more robust and makes it even easier for non-programmers to 
turn existing tools into web services [29]. BioMart, which was developed specifically 
to provide web service access to database systems, is currently at version 0.7. 
Hence, there are still items the developers’ want to implement before they call 
it 1.0, but the current version is stable and more or less the de facto standard to 
develop web service interfaces for bioinformatics databases: BioMart is currently 
adopted amongst others by the Ensembl, UniProt, WormBase, Gramene, RGD, 
HapMap, PRIDE and HGNC databases with third party software support by Bioclipse, 
BioConductor, Cytoscape, Galaxy, Taverna and WebLab. 
 Despite these important developments web services have not taken the world 
of Bioinformatics by storm yet, because several essential pieces of the puzzle are 
still missing.
Service discovery 
Service discovery is still anything but easy, although BioMoby does provide part of 
the solution. In theory the BioMoby ontologies allow users to discover compatible 
services based on their inputs and outputs, but that requires developers to firstly 
design their objects with easy recyclability in mind and secondly to recycle objects 
where possible. Registration of new services and objects in the official public 
BioMoby Central repository is free to all and new entries are neither curated nor 
reviewed. The open character of BioMoby Central allowed BioMoby to quickly gain 
wide support from the bioinformatics community, but also resulted in registration of 
many different objects for the same data making discovery of compatible services 
a pain.
 Another problem is that the information in the BioMoby Central ontologies is 
sometimes not enough for successful service discovery. Firstly, although the input 
and output objects of services are part of an ontology, the service operations are 
not: the action that a service performs is only stored as human readable “free” 
text. So it is possible to automatically discover services that turn a certain input 
into a certain output, but it is not possible to do automatically discover how the 
service does that. Hence, the relationship between the input and output is not 
captured by machine-readable semantics. Secondly, BioMoby contains support for 
cross-reference information blocks (CRIBs). These can be appended to BioMoby data 
objects at any level of their data structure and contain cross-references to other 
BioMoby objects. The cross-references come in two flavours: simple and complex. 
The simple ones contain only an identifier and a namespace to which that identifier 
belongs. The complex cross-references also contain a service name with service 
provider combination and a cross-reference type. The former is the “suggested” 
service that can be used to resolve the given cross-reference. The latter should 
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define the semantic relationship between the cross-reference and the object that 
contained the cross-reference. However, in the current BioMoby specifications “This 
Cross-Reference-Type Ontology doesn’t exist yet. Therefore xrefTypes are free form 
strings for now.” This means that a human may be able to interpret the cross-
references, but it will be virtually impossible for a computer to figure out the 
relationship between object and cross-reference. Nevertheless this is still better 
than a simple cross-reference where both humans and machines will have to guess 
the nature of the relationship between parent object and its cross-reference.
 In the near future the Semantic Automated Discovery and Integration (SADI) 
project will take service discovery to the next level. SADI can be considered the 
successor of BioMoby. Both projects were conceived by Mark Wilkinson, but in 
contrast to BioMoby, which defines its own data format, SADI services consume and 
produce data in Resource Description Framework (RDF) instead. (RDF was not a 
mature standard and hence no option when the BioMoby project started. The BioMoby 
RDF agent was added later, but BioMoby can not take full advantage of RDF with 
its current custom data format.) Using RDF provides richer semantics and enables 
SADI to use existing web ontology language (OWL) reasoners and SPARQL protocol 
and RDF query language (SPARQL) query engines. In addition to richer semantics 
SADI will bring better standardisation for service discovery in bioinformatics, as 
RDF, OWL and SPARQL are all official W3C standards, whereas BioMoby is not. It 
will take some time though, before SADI services will outnumber BioMoby services: 
The project is very young and so far there is one proof of principle service publicly 
available [30].
Quality of Service (QoS)
An important issue is that of outdated information in BioMoby Central: services are 
never removed. As result many services are either dead or no longer function the 
way they are advertised in BioMoby Central. This problem was partially solved by 
creating an RDF agent. This agent can regularly check the published RDF describing 
a service and can send services a BioMoby ping to see if they are alive. Client 
software can check the list of dead services produced by the RDF agent to remove 
these services from the list of available services, but there are several limitations 
to this approach.
 Firstly the RDF agent cannot crawl the web to discover new RDF documents 
describing previously unknown services: a service provider must register new 
services in BioMoby Central manually. Secondly, providing a link to an RDF document 
is optional when registering new services. Many services do not have a link to an 
RDF document and hence changes in their service behaviour cannot be detected 
automatically. Even if the RDF agent can index the RDF for an updated service, there 
is no guarantee a service provider will not forget to update the RDF accordingly. 
Thirdly, a BioMoby ping is an empty data packet. When a service responds by sending 
an empty data packet back, we do know the server on which the service resides 
is at least still alive, but this will not tell us whether the service still provides the 
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advertised operation. Databases or algorithms used by services might be outdated, 
the description of the service inputs and outputs might be outdated or the service 
might simply have been miss-registered from the start. Since web services can be 
considered remote software modules / packages, it is important that a de facto 
standard will be developed for remote unit tests so developers and users can easily 
check if remote modules (still) work properly. So, the BioMoby RDF Agent can help 
a little in getting more reliable information from BioMoby Central, but there is still 
no “Google for web services”. Hence there is no robot / agent that regularly crawls 
the entire Internet in search for web services to index their properties and check 
service behaviour.
 Despite the lack of such a crawler, which is essential for easy discovery of 
reliable and compatible services, the situation with regard to service discovery may 
already improve in the near future thanks to BioCatalogue [31]. BioCatalogue is a 
project that aims to provide a curated catalogue of “Life Science Web Services”. 
This project started with incorporating information from BioMoby Central and 
manual annotation generated for the Taverna Feta plug-in. In addition BioCatalogue 
allows users to review and rate services and checks whether servers are alive like 
the BioMoby RDF Agent. Furthermore the BioCatalogue roadmap contains an entry 
for “test scripts”. These scripts must be provided by the service providers and will 
allow BioCatalogue to test regularly and automatically whether services still work 
as advertised. Hence this would allow BioCatalogue to determine QoS, which could 
improve service discovery dramatically. Of course the scale of the improvement 
will depend heavily on the quality and thoroughness of the tests. For the short 
term this may be a pragmatic solution, but in the long term the BioCatalogue 
approach is futile, because it still relies partially on manual curation. In the last 
decade of the previous century it was very popular to maintain “bookmark-lists” 
of interesting Internet resources, but as the Internet expanded rapidly and the 
data was in high flux, such lists quickly became collections of mostly dead links. 
Although BioCatalogue employs a web 2.0 massive parallel annotation strategy 
allowing users to review, comment and tag registered services, it is questionable 
whether BioCatalogue will be able to keep up with the pace of changing trends in 
bioinformatics and the rapidly growing list of available services.
Wetlab-biologist-proof clients
Many web service developers claim to work on technology that enables biologists to 
easily create workflows using web services. Although their services might provide 
part of the solution, a user will also need a client or workflow management system to 
orchestrate the execution of their favourite services. To the best of our knowledge 
the first really user-friendly client still needs to emerge. There are some interesting 
clients being developed in research labs, but these beta versions are not suitable 
for production work yet. So far I haven’t spotted any client in the wild that does not 
drive biologists (or even professors with a chair in Bioinformatics) nuts in no time.
 Some groups have developed “clients” using web servers. The advantage of 
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these clients is that they can be accessed, with normal web browsers. Next to 
a pipette and a pen, a web browser is maybe one of the most used and widely 
available tools for biologists. Some of these clients might have a relatively intuitive 
interface, but the problem is that they are no real clients. The web browser is the 
real client and the tool to create workflows of web services runs on a web server. 
Users will not have access to the configuration of that web server and hence the 
first problem users run into is that they will be limited to a list of available services 
configured by the administrator of the web server. If a user for example would like 
to add a different BioMoby Central repository to search additional services, this is 
not possible. Even if a user managed to find an interesting service elsewhere by 
alternative means, he cannot use it with such clients, which quickly limits their 
usefulness.
 There are also many “stand-alone” clients, which users will need to install on 
their local machine. Taverna is probably the one, which is most widely used. It was 
quickly adopted by a large community of academic service developers, because it 
is Open Source, freely available and the only client providing out-of-the-box support 
for all major web service frameworks used in Bioinformatics (plain WSDL services, 
BioMoby, BioMart, Soaplab and RShell). Taverna has a graphical user interface, but it 
is anything but consistent and has a large list of known “minor” artifacts. Although 
these issues do not necessarily prohibit users from creating functional workflows, 
the steep learning curve and requirement of all sorts of hacks has prevented Taverna 
from becoming popular with bench-biologists.
 As result, so far most web service users are service developers too. There are 
only very few users who can be considered real “end users” that only execute 
services and build workflows. For the web services described in this thesis the 
situation was no different. They were and still are mostly executed by service 
developers based on requests from biologists. For the individual BioMoby services 
and the OligoRAP pipeline this was done using Perl commandline scripts or Taverna 
workflows. New wetlab-biologist-proof clients will be needed to make web services 
clients escape the computers of bioinformaticians.
De facto standards
Standards are only standards if they are de facto standards, i.e. if they are well 
defined, well implemented and widely accepted. It is not uncommon for many 
competing “standards” to be developed when a technology is in its infancy, but it 
would be better to refer to them as technical specifications instead of standards. 
Interoperability is paramount for web services and therefore it is essential that a de 
facto standard will emerge as web service technology matures. Currently that is not 
yet the case especially not for service discovery. Of the service discovery, service 
description and service execution trio the latter is currently best standardised with 
most projects relying on SOAP for service execution, but the question is for how long 
this situation will last. The SOAP standard itself serves its purpose pretty well, but 
problematic SOAP toolkits/implementations for popular programming and scripting 
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languages have resulted in compatibility and scalability issues. This has lead to a 
revival of the interest in alternatives for service execution with many projects 
exploring a representational state transfer (REST) software architecture. This can 
be used to develop so called RESTful services based on the HTTP methods (POST, 
GET, PUT and DELETE). Although execution of such services is in general more 
lightweight compared to the large amount of XML required for SOAP envelopes, 
RESTful services are currently a step backward for service discovery. As of version 
2.0 WSDL does provide bindings for all HTTP methods, but support of WSDL 2.0 in 
software development kits (SDKs) is still poor making most RESTful services poorly 
described and hampering service discovery. On the other hand the HTTP standard 
is older and more widely used than SOAP resulting in more mature SDK support.
  Compared to HTML web form based tools a lack of standards for service 
inputs and outputs is less of a problem for XML-based web services, because the 
interfaces are less brittle and hence the adaptors/converters to link one service 
to the next are also less brittle. Nevertheless, it would be a lot easier if users 
can link compatible web services directly to build workflows instead. A survey by 
Wassink et al. of all workflows uploaded to myExperiment showed that only 22% 
of the workflow components execute a web service [32]. The rest is glue either in 
the form of processors to control the workflow (for example to ask for user input 
or save a file to disk) or in the form of data conversion processors. With 30 % local 
processors for data conversion and an additional 14 % BeanShells, most of which 
are used for data conversion too, almost half of all the workflow components are 
required for data conversion. BeanShell is a small interpreter that allows one to 
use Java as a scripting language. So, if BeanShell scripts are required to make 
workflows this means that, instead of simply linking web service building blocks 
using drag and drop, users need to write code in Java. The average biologist is 
not a master in scripting or programming and hence this analysis of workflows on 
myExperiment illustrates that the promise of a semantic web where biologists can 
automatically discover interesting web services, which can easily be linked together 
into workflows, is still a fairytale.
 There are a few other issues where standardisation is notoriously absent: 
scalability (hacks), authentication and asynchronous services. Services, which 
consume and produce little data and take less than a minute or two to execute, 
can be easily implemented using most popular SDKs. But when services require 
large amounts of data to be processed or generated most software development 
frameworks run into scalability problems. The reason is usually the use of DOM 
XML parsers: such parsers create a data structure in memory representing the XML 
tree, which mostly results in an expansion factor of at least 10. Hence a 100 MB 
XML document will easily blow up into a data structure that requires more than 
1000 MB of memory. To reduce the memory footprint developers can choose to 
use streaming SAX XML parsers instead, but working with a SAX parser is often 
much more complicated. Therefore developers have preferred to look for other 
alternatives to keep the memory footprint of web services within reasonable limits.
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 One alternative would be to use attachments: similar to e-mail attachments, 
one can create SOAP attachments. The advantage of SOAP attachments is that the 
main data in the message body and the supplemental data in the attachment are 
kept together: they are sent over the wire using the same transport protocol and 
in a single transaction. The disadvantage is that support for SOAP attachments in 
Perl is very problematic and that some firewalls block attachments over as little 
as 5MB in size. One of the key advantages of web services is to tunnel over HTTP 
allowing web services to by-pass the firewalls of paranoid system administrators 
that plagued older technology for distributed systems. Using SOAP attachments 
would kill this advantage or at least allow only a minor group of users to use web 
services that require or produce large datasets.
 Another alternative is to split the data and send it in separate transactions over 
the wire. Instead of sending a large job at once, jobs can sometimes easily be split 
into several chunks. The additional advantage of chunking is that a smart client can 
redo the job for a single chunk in case it failed, whereas without chunking the entire 
analysis would have to be re-run. In addition to chunking, data can also be split using 
“pass-by-reference”. This means that (part of) the data in the job’s message body 
is replaced with a reference. A web service or client can then use different tools/
libraries to fetch that large piece of data using the reference. The disadvantage 
of using references is that the two pieces of data are no longer kept together and 
services might be unable to resolve the reference if it uses a different transport 
protocol. For example a web service might be executed over HTTP with part of the 
input data replaced with an URL that requires the FTP protocol. If the service does 
not understand FTP it will not be able to complete the job. Once the large piece of 
data is fetched it still needs to be parsed of course, but using streaming SAX parsers 
is less problematic for the developer of a specific service as he knows exactly what 
parts of the data he needs and in which order. For developers of web service SDKs it 
is not possible to know what services will be build by others. Hence, it’s not possible 
for them to know what (parts of the) data the services will need and in which order, 
which explains their preference for parsers that process the entire incoming XML 
message into a memory structure, so that downstream methods for the “bio logic” 
can quickly access the data in whatever order they need. Most web services are 
tunnelled over HTTP, so if that works, fetching data from an HTTP reference should 
not be a problem.
 Therefore, although pass-by-reference is theoretically a less elegant solution, 
it is a pragmatic one that works well as long as service providers stick to HTTP 
references. All the services described in this thesis and which either consume or 
produce potentially large datasets use pass-by-reference. This includes most of the 
OligoRAP services and the MADMAX services. Clients should also use chunking with 
the OligoRAP pipeline to prevent overloading the servers. Using pass-by-reference 
with BioMoby was easily implemented by creation of an URL object. Using such 
an URL object is 100 % compatible with the current BioMoby specifications, but 
unfortunately defeats one of the key features of BioMoby: its ontologies. When 
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the actual data are replaced with a reference using an URL object, we can now 
automatically discover that two services are “compatible”, because one service 
produces a reference that another one can consume, but the fact that a service 
can consume a reference does not necessarily mean that it will also understand the 
data the reference points to. This problem can be partially solved by using tight 
namespace restriction for the references, but then it is still not possible to discover 
that a service, which consumes a relatively simple object, is compatible with a 
service, that produces a more complex object, which inherits from the simpler one. 
There are several other options for sending references with BioMoby or other web 
service frameworks. The problem is the lack of a proper standard. The Taverna 
developers did realise that the lack of scalability due to DOM XML parsing, was one 
of the most problematic issues with Taverna 1. Admittedly, Taverna was originally 
not designed to handle large data sets, but it is what a lot of their users tried 
to do anyway (using all sorts of hacks.) Therefore, instead of waiting for service 
developers to come up with a standard, they decided to implement extensive 
support for pass-by-reference as one of the key features for Taverna 2. The first 
public releases of Taverna 2 are already available, but it will take some time for all 
service providers to update existing services and take advantage of Taverna’s pass-
by-reference infrastructure.
 Asynchronous service execution is another issue due to a lack of standardisation 
and frequently co-occurs with scalability problems, because services that consume 
or produce lots of data tend to run longer. Synchronous services become problematic 
as soon as it takes them more than 5 minutes to process a job, because that is the 
default internet communication time-out for many servers and clients. Of course 
there can also be services that are CPU intensive without being IO intensive, but 
in transcriptomics with its high throughput experiments data sets tend to be 
large. The relatively simple solution for long running jobs is to use multiple fast 
synchronous calls, which together provide asynchronous behaviour. This usually 
means asynchronous services consist of three synchronous ones: a service to submit 
a job and receive a job ticket, a service to check job status given a certain job 
ticket and a service to retrieve the results once the job has finished. Asynchronous 
services need to store the results temporarily, while they wait for the client’s 
retrieve service call. Sometimes a fourth service is implemented that allows the 
client to actively delete the temporarily stored results, once they have retrieved 
them successfully. When jobs are processed using multiple synchronous service 
calls, this quickly results in a demand for authentication to make sure that the 
client who tries to retrieve certain results is the same as the one who submitted 
the corresponding job. Of course authentication can also be used to limit access to 
synchronous services, but in academia where the majority of services are developed 
to be freely available this is less common.
 Authentication can be implemented on different levels in the software: at the 
level of the transport protocol (for example in the configuration of an Apache web 
server), at the level of the communication protocol (for example in SOAP) or in the 
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web service. For BioMoby services several solutions have been suggested over the last 
years. SDK support for handling authentication in the transport or communication 
protocol layers is relatively mature and technically maybe more elegant, but making 
sure a user can discover how to use such authentication would require extensions 
to the current BioMoby specs and subsequent updating of existing clients, services 
and BioMoby Centrals. Implementing authentication inside BioMoby services on the 
other hand is extremely easy: one can simply create a BioMoby object to hold a 
user’s login and password. A service developer who wants to use authentication 
this way will have to add a little code to check the user’s credentials, but putting 
credentials in the web service payload does not require any modification of existing 
clients nor of BioMoby Central repositories. Therefore adding credentials to the web 
service payload is a pragmatic solution and that is why this approach was chosen for 
several of the services described in this thesis. Just like with other service inputs 
it would be better if BioMoby would standardise on the BioMoby objects to hold the 
credentials, to make it easier for clients to figure out how to use a service, but even 
without a standard BioMoby credentials object authentication in BioMoby is simple 
to implement and works well. 
The future of web services in Bioinformatics
Web services have come a long way over the past years, but the dream of a semantic 
web has yet to materialise. On the other hand the dream has fortunately not turned 
into a nightmare either. Web services elegantly deal with firewalls and provide 
more robust interfaces compared to older technology for distributed systems. 
With web services it is no longer necessary to maintain specialised software for 
many different environments. For synchronous services that do not require nor 
produce large amounts of data, like GeneIlluminator the current state of the 
art already works very well. For services that need to handle large amounts of 
data or that need to authenticate in order to run asynchronous jobs on a grid 
the current situation is sub-optimal, but with some simple workarounds complex 
workflows like OligoRAP can already be developed. In order to make the dream of 
a semantic web come true, additional advances will need to be made especially 
with regard to improved service discovery and automated QoS analysis, as well as 
in the development of better clients or workflow management systems. With the 
current workflow management systems, bioinformaticians will not be out of a job 
any time soon, but it would be desirable to reach a situation where biologists can 
use workflow management systems to analyse their data, so bioinformaticians can 
focus on development of new algorithms, on implementation of these algorithms in 
tools and on development of web service interfaces to make these tools available 
for the biologists.  
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Summary 
Transcriptomics
Transcriptomics is part of a family of disciplines focussing on high throughput 
molecular biology experiments. In the case of transcriptomics, scientists study the 
expression of genes resulting in transcripts. These transcripts can either perform 
a biological function themselves or function as messenger molecules containing 
a copy of the genetic code, which can be used by the ribosomes as templates to 
synthesise proteins. Over the past decade microarray technology has become the 
dominant technology for performing high throughput gene expression experiments.
 A microarray contains short sequences (oligos or probes), which are the reverse 
complement of fragments of the targets (transcripts or sequences derived thereof). 
When genes are expressed, their transcripts (or sequences derived thereof) can 
hybridise to these probes. Many thousand copies of a probe are immobilised in a 
small region on a support. These regions are called spots and a typical microarray 
contains thousands or sometimes even more than a million spots. When the 
transcripts (or sequences derived thereof) are fluorescently labelled and it is known 
which spots are located where on the support, a fluorescent signal in a certain 
region represents expression of a certain gene.
 For interpretation of microarray data it is essential to make sure the oligos are 
specific for their targets. Hence for proper probe design one needs to know all 
transcripts that may be expressed and how well they can hybridise with candidate 
oligos. Therefore oligo design requires:
 1.   A complete reference genome assembly.
 2.   Complete annotation of the genome to know which parts may be transcribed.
 3.   Insight in the amount of natural variation in the genomes of different 
individuals.
 4.   Knowledge on how experimental conditions influence the ability of probes to 
hybridise with certain transcripts.
Unfortunately such complete information does not exist, but many microarrays 
were designed based on incomplete data nevertheless. This can lead to a variety of 
problems including cross-hybridisation (non-specific binding), erroneously annotated 
and therefore misleading probes, missing probes and orphan probes.
 Fortunately the amount of information on genes and their transcripts increases 
rapidly. Therefore, it is possible to improve the reliability of microarray data analysis 
by regular updates of the probe annotation using updated databases for genomes 
and their annotation. Several tools have been developed for this purpose, but these 
either used simplistic annotation strategies or did not support our species and/
or microarray platforms of interest. Therefore, we developed OligoRAP (Oligo Re-
Annotation Pipeline), which is described in chapter 2. OligoRAP was designed to 
take advantage of amongst others annotation provided by Ensembl, which is the 
largest genome annotation effort in the world. Thereby OligoRAP supports most of 
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the major animal model organisms including farm animals like chicken and cow. In 
addition to support for our species and array platforms of interest OligoRAP employs 
a new annotation strategy combining information from genome and transcript 
databases in a non-redundant way to get the most complete annotation possible.
 In chapter 3 we compared annotation generated with 3 oligo annotation 
pipelines including OligoRAP and investigated the effect on functional analysis 
of a microarray experiment involving chickens infected with Eimeria bacteria. As 
an example of functional analysis we investigated if up- or downregulated genes 
were enriched for Terms from the Gene Ontology (GO). We discovered that small 
differences in annotation strategy could lead to alarmingly large differences in 
enriched GO terms.
 Therefore it is important to know, which annotation strategy works best, but 
it was not possible to assess this due to the lack of a good reference or benchmark 
dataset. There are a few limited studies investigating the hybridisation potential 
of imperfect alignments of oligos with potential targets, but in general such data 
is scarce. In addition it is difficult to compare these studies due to differences 
in experimental setup including different hybridisation temperatures and different 
probe lengths. As result we cannot determine exact thresholds for the alignments 
of oligos with non-targets to prevent cross-hybridisation, but from these different 
studies we can get an idea of the range for the thresholds that would be required 
for optimal target specificity. Note that in these studies experimental conditions 
were first optimised for an optimal signal to noise ratio for hybridisation of oligos 
with targets. Then these conditions were used to determine the thresholds for 
alignments of oligos with non-targets to prevent cross-hybridisation.
 Chapter 4 describes a parameter sweep using OligoRAP to explore hybridisation 
potential thresholds from a different perspective. Given the mouse genome 
thresholds were determined for the largest amount of gene specific probes. Using 
those thresholds we then determined thresholds for optimal signal to noise ratios. 
Unfortunately the annotation-based thresholds we found did not fall within the 
range of experimentally determined thresholds; in fact they were not even close. 
Hence what was experimentally determined to be optimal for the technology was 
not in sync with what was determined to be optimal for the mouse genome. Further 
research will be required to determine whether microarray technology can be 
modified in such a way that it is better suited for gene expression experiments. The 
requirement of a priori information on possible targets and the lack of sufficient 
knowledge on how experimental conditions influence hybridisation potential can be 
considered the Achiles’ heels of microarray technology. 
 Chapter 5 is a collection of 3 application notes describing other tools that can 
aid in analysis of transcriptomics data. Firstly, RShell, which is a plugin for the 
Taverna workbench allowing users to execute statistical computations remotely 
on R-servers. Secondly, MADMAX services, which provide quality control and 
normalisation of microarray data for AffyMetrix arrays. Finally, GeneIlluminator, 
which is a tool to disambiguate gene symbols allowing researchers to specifically 
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retrieve literature for their genes of interest even if the gene symbols for those 
genes had many synonyms and homonyms.
Web services
High throughput experiments like those performed in transcriptomics usually require 
subsequent analysis with many different tools to make biological sense of the data. 
Installing all these tools on a single, local computer and making them compatible so 
users can build analysis pipelines can be very cumbersome. Therefore distributed 
analysis strategies have been explored extensively over the past decades. In a 
distributed system providers offer remote access to tools and data via the Internet 
allowing users to create pipelines from modules from all over the globe.
 Chapter 1 provides an overview of the evolution of web services, which 
represent the latest breed in technology for creating distributed systems. The 
major advantage of web services over older technology is that web services are 
programming language independent, Internet communication protocol independent 
and operating system independent. Therefore web services are very flexible and 
most of them are firewall-proof. Web services play a major role in the remaining 
chapters of this thesis: OligoRAP is a workflow entirely made from web services and 
the tools described in chapter 5 all provide remote programmatic access via web 
service interfaces. Although web services can be used to build relatively complex 
workflows like OligoRAP, a lack of mainly de facto standards and of user-friendly 
clients has limited the use of web services to bioinformaticians. A semantic web 
where biologists can easily link web services into complex workflows does not yet 
exist, but several interesting developments may change this in the near future.
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Samenvatting
Transcriptomics
Transcriptomics is onderdeel van een familie van omics vakgebieden in de 
moleculaire biologie, waarbij met behulp van massief parallelle metingen in een 
enkel experiment grote hoeveelheden data verkregen kunnen worden. In het geval 
van transcriptomics gaat het om het meten van transcripten welke het gevolg 
zijn van de expressie van genen (het erfelijk materiaal). Het erfelijk materiaal is 
opgebouwd uit dubbelstrengs moleculen, maar bij het maken van transcripten wordt 
slechts één van beide strengen gekopieerd. De transcripten kunnen ofwel zelf een 
biologische functie vervullen of dienen als een kopie van de genetische code welke 
gebruikt kan worden als mal voor het synthetiseren van eiwitten in de ribosomen. In 
het afgelopen decennium is microarray technologie snel de dominante technologie 
geworden voor massief parallelle genexpressie experimenten.
 Een microarray is een drager welke korte sequenties bevat (oligo’s of probes), 
die een fragment zijn van de complementaire strengen van de transcripten (of 
daarvan afgeleide sequenties), welke targets worden genoemd. Hierdoor kunnen 
de targets aan de oligo’s binden waardoor opnieuw een dubbelstrengs molecuul 
ontstaat. Vele duizenden kopieën van dezelfde oligo kunnen worden vastgemaakt 
op een klein gebiedje van een dragermateriaal. Deze gebiedjes op de drager worden 
spots genoemd en er kunnen er vele duizenden van op de drager worden gezet. 
Als genen tot expressie komen kunnen de targets fluorescent gelabeld worden en 
als die dan binden aan de oligo’s in een bepaalde spot op de array, dan is een 
fluorescent signaal op die spot representatief voor de expressie van een bepaald 
gen.
 Voor een juiste interpretatie van microarray data is het van essentieel belang 
dat de oligo’s specifiek transcripten van één enkel gen binden. Om te kunnen 
bepalen of een oligo specifiek is heb je dus de sequenties van alle transcripten 
nodig en moet je kunnen bepalen hoe goed een bepaalde oligo die transcripten kan 
binden. Het ontwerpen van goede oligo’s vereist daarom de volgende informatie:
 1.   Het complete genoom (al het erfelijk materiaal) van een soort.
 2.   Complete annotatie voor het genoom om te weten welke delen potentieel 
tot expressie kunnen komen
 3.   Inzicht in de mate van natuurlijke variatie tussen de genomen van individuen 
van dezelfde soort.
 4.   Kennis van hoe experimentele omstandigheden de bindingsaffiniteit van een 
oligo met een target kunnen beïnvloeden.
Helaas beschikken we nog niet over zulke complete informatie, maar desondanks zijn 
vele microarrays ontworpen op basis van incomplete data. Dit kan tot verschillende 
problemen leiden, waaronder non-specifieke binding (cross-hybridisation), verkeerd 
geannoteerde en daarmee misleidende oligo’s, ontbrekende oligo’s en weesoligo’s.
 Gelukkig neemt onze kennis van genen en hun transcripten in rap tempo toe en 
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dat maakt het mogelijk om de betrouwbaarheid van microarray data te verbeteren 
door regelmatig de oligo’s opnieuw te annoteren en opnieuw hun specificiteit te 
bepalen. Daarvoor zijn verschillende programma’s ontwikkeld, maar die maken 
niet optimaal gebruik van alle beschikbare informatie en/of ondersteunen niet 
de microarrays en soorten, waarin wij geïnteresseerd waren. Daarom hebben we 
een nieuwe oligo annotatie pijplijn “OligoRAP” gemaakt zoals beschreven in het 
tweede hoofdstuk. OligoRAP maakt onder andere gebruik van Ensembl annotatie en 
ondersteund daarmee het merendeel van de belangrijke dierlijke modelorganismen 
inclusief landbouwhuisdieren zoals de kip en koe. Daarnaast gebruikt OligoRAP een 
nieuwe strategie, die op een non-redundante manier informatie van zowel genoom- 
als transcriptdatabases gebruikt voor een zo compleet mogelijk plaatje.
 In hoofdstuk 3 is annotatie van 3 oligo annotatie pijplijnen, waaronder OligoRAP, 
vergeleken en gekeken in hoe verre verschillen in annotatie effect kunnen hebben 
op de resultaten van de functionele analyse van microarray data. Als voorbeeld 
van functionele analyse is gekeken naar de verrijking van in- of uitgeschakelde 
genen voor termen uit de Gene Ontology (GO) in een experiment met kippen, die 
geïnfecteerd waren met Eimeria bacteriën. Daarbij viel op dat kleine verschillen 
in annotatie strategie kunnen leiden tot alarmerend grote verschillen in verreikte 
GO termen. Dat maakt dat het van groot belang is om te weten welke van de 
vergeleken annotatie strategieën de beste is, maar het is vooralsnog niet mogelijk 
om die vraag te beantwoorden bij gebrek aan een grote, betrouwbare referentie 
dataset. Er is slechts een beperkt aantal studies naar het effect van mismatches 
(verkeerde basencombinaties) tussen de sequenties van oligo’s en targets op hun 
bindingspotentiaal. Bovendien zijn de resultaten van deze studies moeilijk te 
vergelijken door de variatie in gebruikte experimentele omstandigheden zoals 
verschillen in temperatuur en in de lengte van de gebruikte oligo’s. Vandaar dat 
we niet de precieze drempelwaardes kennen voor de mate waarin transcripten 
van elkaar moeten verschillen om te voorkomen dat ze aan dezelfde oligo kunnen 
binden. Wel geven deze studies ons een idee van de intervallen die de precieze 
waardes voor specifieke binding zouden moeten bevatten.
 In hoofdstuk 4 is het probleem vanuit een ander perspectief benaderd. Gegeven 
het genoom van de muis en een muizen microarray is het aantal specifieke oligo’s 
bepaald voor een veelvoud aan combinaties van drempelwaardes voor de sequentie 
homologie tussen oligo’s en non-targets. Helaas komen de drempelwaardes voor 
optimale specificiteit gebaseerd op de annotatie niet in de buurt van de intervallen 
van experimenteel vast gestelde drempelwaardes welke optimaal zouden zijn 
voor de gebruikte techniek. We kunnen ons dus afvragen in hoeverre microarray 
technologie geschikt is voor experimenten, waarbij de expressie van een compleet 
genoom in één keer bestudeerd wordt. Een mogelijke verklaring voor de verschillen 
is adat de experimenteel bepaalde drempelwaardes primair geotimaliseerd zijn 
voor een hoge signaal/ruis verhouding terwijl onze drempelwaardes gebaseerd op 
de annotatie primair geoptimaliseerd zijn voor specificiteit van de oligo’s voor hun 
targets. Aanvullend onderzoek is nodig om te kijken of de voor microarrays gebruikte 
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chemie en experimentele condities aangepast kunnen worden, zodat microarrays 
beter geschikt zijn voor transcriptomics. Het feit dat a priori kennis van de te 
detecteren transcripten nodig is voor een gedegen microarray ontwerp alsmede 
het gebrek aan gschikte referentie datasets voor het testen van de specificiteit van 
oligo’s voor hun targets is een Achilleshiel van microarray technologie.
 Hoofdstuk 5 beschrijft drie andere programma’s voor het analyseren van 
transcriptomics data. Het eerste is RShell, een plugin voor het workflow management 
systeem Taverna, die gebruikers in staat stelt via het internet statistische 
berekeningen uit te voeren op R-servers. Het tweede artikel beschrijft MADMAX 
services, die gebruikt kunnen woren voor normalisatie en kwaliteitscontrole van 
AffyMetrix microarrays. GeneIlluminator tot slot is een programma om genen 
uit elkaar te houden indien de symbolen waarmee ze aangeduid worden niet 
gestandaardiseerd zijn en inconsequent gebruikt worden. Dit maakt het mogelijk 
om bijvoorbeeld specifiek artikelen, die betrekking hebben op een bepaald gen, op 
te zoeken zelfs als een gensymbool vele synoniemen en homoniemen heeft.
Web services
Massief parallelle transcriptomics experimenten maken het meestal noodzakelijk 
om grote hoeveelheden data met verschillende programma’s te analyseren om de 
onderliggende biologie te kunnen doorgronden. Het installeren en integreren van 
al deze programma’s op een lokale computer, zodat analyse pijplijnen gemaakt 
kunnen worden, kan lastig en kostbaar zijn. Vandaar dat in de afgelopen decennia 
uitgebeid geëxperimenteerd is met gedistribueerde systemen. Bij gedistribueerde 
systemen wordt programmatuur en data via het internet op afstand benaderd, 
zodat pijplijnen kunnen worden gebouwd met modules vanuit de hele wereld.
 Hoofdstuk 1 beschrijft een overzicht van de evolutie van web services, die gezien 
kunnen worden als de nieuwste loten aan een evolutionaire boom van technologie 
voor gedistribueerde systemen. De belangrijkste voordelen van web services 
ten opzichte van oudere technologie is dat ze computer platform onafhankelijk, 
programmeer taal onafhankelijk en netwerk protocol onafhankelijk zijn. Dit maakt 
web services uitermate flexibel en veelal ook firewall-bestendig. Web services 
spelen een belangrijke rol in alle andere hoofdstukken van dit proefschrift. OligoRAP 
is een pijplijn volledig opgebouwd uit web services en de applicaties beschreven 
in hoofdstuk 5 beschikken allemaal over een interface voor toegang op afstand via 
het internet. Hoewel relatief complexe pijplijnen zoals OligoRAP gemaakt kunnen 
worden met web services, is gebruik van web services veelal beperkt gebleven 
tot gebruik door bioinformatici voornamelijk als gevolg van een gebrek aan de 
facto standaarden en aan gebruiksvriendelijke programmatuur om web services te 
vinden en te koppelen tot pijplijnen. Een semantisch wereldwijd web waar biologen 
makkelijk complexe pijplijnen van web services kunnen maken bestaat nog niet, 
maar verschillende interessante ontwikkelingen kunnen daar in de nabije toekomst 
verandering in brengen.
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